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ABSTRACT 
 
Information transfer at neuronal synapses requires rapid fusion of docked synaptic vesicles in response to 
calcium influx during action potentials.  The molecular nature of the fusion clamp machinery that 
prevents exocytosis of synaptic vesicles in the absence of a calcium signal is still unclear.  Here we show 
that complexin, a small alpha-helical protein that binds fully assembled SNARE complexes, functions as 
the synaptic vesicle fusion clamp in vivo.  Drosophila has a single complexin homolog that is abundantly 
expressed in presynaptic nerve terminals.  Animals lacking complexin die throughout development, with 
adult escapers showing severe locomotion defects and a loss of visual function.  Electrophysiological 
analysis at neuromuscular junctions in complexin null mutants reveals a dramatic increase in spontaneous 
synaptic vesicle fusion that is independent of nerve stimulation or extracellular calcium.  High frequency 
stimulation at high calcium concentrations shows that the readily releasable pool in complexin mutants is 
severely depleted.  Thus, complexin is required for maintenance of the readily releasable pool of vesicles 
at the synapse, and without it vesicles exocytose directly after priming.  These data indicate that 
complexin interacts with assembled SNARE complexes to prevent premature vesicle fusion in the 
absence of calcium entry.  In addition, a preliminary analysis of synaptotagmin 1; complexin double 
mutants reveals that the elevated mini frequency in complexin single mutants is dependent on 
synaptotagmin 1.  This finding suggests that the dominant function of complexin at the synapse is to 
prevent synaptotagmin 1 from triggering fusion in the absence of calcium.  Further analysis of 
synaptotagmin 1; complexin double mutants may reveal new aspects of the mechanism of the calcium-
regulated vesicle fusion reaction. 
 
Minis have long been thought to represent background noise at the synapse, but there is now growing 
evidence that mini frequency is important in synaptic maintenance and plasticity.  Complexin mutants 
display a substantial synaptic overgrowth phenotype.  We hypothesized that the enhanced mini frequency 
in complexin mutants drives synaptic overgrowth and that complexin is phosphorylated by PKA to 
regulate mini frequency at Drosophila synapses in an activity-dependent retrograde signaling pathway 
that mediates a large increase in mini frequency and a concomitant induction of synaptic growth.  Like 
complexin mutants, a syntaxin mutant with elevated mini frequency also displays enhanced synaptic 
growth, providing further evidence that an increase in mini frequency drives synaptic plasticity.  S126 in 
complexin is phosphorylated by PKA in vitro.  Future results may reveal that S126 is phosphorylated by 
PKA in vivo to regulate mini frequency in an activity-dependent manner.  These results have the potential 
to reveal a new role for minis in local synaptic plasticity in response to neuronal activity. 
 
Advisor: J. Troy Littleton, Associate Professor of Biology 
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Synaptic Transmission 
The process of synaptic transmission is the basis for neuronal function and is regulated during 
several types of synaptic plasticity.  Proper function of the nervous system requires that synaptic 
transmission be a rapid and highly regulated process to produce specific neuronal connections 
and firing patterns.  Early work at the neuromuscular junction by Katz and colleagues to gain 
insight into mechanisms of synaptic transmission showed that action potentials arriving at nerve 
terminals trigger rapid calcium influx into the presynaptic compartment, promoting release of 
neurotransmitter into the synaptic cleft (Katz and Miledi 1967; Mulkey and Zucker 1991).  It was 
observed that release of neurotransmitter is quantal, i.e. it occurs in discrete, rather than graded, 
amounts (Fatt and Katz 1952).  This observation was explained by the discovery that quantal 
transmission occurs by fusion of synaptic vesicles with the presynaptic membrane, releasing 
neurotransmitters into the synaptic cleft that open ligand-gated ion channels in the postsynaptic 
membrane (Heuser, Reese et al. 1979).  The time period between an action potential reaching a 
nerve terminal and production of a postsynaptic potential is approximately 200 µsec (Llinas, 
Steinberg et al. 1981; Cope and Mendell 1982).  While there are still many questions about how 
such a rapid and tightly regulated process can occur, much has been learned over the past two 
decades about the formation, processing, and recycling of synaptic vesicles at the nerve terminal; 
the process of membrane fusion itself; and the molecular machinery required for calcium-
regulated vesicle fusion. 
The Synaptic Vesicle Cycle 
Synaptic vesicle exocytosis occurs at specialized electron-dense structures known as active 
zones, which are directly apposed to postsynaptic densities at the synaptic cleft.  Active zones 
contain the specialized molecular infrastructure for synaptic vesicle exocytosis, including 
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calcium channels, scaffolding proteins, synaptic vesicles, and vesicle fusion machinery.  Many 
synapses contain only one active zone, whereas other types of synapses contain many active 
zones.  Examples of this second category include the Calyx of Held in the mammalian auditory 
brainstem or neuromuscular junctions. At the active zone, synaptic vesicles cycle through a 
series of maturation steps as they are prepared for release, undergo exocytosis, and then are 
recycled for another round of fusion (Figure 1).  After being filled with neurotransmitter, 
synaptic vesicles are targeted to the presynaptic membrane at an active zone, where they dock 
and undergo priming, in which synaptic vesicles are made competent for fusion.  After priming, 
synaptic vesicles wait for calcium influx through nearby calcium channels, at which point fusion 
with the presynaptic membrane proceeds.  Synaptic vesicles are then recycled for another round 
of vesicle fusion (Sudhof 2004).  Each of these steps are governed by a set of proteins 
specialized for neurotransmitter release and membrane recycling.  For example, targeting and 
docking are known to involve Rab3, a GTP-binding protein, and RIMs, components of the active 
zone apparatus that act as Rab effectors at the synapse.  Munc18 and munc13 are both absolutely 
required for synaptic vesicle exocytosis and function in priming.  Complexins function in a post-
priming step in the last moments before fusion, and synaptotagmin 1 functions as a calcium 
sensor for neurotransmitter release (Sudhof 2008).  
Vesicle pools in synaptic transmission 
The available synaptic vesicles at a synapse are divided into separate pools based on the 
conditions under which they are released.  While the terminology for these pools varies from 
system to system, at least three distinct pools of vesicles exist at most synapses investigated 
(Rizzoli and Betz 2005).  During a single stimulation, or a series of low frequency stimulations, 
the vesicles that are released come from the Readily Releasable Pool (RRP), which is generally 
10 
 
thought to consist of those vesicles that are docked and primed for release (Schikorski and 
Stevens 2001).  During high frequency stimulation, the RRP is depleted within five to fifteen 
seconds (Schneggenburger, Meyer et al. 1999; Delgado, Maureira et al. 2000; Richards, 
Guatimosim et al. 2003). The RRP contains only a small percentage of the total number of 
vesicles at a synapse (Delgado, Maureira et al. 2000; Schikorski and Stevens 2001; Rizzoli and 
Betz 2004).  During moderate frequency stimulation, vesicles are continuously released from and 
rapidly recycled into the Recycling Pool (Harata, Ryan et al. 2001; Kuromi and Kidokoro 2003; 
Richards, Guatimosim et al. 2003), which contains about 10 to 20% of the total vesicles at a 
synapse (Delgado, Maureira et al. 2000; Harata, Ryan et al. 2001).  During high frequency 
stimulation, the rate of endocytosis and recycling is limiting, and the terminal must therefore 
mobilize vesicles from the Reserve Pool (RP) to maintain release from the synapse (Heuser and 
Reese 1973; Kuromi and Kidokoro 2000).  The reserve pool is only mobilized at a synapse once 
the other pools have been depleted and contains 80 to 90% of the total vesicle population at a 
synapse (Kuromi and Kidokoro 1998; Richards, Guatimosim et al. 2000; Richards, Guatimosim 
et al. 2003). The RRP and the recycling pool recycle quickly and directly from the plasma 
membrane, whereas the Reserve Pool recycles more slowly and may rely on endocytic 
intermediates such as endosomes (Heuser and Reese 1973; Richards, Guatimosim et al. 2000; 
Richards, Guatimosim et al. 2003; Rizzoli and Betz 2004).  While the RRP by necessity must be 
localized near active zones and the plasma membrane, the recycling pool and the reserve pool are 
not spatially segregated at synapses and one cannot distinguish the pools visually by EM (Harata, 
Ryan et al. 2001; de Lange, de Roos et al. 2003; Rizzoli and Betz 2004), although in Drosophila 
neuromuscular junction boutons the reserve pool tends to cluster near the periphery (Kuromi and 
Kidokoro 1998). 
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Regulation of mini frequency at synapses 
Two modes of release exist at synapses: evoked release, in which synaptic vesicles exocytose in 
response to an action potential arriving at the nerve terminal, and spontaneous release, in which 
individual synaptic vesicles fuse with the presynaptic membrane in the absence of an action 
potential.  These spontaneous release events produce miniature postsynaptic potentials, or minis.  
Evoked responses are well known to be modulated during synaptic plasticity events, as in the 
case of LTP or LTD.  In contrast, minis are generally thought to represent background noise in a 
synapse.  There is a growing range of evidence, however, that spontaneous release frequency is 
modulated at synapses during synaptic development and plasticity, adding a new layer of 
regulation of synaptic activity. 
 When minis were first described in detail by Fatt and Katz at the frog neuromuscular 
junction, it was noted that frequency of minis at a given NMJ can vary over 1000-fold, while 
average mini amplitude remains fairly constant (Fatt and Katz 1952) (Figure 2).  Mini frequency 
was shown to be highly sensitive to changes in temperature and osmolarity of the bath.  For 
example, exposure of the preparation to a 50% sucrose solution increased mini frequency 45-
fold.  Some evidence suggests that this potential for variation in mini frequency is utilized by the 
nervous system.  Mini frequency can be enhanced by at least 50-fold by natural products such as 
forskolin and nicotine in the nerve terminal, as well as by intracellular pathways that increase the 
concentration of cyclic AMP (Dryden, Singh et al. 1988; Yoshihara, Suzuki et al. 2000), 
indicating that second messenger cascades can regulate mini frequency.   
This regulation is known to be involved in activity-dependent synaptic plasticity at the 
Drosophila neuromuscular junction (Yoshihara, Adolfsen et al. 2005).  At embryonic 
neuromuscular junctions, postsynaptic calcium influx due to high frequency stimulation induces 
a retrograde signaling mechanism to activate a PKA-dependent increase in cyclic AMP 
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concentration that enhances mini frequency about 100-fold over a time period of several minutes.  
This enhancement in mini frequency requires release of postsynaptic vesicles by synaptotagmin 
4, which serves as a calcium sensor in this pathway.  Synaptic growth is also stimulated in a 
synapse-specific manner by the action of synaptotagmin 4.  Enhancement in mini frequency 
might therefore be used as a synaptic tag to specifically enhance growth at active synapses.   
The Drosophila neuromuscular junction is not the only system in which minis have been 
observed to modulate synaptic function.  Minis have been shown to be intimately involved in 
synaptic maintenance of dendritic spines in the mammalian central nervous system.  Dendritic 
spines are the sites of synaptic input for many types of neurons in the CNS, and dendritic spine 
density must therefore be maintained in order to receive input from a large number of neurons.  
Dendritic spine density in pyramidal cells of the CA1 hippocampus layer is highly dependent on 
minis but not on evoked release (McKinney, Capogna et al. 1999).  While blocking action 
potentials in acute hippocampal slices by application of tetrodotoxin had no effect on dendritic 
spine density, application of botulinum neurotoxin, which blocks all synaptic transmission, 
reduced dendritic spine density to about 25% of the density found in untreated neurons.  This 
effect was rescued by external application of AMPA, demonstrating that loss of spontaneous 
neurotransmitter release leads to a large decrease in dendritic spine density in neurons of the 
hippocampus. 
In addition to dendritic spine density, protein synthesis in dendritic spines is also highly 
regulated by minis (Sutton, Wall et al. 2004).  In hippocampal cultures, inhibition of action 
potentials by tetrodotoxin had no effect on protein synthesis in dendrites, whereas inhibition of 
all synaptic transmission produced a large, rapid increase in protein synthesis.  Enhancing mini 
frequency with α-latrotoxin produces a rapid, acute decrease in protein synthesis in dendritic 
13 
 
spines.  Minis therefore strongly regulate postsynaptic translation in a frequency-dependent 
manner.  The products of protein synthesis contribute to structural plasticity (Casadio, Martin et 
al. 1999; Johnson and Ouimet 2004), so regulation of dendritic protein synthesis by mini 
frequency may provide a mechanism for tight regulation, and rapid recruitment, of plasticity at 
least in the hippocampus and possibly in other areas of the brain. 
In another example of the importance of mini frequency in modulating synaptic function, 
bursts of enhanced mini frequency lasting several minutes caused by application of nicotine to 
hippocampal slices produced concomitant bursts of firing in postsynaptic pyramidal neurons 
(Sharma and Vijayaraghavan 2003).  This effect is due to the small but significant increase in 
membrane potential that a large increase in mini frequency produces.  Thus, firing patterns of 
neurons in the hippocampus could be regulated in part by regulation of mini frequency.   
While the dataset supporting the importance of minis in a wide range of neuronal 
processes is so far small, it is clear that minis are not simply noise.  Their modulation can be 
used as a tool to mark synapses for growth, to maintain synaptic connections, to regulate 
postsynaptic translation, and to modulate neuronal firing patterns.  It is probable that future work 
will reveal further functions for minis in neurobiological systems, providing a new avenue of 
regulation of synaptic function and plasticity at synapses. 
Membrane Fusion 
Synaptic vesicle exocytosis involves the fusion of two lipid bilayers, one in the synaptic vesicle 
and one in the presynaptic membrane.  Membrane fusion is not unique to synaptic vesicle fusion, 
but is instead a common process central to many cellular functions, including vesicle trafficking 
both among organelles and from the Golgi apparatus to the cell surface.  All membrane fusion 
events involve the joining of two separate lipid bilayers into one continuous bilayer.  Because the 
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negatively-charged phospholipid head groups of the bilayer must come into close proximity 
during fusion, and because the hydrophobic core of the membrane must be bent out of its natural 
shape and come into contact to some degree with water, membrane fusion is an energetically 
expensive process.  While the precise molecular events of membrane fusion have not been 
conclusively defined, one popular model of membrane fusion is the stalk hypothesis (Jahn, Lang 
et al. 2003) (Figure 3).  In this model, two membranes come into close proximity with each 
other and the two outer layers fuse while the inner layers remain distinct, forming a stalk where 
contact is initiated.  Following stalk formation, stalk expansion may occur, allowing the two 
inner layers to form a bilayer and producing a hemifused intermediate.  Finally, fusion pore 
opening is initiated from this intermediate by fusion of the two inner layers, the two aqueous 
compartments can mix freely, and membrane fusion may proceed to completion.  Both protein-
free bilayers (Chanturiya, Chernomordik et al. 1997; Lee and Lentz 1997; Yang and Huang 
2002) and bilayers containing SNARE fusion proteins (Xu, Zhang et al. 2005; Yoon, Okumus et 
al. 2006) have been shown in in vitro assay systems to proceed through this hemifusion 
intermediate, adding weight to its biological relevance. 
Molecular Mechanisms of Intracellular Membrane Fusion 
Synaptic vesicle fusion is one example of the many types of intracellular membrane fusion 
events.  Other well-characterized examples include vacuole fusion and trafficking between 
cisternae in the Golgi apparatus.  Synaptic vesicle fusion is highly specialized in several aspects 
(Figure 4).  It occurs very rapidly, proceeding to completion in less than a millisecond (Llinas, 
Steinberg et al. 1981; Cope and Mendell 1982; Sabatini and Regehr 1998), versus seconds to 
minutes for other trafficking events (Kjeken, Egeberg et al. 2004). It is highly restricted in space 
to active zones, which typically have an area on the order of 1 µm
2 
(Pierce and Lewin 1994), 
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whereas other fusion events are typically much less restricted.  Fusion of synaptic vesicles is 
elicited by calcium, whereas other types of fusion events are not regulated by calcium.  Finally, 
synaptic vesicles must wait at the plasma membrane for calcium influx to occur and then fuse in 
a synchronous manner whereas constitutive intracellular vesicles fusion occurs as soon as 
vesicles reach their target membranes.   
While synaptic vesicle exoctyosis is the best characterized example of calcium evoked 
vesicle fusion, calcium-regulated fusion occurs in several other cases where vesicle fusion must 
be exquisitely controlled.  During fertilization, sperm meeting an egg release an acrosomal 
granule vesicle located in the head of the sperm that contains enzymes that assist in penetrating 
the zona pellucida to reach the egg membrane.  Acrosomal exocytosis is regulated by 
extracellular calcium influx as well as release of calcium from the acrosome itself (Darszon, 
Beltran et al. 2001; De Blas, Michaut et al. 2002).  Like acrosomal exocytosis, mast cell 
activation in the immune system in response to antigen binding releases a vesicular granule in 
response to extracellular calcium influx and release of intracellular calcium stores (Kim, 
Eddlestone et al. 1997).  Finally, insulin is released from pancreatic beta cells following a rise in 
intracellular calcium concentration triggered by increased glucose in the blood (Ashcroft, Proks 
et al. 1994).  Besides these examples and synaptic vesicle fusion, other types of vesicular fusion 
events are not regulated by calcium and occur on a constitutive basis.   
How are the specialized properties of synaptic vesicle exocytosis achieved?  One 
hypothesis is that there are distinct molecular mechanisms of fusion between constitutive 
intracellular vesicle fusion and calcium-regulated vesicle fusion.  An alternative hypothesis is 
that they occur by similar molecular mechanisms but that calcium-regulated fusion is modulated 
by neuronal proteins that confer the specialized properties seen in synaptic vesicle fusion.  A 
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large body of evidence has demonstrated that a set of evolutionarily conserved proteins function 
in both constitutive and calcium-regulated fusion, and that neuronal-specific proteins confer 
calcium sensitivity to synaptic vesicle exocytosis, arguing for the second hypothesis. 
The SNARE complex 
The neuronal SNARE proteins, syntaxin, SNAP-25, and synaptobrevin, are present 
presynaptically either in synaptic vesicles (synaptobrevin) or in the plasma membrane (syntaxin 
and SNAP-25) and play a central role in synaptic transmission (Trimble, Cowan et al. 1988; 
Baumert, Maycox et al. 1989; Bennett, Calakos et al. 1992).  The SNAREs were demonstrated to 
be necessary for synaptic vesicle fusion by a series of studies showing the three proteins to be the 
targets of cleavage by the botulinum and tetanus neurotoxins, peptidases that block 
neurotransmitter release (Schiavo, Benfenati et al. 1992; Blasi, Chapman et al. 1993; Blasi, 
Chapman et al. 1993).  In a parallel set of experiments, NSF (N-ethylmaleimide-sensitive factor) 
was identified as a cytosolic protein necessary in yeast and mammals for all steps of intracellular 
vesicle trafficking (Novick, Field et al. 1980; Eakle, Bernstein et al. 1988; Wilson, Wilcox et al. 
1989; Schekman and Novick 2004).  Importantly, the three proteins that are targeted by 
botulinum and tetanus neurotoxins, syntaxin, SNAP-25, and synaptobrevin, and are thus integral 
to synaptic vesicle fusion, were found to form a complex that is the receptor for NSF and its 
binding adaptor protein alpha-SNAP (Soluble NSF Adaptor Protein), both of which are 
universally involved in vesicle trafficking (Sollner, Whiteheart et al. 1993).  This finding 
strongly suggested that synaptic vesicle exocytosis occurs by a molecular mechanism common to 
other types of vesicle fusion events.  Consistent with this idea, syntaxin, SNAP-25, and 
synaptobrevin have homologs in yeast that are necessary for membrane trafficking between 
intracellular compartments (Bennett and Scheller 1993).  Because they bind to alpha-SNAP, 
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syntaxin, SNAP-25, synaptobrevin, and the larger family of homologs involved in vesicle 
trafficking are called SNAREs, soluble N-ethylmaleimide-sensitive factor attachment protein 
receptors.  The SNAREs constitute a superfamily of proteins with members in all eukaryotes, 
including 25 members in S. cerevisiae, 36 members in humans, and 54 members in Arabidopsis 
thaliana (Jahn and Scheller 2006). 
 The SNAREs have been shown to be sufficient to drive fusion of membranes in in vitro 
liposome fusion assays (Weber, Zemelman et al. 1998), and this in combination with the clear 
necessity of the neuronal SNAREs for neurotransmitter release has led to general agreement that 
they represent the core machinery that drives fusion of membranes.  The domain structures of the 
neuronal SNAREs and the crystal structure of the assembled SNARE complex are shown in 
Figure 5.  All SNAREs contain at least one SNARE motif, a series of 60-70 amino acids 
arranged in heptad repeats.  Syntaxin and synaptobrevin each have one SNARE motif and one 
transmembrane domain, while SNAP-25 has two SNARE motifs separated by a flexible linker 
that is palmitoylated to tether the protein to the plasma membrane.   
In addition to a transmembrane domain and a SNARE motif, syntaxin has an N-terminal 
domain, termed the HABC domain, attached to the rest of the protein by a flexible linker 
(Margittai, Fasshauer et al. 2003).  This N-terminal domain contains an anti-parallel three-helix 
bundle that can bind intramolecularly with the syntaxin SNARE motif in the syntaxin “closed 
conformation” (Fernandez, Ubach et al. 1998; Lerman, Robblee et al. 2000; Misura, Scheller et 
al. 2000; Bracher and Weissenhorn 2004).  The closed conformation of syntaxin is incompatible 
with binding to the other SNAREs and may be stabilized by the neuronal protein 
nSec1/Rop/munc18 (Pevsner, Hsu et al. 1994; Yang, Steegmaier et al. 2000).  It is also possible 
that binding of munc18 to syntaxin is promoted by the closed conformation.  Regulation of the 
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closed and open states of syntaxin appears to be a key point of regulation of docking or priming 
possibly mediated by munc18 and munc13 (Misura, Gonzalez et al. 2001; Richmond, Weimer et 
al. 2001; Varoqueaux, Sigler et al. 2002).   
The crystal structure of the assembled SNARE complex (Sutton, Fasshauer et al. 1998) 
shows that the SNAREs bind via coiled-coil interactions of four parallel alpha-helices, two 
contributed by SNAP-25 and one each contributed by syntaxin and synaptobrevin.  While the 
SNARE motifs of the individual SNAREs are not well structured, binding with the other 
SNAREs to form a ternary complex drives spontaneous formation of the alpha-helices, releasing 
free energy.  The ternary SNARE complex is remarkably stable, resisting denaturation by 
sodium dodecyl sulfate (SDS), and impervious to cleavage by the botulinum and tetanus 
neurotoxins (Hayashi, McMahon et al. 1994).  The ternary SNARE complex is unwound in an 
ATP-dependent mechanism by NSF, a reaction that requires alpha-SNAP for binding of NSF to 
the SNARE complex (Sollner, Bennett et al. 1993; Hayashi, Yamasaki et al. 1995).   
 Originally, synaptobrevin and its homologs in other trafficking vesicles were called v-
SNAREs, and syntaxin, SNAP-25, and their homologs in target membranes were called t-
SNAREs.  It was thought that v-SNAREs in the vesicle and t-SNAREs in the target membrane 
bind, driving fusion.  This is a convenient and easily conceptualized model.  However, it is 
somewhat inaccurate because it does not account for homotypic fusion of two similar 
membranes, two vesicles for example, and because many membranes contain both v- and t-
SNAREs.  A more relevant classification scheme for SNAREs was developed based on an 
analysis of the structure of the neuronal SNARE complex and conservation of residues within 
that structure (Fasshauer, Sutton et al. 1998).  Within the four-helix bundle, conserved residues 
contributed by each of the helices meet in a series of 16 layers to make a hydrophobic core of the 
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complex.  However, the center layer, or 0 layer, contains four charged residues buried within this 
hydrophobic core, one glutamine from syntaxin, two glutamines from the two helices of SNAP-
25 and one arginine from synaptobrevin (Sutton, Fasshauer et al. 1998).  This arrangement of 
charged residues is conserved among all known SNARE complexes and it is therefore thought 
that functional SNARE complexes always have three glutamines and one arginine at the zero 
layer, each contributed by one SNARE motif.  Thus, the members of the SNARE superfamily 
have been classified into R-SNAREs and Q-SNAREs.  The 3Q:1R rule has been tested in a 
variety of experimental conditions using site-directed mutagenesis (Katz and Brennwald 2000; 
Ossig, Schmitt et al. 2000; Graf, Riedel et al. 2005) and has largely been verified by these 
studies.  In the neuronal SNARE complex, synaptobrevin is the R-SNARE and syntaxin and 
SNAP-25 are Q-SNAREs (Fasshauer, Sutton et al. 1998).   
The zipper model of membrane fusion driven by SNAREs 
How do the SNAREs drive membrane fusion? While there is still much to be learned about this 
process, many details have emerged.  The “zipper” model of membrane fusion driven by 
SNAREs holds that SNARE binding begins in trans, i.e. with SNAREs on opposing membranes 
binding at their N termini.  More specifically, an acceptor complex consisting of syntaxin bound 
to SNAP-25 in a 1:1 stoichiometry is formed in the acceptor membrane.  This complex is 
partially helical and its formation is rate-limiting for fusion (Fiebig, Rice et al. 1999; Fasshauer 
and Margittai 2004).  During priming, synaptobrevin binds to the N termini of the acceptor 
complex SNARE motifs with its N terminus.  Binding then proceeds like a zipper from the N 
termini of the helices to the C termini, with the unstructured SNARE domains spontaneously 
folding into alpha helices as binding proceeds and the stable four-helix structure forms.  It is this 
spontaneous folding that provides the energy to overcome the energy barrier for lipid fusion.  As 
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the binding reaction proceeds to the C termini of the SNARE complex, the transmembrane 
domains of the SNAREs, still in separate membranes, are drawn together, pulling the membranes 
with them until they join.  Once this happens, the SNARE complex is in its cis formation, with 
the SNAREs in the same membrane.  Finally, alpha-SNAP and NSF bind the cis-SNARE 
complexes and unwind them to free the individual SNAREs for another round of binding and 
fusion. 
 Several lines of evidence support the zipper model of SNARE complex function in 
vesicle fusion.  The ternary SNARE complex has its alpha helices arranged in a parallel manner 
(Sutton, Fasshauer et al. 1998), as is required for zippering from the N to C terminus of the 
SNARE complex.  The formation of the SNARE complex is associated with large structural 
changes in the individual SNAREs from disordered to highly alpha helical in both the neuronal 
SNARE complex and a distantly related yeast SNARE complex, and these structural changes are 
associated with a large release in energy as measured by thermal stability (Fasshauer, Otto et al. 
1997; Rice, Brennwald et al. 1997).  HSQC NMR spectra of individual yeast SNAREs and the 
assembled SNARE complex reveal that the N termini of the monomeric SNAREs are structured 
and alpha helical whereas the C termini are unstructured, while the structure of the assembled 
SNAREs is almost entirely ordered as a set of alpha helices (Fiebig, Rice et al. 1999).  This 
suggests that binding of the SNARE complex is likely to start at the N termini and proceed to the 
C termini, which are closest to the vesicles.  Indeed, recent in vitro analysis of synaptobrevin 
binding to syntaxin-SNAP-25 acceptor complexes in the presence of N and C terminal 
truncations of synaptobrevin demonstrated that it is critical for the N termini of the acceptor 
complex to be available for binding to take place whereas the availability of the C termini is not 
critical (Pobbati, Stein et al. 2006).  Additionally, destabilization of the hydrophobic interactions 
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in the C-terminal SNARE motifs by mutation of key residues in SNAP-25 selectively prevents 
synaptic vesicle exocytosis rather than priming.  A similar mutational approach in the N terminus 
or in the middle of the SNARE motifs prevents priming (Sorensen, Wiederhold et al. 2006).  
Finally, it is clear that the stiffness and length of the linker region between the SNARE motifs 
and the transmembrane domains of syntaxin and synaptobrevin are critical for vesicle fusion to 
proceed.  With increasing length of this linker region efficiency of fusion decreases (McNew, 
Weber et al. 1999; Wang, Dulubova et al. 2001), consistent with the idea that the zippering of the 
SNAREs and drawing together of their transmembrane domains exerts mechanical force on the 
two membranes to drive fusion.  This idea is supported by the finding that the transmembrane 
domains of syntaxin and synaptobrevin are both necessary for SNARE function in driving fusion 
(McNew, Weber et al. 2000).  Atomic Force Microscopy experiments on fusing liposomes 
containing SNARE complexes provide evidence that the transmembrane domains of the 
SNAREs increase tension at the fusion site of two membranes, making deformation of the 
membranes easier and decreasing the energy barrier to fusion (Abdulreda, Bhalla et al. 2008). 
 Some debate exists as to whether SNARE complex assembly and membrane fusion 
occurs in one zippering reaction or if there are intermediates in the reaction.  Evidence is 
mounting that SNARE-driven membrane fusion occurs through a hemifusion intermediate and 
that the zippering reaction of SNARE binding occurs in a two-step process in which the N 
termini form a stable complex followed by formation of the C terminal complex, which is less 
stable.  Evidence for the hemifusion intermediate is based on variety of approaches for observing 
fusion in liposome fusion assays.  Monitoring of total lipid mixing and inner leaflet mixing in a 
fusion assay showed that hemifusion dominated at the beginning of the reaction whereas 
complete fusion proceeded more slowly (Lu, Zhang et al. 2005; Xu, Zhang et al. 2005), arguing 
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for a sequential mechanism from hemifusion to full fusion.  Observations of individual 
liposomes fusing using Total Internal Reflection (TIRF) Microscopy clearly demonstrated 
hemifusion intermediates during fusion events (Yoon, Okumus et al. 2006).  Finally, 
measurement of forces contributing to fusing liposomes containing SNAREs indicated two 
different stages of fusion, first hemifusion, then proceeding to full fusion (Abdulreda, Bhalla et 
al. 2008).  It has been suggested that the N and C termini of the SNARE complex might bind in 
separate stages during zippering.  Indeed, the two sections show different thermal stabilities upon 
binding of synaptobrevin (Pobbati, Stein et al. 2006).  It is possible therefore that SNARE 
complex formation can be halted at an intermediate stage during zippering.  The authors suggest 
that this might occur at a point where the force generated by SNARE assembly balances with the 
repulsive force of fusing lipid membranes.  Additional force then might be applied after calcium 
influx to allow full SNARE assembly and full fusion (Pobbati, Stein et al. 2006). 
Summary: Sequence of events in SNARE-driven fusion 
Based on the sum of this data, a picture of synaptic vesicle fusion is emerging that proceeds in a 
step-wise manner.  First, an acceptor complex of bound SNAP-25 and syntaxin on the plasma 
membrane awaits binding by synaptobrevin.  At this point, the N termini of the SNARE motifs 
are alpha helical whereas the C termini close to the transmembrane domain of syntaxin are 
disordered.  During priming, the N terminus of synaptobrevin binds the N terminus of the 
acceptor complex and zippering partially proceeds, forming fusion-competent vesicles 
maintained in a hemifused state with the outer leaflets fused but the inner leaflets remaining 
separate and the SNARE complex in a trans formation.  Finally, upon influx of calcium 
following an action potential full fusion proceeds as zippering is completed and the 
transmembrane domains of the SNARE complex are drawn together, creating tension in the 
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fusing membranes and pulling the reaction from hemifusion to full fusion with opening of a 
fusion pore.  Presumably additional proteins present at the nerve terminal mediate some of these 
steps.  For example, it is known that synaptotagmin 1 is the calcium sensor for neurotransmitter 
release that triggers synchronous fusion of synaptic vesicles after an action potential.  Details of 
this reaction are discussed below. 
Regulators of Synaptic Vesicle Exocytosis 
While the neuronal SNAREs are sufficient to drive fusion, it is clear that additional regulators 
are present that confer the specialized properties of neurotransmitter release.  Synaptic vesicle 
exocytosis is rapidly triggered by calcium influx, so a calcium sensor must be present that binds 
calcium and triggers fusion.  Additionally, synaptic vesicle exocytosis is distinct from 
constitutive fusion because synaptic vesicles must wait in a primed, fusion competent state for 
calcium influx to occur, whereas in constitutive exocytosis vesicles fuse as soon as they are 
competent to do so.  Because calcium-regulated fusion and constitutive fusion occur via a 
common SNARE-driven mechanism, calcium-regulated exocytosis is thought to require a fusion 
clamp.  A fusion clamp would prevent release prior to calcium influx and allow release after 
calcium influx, acting to synchronize and speed the fusion process (Bennett and Scheller 1993; 
Popov and Poo 1993; Sollner, Whiteheart et al. 1993).   
Given that the SNAREs drive exocytosis, it is highly probable that any regulators of the 
late stages of neurotransmitter release, such as a calcium sensor or a fusion clamp, would 
impinge on the SNARE complex.  While there are many different proteins present at nerve 
terminals, only a small subset bind assembled or partially assembled neuronal SNARE 
complexes.  The functions of these proteins give us insight into the final sequence of synaptic 
vesicle exocytosis, its regulation by calcium, and the ways that accessory proteins have been 
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used to confer the special properties of neurotransmitter release.  Two proteins that are critical 
for triggering of exocytosis by calcium are synaptotagmin, a calcium sensor for synchronous 
neurotransmitter release, and complexin, a neuronally expressed protein that binds the SNARE 
complex whose function is less well defined. 
Synaptotagmin 1 
The dependence of quantal release on calcium is highly cooperative with a Hill coefficient of 
nearly four (Dodge and Rahamimoff 1967).  For this reason, it was proposed that a calcium 
sensor exists at the nerve terminal that binds calcium and triggers release with a similar 
cooperativity.  Synaptotagmin 1 is one of the best-characterized SNARE-interacting proteins in 
the nerve terminal and is widely acknowledged to be the calcium sensor for neurotransmitter 
release.  It binds calcium at the elevated calcium concentrations of at least 20 µM found at active 
zones during calcium influx and synaptic vesicle exocytosis (Brose, Petrenko et al. 1992; Llinas, 
Sugimori et al. 1992; Heidelberger, Heinemann et al. 1994).  It is localized to synaptic vesicles at 
active zones, it can bind up to 5 calcium ions, and it exhibits calcium-dependent phospholipid 
binding with a Hill coefficient of two to three (Davletov and Sudhof 1993).  Therefore, it 
possesses the properties necessary for a synchronous calcium sensor. 
Synaptotagmin 1 is a 65-kDa protein that is part of a large family of proteins with 17 
isoforms in humans and 7 isoforms in flies (Adolfsen, Saraswati et al. 2004; Craxton 2007).  It 
consists of a short intralumenal domain, a transmembrane domain, and two calcium-binding C2 
domains, C2A and C2B, connected by a flexible linker (Matthew, Tsavaler et al. 1981; Perin, 
Fried et al. 1990).  C2 domains are approximately 130-amino-acid beta sandwich structures with 
three flexible loops extending from one end, and are found in many proteins where they 
frequently serve to coordinate calcium binding and lipid binding (Nalefski, Wisner et al. 2001).  
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The C2 domains in synaptotagmin have been shown to bind calcium when synaptotagmin is in a 
lipid environment (Brose, Petrenko et al. 1992).  Furthermore, the C2 domains of synaptotagmin 
bind lipid membranes in a calcium-dependent manner (Perin, Fried et al. 1990; Brose, Petrenko 
et al. 1992; Davletov and Sudhof 1993; Chapman and Jahn 1994; Fernandez, Arac et al. 2001) 
by inserting their flexible loops into lipid bilayers once calcium binding has occurred (Brose, 
Petrenko et al. 1992; Davletov and Sudhof 1993; Davis, Bai et al. 1999).  This reaction proceeds 
within the millisecond time frame required for triggering of synaptic vesicle exocytosis (Davis, 
Bai et al. 1999).  The two C2 domains are partially redundant for calcium-dependent lipid 
binding function (Earles, Bai et al. 2001) and cooperate with each other to induce lipid 
penetration in response to calcium binding (Bai, Wang et al. 2002).  Recent evidence suggests 
that calcium binding by the C2B domain induces C2B binding to two membranes via basic 
residues on the surface of the domain, bringing the membranes into close proximity and possibly 
aiding the SNAREs in bringing the vesicle into close proximity with the plasma membrane 
(Arac, Chen et al. 2006).     
Synaptotagmin interacts with individual SNAREs and the SNARE complex in a calcium-
dependent manner (Li, Ullrich et al. 1995; Davis, Bai et al. 1999; Gerona, Larsen et al. 2000).  
Both C2 domains are required for synaptotagmin binding to t-SNAREs and the assembled 
SNARE complex (Davis, Bai et al. 1999; Gerona, Larsen et al. 2000).  This binding reaction is 
necessary for calcium-evoked fusion (Gerona, Larsen et al. 2000), but it is unclear what role 
calcium-dependent binding of synaptotagmin to the SNARE complex might play.   
Biochemical evidence indicates that synaptotagmin has many of the properties expected 
of a calcium sensor for synaptic vesicle exocytosis, including calcium binding in the range of 
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calcium concentrations found at active zones and calcium-dependent conformational changes 
such as binding of lipids and binding of the SNARE complex.   
Synaptotagmin is necessary for fast, synchronous neurotransmitter release in vivo 
In addition to biochemical evidence, there is also substantial genetic evidence for 
synaptotagmin’s role as a calcium sensor in neurotransmitter release.  Synaptotagmin knockouts 
in mice (Geppert, Goda et al. 1994) and in flies (Littleton, Stern et al. 1993; DiAntonio and 
Schwarz 1994; Littleton, Stern et al. 1994) both show a severe decrease in synchronous fusion, 
indicating synaptotagmin’s importance in fast exocytosis in response to calcium influx.  
Synaptotagmin 1 null mutants in Drosophila also display an asynchronous phase of vesicle 
fusion that is suppressed in wild type animals (Yoshihara and Littleton 2002). This asynchronous 
phase of release has been observed in other systems (Goda and Stevens 1994) and shows fourth-
order cooperativity with respect to calcium concentration just as synchronous fusion does, 
suggesting the presence of a second calcium sensor with low calcium affinity responsible for 
slow, asynchronous fusion.  Synaptotagmin mutants in Drosophila that are missing the C2B 
domain but have a fully functional C2A domain show both synchronous and asynchronous 
phases of release, albeit with a lower cooperativity of release in the synchronous phase.  This 
demonstrates that asynchronous and synchronous release can be genetically separated and further 
argues for a separate asynchronous calcium sensor whose function is suppressed by 
synaptotagmin 1 (Yoshihara and Littleton 2002).  Most importantly for the hypothesis that 
synaptotagmin 1 functions as a calcium sensor in neurotransmitter release, when the degree of 
dependence of lipid binding by synaptotagmin on calcium is changed, there is a concomitant 
change in the dependence of release on calcium without changing the readily releasable pool or 
calcium influx (Fernandez-Chacon, Konigstorfer et al. 2001; Yoshihara and Littleton 2002).  
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This demonstrates synaptotagmin’s role in specifically regulating calcium-evoked fusion as 
opposed to it acting at earlier stages such as docking or priming.  Thus, synaptotagmin 1 
functions as a calcium sensor for the fast, synchronous phase of release and suppresses 
asynchronous release in Drosophila.   
Synaptotagmin knockouts display a large enhancement in mini frequency 
In addition to eliminating synchronous neurotransmitter release, early reports from Drosophila 
synaptotagmin knockouts showed an increase in spontaneous release by about two- to six-fold 
(Littleton, Stern et al. 1993; Broadie, Bellen et al. 1994; DiAntonio and Schwarz 1994).  This 
phenotype was not observed in early studies of mouse synaptotagmin null mutants using 
recordings from autaptic cultured hippocampal neurons (Geppert, Goda et al. 1994).  However, a 
recent study found a five-fold increase in mini frequency compared to wild type in mouse 
synaptotagmin 2 loss-of-function mutants at the Calyx of Held and at the NMJ (Pang, Sun et al. 
2006).  Similarly, when recordings were taken from cultured cortical neurons of synaptotagmin 1 
null mutants, a five-fold increase in mini frequency was observed.  In early discussions of 
synaptotagmin’s function at synapses it was proposed that synaptotagmin might be a vesicle 
fusion clamp based on the facts that synaptotagmin binds both the assembled SNARE complex 
and lipid membranes, that it is specifically expressed in neurons, and that it is highly conserved 
(Bennett and Scheller 1993; Popov and Poo 1993; Sollner, Whiteheart et al. 1993).  The 
enhanced mini frequency observed in Drosophila mutants bolstered this view (Popov and Poo 
1993), but because no enhancement in mini frequency was seen in mammalian mutants the idea 
fell out of favor.  With new evidence, it now seems more likely that synaptotagmin plays some 
role in vesicle fusion clamping.  Indeed, a recent report demonstrates that in vitro synaptotagmin 
can inhibit fusion in the absence of calcium but can also promote fusion in the presence of 
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calcium (Chicka, Hui et al. 2008).  Unfortunately, complexin, another protein implicated 
clamping synaptic vesicles prior to calcium influx, was not included in the analysis, which might 
have revealed much about how these two protein function together, if at all, during calcium-
evoked fusion. 
While the exact molecular sequence of events involved in synaptotagmin’s triggering of 
synaptic vesicle exocytosis is still under debate, it is clear that it functions as a calcium sensor for 
fast synchronous neurotransmitter release.  Key aspects of its function include calcium-
dependent binding to phospholipids and to the SNARE complex.  Thus, it is likely that upon 
calcium binding of synaptotagmin, binding to the SNARE complex is enhanced and synaptic 
vesicles and the plasma membrane are pulled together, activating fusion.  There is also evidence 
that synaptotagmin suppresses fusion in the absence of high calcium concentrations. 
Complexin  
In addition to synaptotagmin, a second neuronal-specific protein known to bind the SNARE 
complex and modulate its function is complexin. There is growing evidence that complexin 
levels are altered in several neurodegenerative diseases and mental disorders, including 
Parkinson’s Disease (Basso, Giraudo et al. 2004), schizophrenia and bipolar disorder (Eastwood 
and Harrison 2000), Wernicke’s encephalopathy (Hazell and Wang 2005), and Huntington’s 
Disease (Morton, Faull et al. 2001).  Four isoforms of complexin exist in mammals, and they 
were first identified as novel proteins that co-immunoprecipitate from rat brain extracts with the 
SNAREs, synaptotagmin, and N-type calcium channels (Saisu, Ibaraki et al. 1991; McMahon, 
Missler et al. 1995).  Initial analysis showed that complexins are small, highly charged proteins 
of 15-20 kDa that are well conserved from invertebrates to vertebrates (Figure 6) and contain no 
transmembrane domains.  They display high alpha-helical content, and specifically bind the 
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neuronal SNARE complex with a 1:1 stoichiometry (Ishizuka T., Saisu H. et al. 1995; 
McMahon, Missler et al. 1995; Pabst, Hazzard et al. 2000).   
Phylogenic analysis of the complexin family highlights certain features of complexin’s 
lineage (Figure 7).  The four mammalian complexins consist of two subfamilies, complexin 1/2 
and complexin 3/4.  Other vertebrate species with sequence available have homologs of 
complexin 1/2 but not 3/4, although this might be due to incomplete sequence availability rather 
than an actual absence of complexins 3 and 4 in these species.  The two complexin subfamilies 
split off from a common ancestor shared with the invertebrate complexins.  Invertebrate 
organisms typically have only one complexin gene, with the exception of C. elegans which has 
two complexin genes (only one is included in the phylogenetic analysis because of incomplete 
sequence availability).   
Expression and localization of mammalian complexins 
Mammalian complexins contain between 134 and 160 amino acids.  Complexins 1 and 2 are 
expressed at high levels throughout the brain (Yamada, Saisu et al. 1999).  Complexins 3 and 4 
are mainly restricted to expression in the retina, with limited expression of complexin 3 in the 
hippocampus and several other areas of the brain (Reim, Wegmeyer et al. 2005).  Immuno-
electron microscopy images show that complexin localizes to presynaptic terminals (Takahashi, 
Yamamoto et al. 1995).  Complexins 1 and 2 have distinct but overlapping localization within 
the mammalian nervous system.  Complexin 1 is the main isoform present at neuromuscular 
junctions, and the two isoforms are differentially expressed in the synaptic layers of the 
hippocampus (McMahon, Missler et al. 1995).  Consistent with this observation, in hippocampal 
cultures complexins 1 and 2 are both present but generally localize to separate synapses (Ono, 
Baux et al. 1998).  Additionally, complexin 1 has been observed to mainly localize to axo-
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somatic synapses while complexin 2 mainly localizes to axo-dendritic synapses (Takahashi, 
Yamamoto et al. 1995).  In situ hybridization to complexin 1 and 2 mRNAs and electron 
microscopy immunohistochemistry demonstrated they are differentially expressed in many areas 
of the mouse brain including the olfactory bulb, hippocampus, cerebral cortex, pyriform cortex, 
cerebellum, thalamus, and facial nuclei (Ishizuka, Saisu et al. 1999; Yamada, Saisu et al. 1999).  
The differential expression of complexins 1 and 2 suggests their distribution is segregated by the 
circuitry of the neurons in which they are expressed, with complexin 2 involved in circuits of 
cognition, emotional behavior and control of voluntary movement and complexin 1 involved in 
circuits of motor learning programs and sensory processing (Freeman and Morton 2004).  
Complexins 3 and 4 also have differential expression patterns.  While both are present in the 
retina, complexin 3 is highly enriched in cone photoreceptor terminals while complexin 4 is 
enriched in rod photoreceptor terminals (Reim, Wegmeyer et al. 2005).  All four isoforms are to 
some extent functionally redundant (Xue, Stradomska et al. 2008), but their highly specific 
differential expression patterns suggest that subtle differences in their function might be used to 
modulate synaptic function. 
In addition to expression in the brain, complexins are also expressed in several other cell 
types in which vesicle exocytosis is a calcium-regulated event.  Complexins 1 and 2 localize to 
the acrosome in rat sperm (Redecker, Kreutz et al. 2003).  Complexin 1 is highly expressed in 
insulin-secreting β cells of the pancreas (Abderrahmani, Niederhauser et al. 2004), while 
complexin 2 is highly expressed in mast cells of the immune system (Tadokoro, Nakanishi et al. 
2005).  Other presynaptic proteins involved in synaptic vesicle exocytosis have been reported to 
be present in these cell types, suggesting that calcium-regulated fusion in these various settings 
occurs by a common mechanism. 
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Complexin knockout mice have strong defects in behavior and synaptic transmission 
Knockouts of complexins 1 and 2 in mice separately or as double knockouts demonstrate the 
necessity of complexin for proper cognitive and nervous system function.  Complexin 2 
knockouts display significant impairment in long term potentiation (LTP) in both the CA1 and 
CA3 pyramidal cell layers of the hippocampus, while basic properties of synaptic transmission 
such as evoked postsynaptic currents are similar to wild type (Takahashi, Ujihara et al. 1999; 
Huang, Ujihara et al. 2000).  This suggests that complexin 2 might be involved in modulating 
presynaptic neurotransmitter release during synaptic plasticity.  Complexin 2 knockouts have 
approximately normal life spans, living to at least one year of age, but have a range of motor and 
cognitive impairments that get progressively worse with age, including impaired performance on 
the rotarod, defects in learning in the Morris water maze, abnormal grooming behavior, and 
decreased exploratory behavior (Glynn, Bortnick et al. 2003).  Complexin 1 knockout mice show 
a more severe phenotype.  They develop a strong ataxia, have sporadic seizures, are infertile, and 
die within two to four months after birth (Reim, Mansour et al. 2001).  Like complexin 2 
knockouts, there are no significant changes in basic synaptic transmission properties in 
hippocampal culture neurons from complexin 1 knockout mice.  When these mice are reared on 
an enhanced feeding regimen that allows them to live a normal life span (>2 years), they display 
severe defects in motor coordination, including running and swimming, impaired rotarod 
performance, dystonia, and resting tremors (Glynn, Drew et al. 2005).  Higher functions are also 
impaired, with deficits in grooming, rearing behavior, exploratory behavior, and complex social 
behavior (Glynn, Drew et al. 2005; Drew, Kyd et al. 2007).  Complexin 1/2 double knockouts 
die within hours after birth and have severe defects in synaptic transmission in cultured 
hippocampal neurons (Reim, Mansour et al. 2001).  The enhanced phenotype observed in double 
knockouts demonstrates that complexins 1 and 2 are partially functionally redundant.   
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The structure of complexin and the complexin / SNARE complex 
The properties of complexin’s structure as an isolated protein and when bound to the SNARE 
complex have been extensively studied by NMR and X-Ray crystallography (Pabst, Hazzard et 
al. 2000; Bracher, Kadlec et al. 2002; Chen, Tomchick et al. 2002).  Isolated complexin has no 
tertiary structure but contains a central conserved alpha-helical domain extending from residues 
26 to 83.  The N and C termini are unstructured and therefore their interactions with the SNARE 
complex or other binding partners are less well characterized than the central alpha helical 
portion.   X-Ray crystallography was performed using residues 26 to 83 of rat complexin bound 
to the minimal SNARE complex (the SNARE motifs minus the transmembrane domains and 
syntaxin’s regulatory N terminal domain) (Chen, Tomchick et al. 2002) (Figure 8).  This showed 
that complexin binds the groove between syntaxin and synaptobrevin in an antiparallel fashion 
via coiled-coil interactions.  Binding induces an overall increase in alpha helical content in 
complexin, mainly due to structural changes in the C terminal portion of the 26-83 fragment.  
Residues 30 to 47 assemble into an alpha helix independently of SNARE binding and this 
portion has been termed the accessory alpha helix, as it does not directly participate in SNARE 
binding.  Contact between complexin and the SNARE complex is localized to the C terminal end 
of the complexin fragment between residues 48 and 70, while the N terminus is unbound and 
extends into solution.  Complexin binds syntaxin and synaptobrevin at residues surrounding the 
SNARE complex zero layer (Bracher, Kadlec et al. 2002).  Binding does not induce a large 
change in the structure of the minimal SNARE complex, but deuterium exchange experiments 
show that it slightly stabilizes the interface between syntaxin and synaptobrevin (Chen, 
Tomchick et al. 2002).   This suggested that complexin might stabilize the assembled SNARE 
complex as part of the fusion process, functioning as a “tape” that assists the SNAREs in 
assembling and driving fusion.  In contrast, Bracher et al proposed based on the squid complexin 
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structure that complexin might function as part of a complex to keep synaptic vesicles in a 
primed and fusion-ready state for calcium-triggered exocytosis.  These opposing views can be 
seen as a microcosm of the competing views of complexin’s function, detailed below. 
Complexins 1 and 2 bind the assembled SNARE complex with dissociation constants in 
the low nanomolar range (Pabst, Margittai et al. 2002).  Complexins 3 and 4 are less well 
characterized with respect to their SNARE complex binding affinities, but complexin 3 has a 
similar binding affinity to those of complexins 1 and 2, whereas complexin 4 has a much lower 
SNARE complex binding affinity (Reim, Wegmeyer et al. 2005).  Complexin can bind 
monomeric syntaxin as well as a binary complex of SNAP-25 and syntaxin, but these 
interactions are much weaker than complexin’s binding to the assembled SNARE complex 
(McMahon, Missler et al. 1995; Weninger, Bowen et al. 2008).   
Evolutionarily conserved post-translational modification of complexins 
A growing body of evidence indicates that complexins are regulated by two forms of post-
translational modification: prenylation and phosphorylation.  Prenylation involves covalent 
addition of a farnesyl (15-carbon) or geranylgeranyl (20-carbon) lipid group to a conserved 
cysteine residue at or near the C terminus of a protein, proteolysis of the remaining C terminus of 
the protein, and methylation of the cysteine.  A “CAAX box” motif, consisting of a cysteine, two 
aliphatic residues (“A”), and a fourth variable residue (“X”), encodes the prenylation site, and 
the X dictates which type of lipid is transferred to the protein (Zhang and Casey 1996).  In the 
case of complexins, the majority of invertebrate isoforms contain CAAX boxes (Figure 6), as do 
mammalian complexins 3 and 4.  In addition, mammalian complexins 3 and 4 are known to be 
farnesylated and this modification is critical for the function of complexin 4 (Reim, Wegmeyer et 
al. 2005).  Farnesylation of invertebrate complexins has not been studied, but all known 
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invertebrate complexins that have CAAX motifs have glutamines in the X position, indicating 
that they too are farnesylated.  Farnesylation of proteins typically is important for concentration 
of the protein at the membrane as well as for protein-protein interactions and protein stability 
(Zhang and Casey 1996).  Indeed, farnesylation of mouse complexins 3 and 4 is required for 
their proper localization to synapses.  Because they are distributed mainly to retinal ribbon 
synapses, it is thought that concentration of complexins 3 and 4 at the membranes of these 
synapses may contribute to the unique release properties of ribbon synapses, which release 
vesicles at a rate 30 times that of conventional synapses (Stevens and Tsujimoto 1995; Reim, 
Wegmeyer et al. 2005), suggesting that the specific properties of the different complexin 
isoforms might be important in determining important properties of synaptic function in 
mammals.  Complexins 3 and 4 are more related to each other than they are to complexins 1 and 
2 (Reim, Wegmeyer et al. 2005), and the fact that invertebrate complexins typically have CAAX 
motifs suggests that the common ancestor of the vertebrate complexins had such a motif, which 
was then lost after the split between the complexin 1/2 and complexin 3/4 subfamilies (Brose 
2008).  
Phosphorylation of mammalian complexins has also been shown to be a potentially 
important mode of regulation of complexin’s function.  Complexin 2 isolated from primary 
cortical cultures from rats is highly phosphorylated on serine 93 (Hill, Callaghan et al. 2006), but 
it is currently unclear what the functional significance of this modification is.  Complexins 1 and 
2 are also phosphorylated in rat brains at serine 115.  Protein kinase CK2 phosphorylates this site 
in vitro, producing enhanced binding of complexins 1 and 2 to the SNARE complex (Shata, 
Saisu et al. 2007).  Both of these phosphorylation sites are 100% conserved among the 
mammalian complexin 1/2 subfamily.  These data suggest that phosphorylation of complexin 
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could provide an avenue by which complexin’s function is regulated.  While the two known 
mammalian phosphorylation sites are not preserved in invertebrates, the invertebrate complexins 
contain several conserved residues in the same region of complexin sequence that may be 
phosphorylated to regulate complexin’s function.  Which residues of complexin are 
phosphorylated in vivo and the functional consequences of these modifications are exciting areas 
for future study of complexin, its overall role in neurotransmitter release, and its possible role in 
synaptic plasticity. 
Function of complexin in synaptic vesicle exocytosis and its mechanism of action 
The properties of complexin binding to the SNARE complex, along with its strong expression in 
the brain and low expression in other tissues, suggest that it is an important modulator of 
SNARE function and neurotransmitter release.  A host of genetic, biochemical, and 
electrophysiological studies confirm this and demonstrate that complexin’s binding to the 
SNARE complex mediates its regulation of calcium-evoked neurotransmitter release in a post-
priming step.  These same studies provide complementary but often seemingly contradictory 
evidence for complexin’s precise role in neurotransmitter release. 
Overexpression studies have concluded that complexin is a negative regulator of 
neurotransmitter release.  Microinjection of complexin II into presynaptic terminals of Aplysia 
buccal ganglia results in a marked decrease in the evoked response, and there is a corresponding 
increase in evoked responses after injecting anti-complexin antibodies.  Two separate studies on 
PC12 cells showed a decrease in neurotransmitter release when complexin was overexpressed 
via transfection (Itakura, Misawa et al. 1999; Edwardson, Wang et al. 2003). Similarly, 
overexpression of complexin in adrenal chromaffin cells by transfection inhibited exocytosis.  
Overexpression of an R59H mutant complexin, which greatly reduces SNARE complex binding, 
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did not inhibit exocytosis, suggesting that the overexpression phenotype requires SNARE 
binding (Archer, Graham et al. 2002).  In pancreatic beta cells, which release insulin-containing 
granules in a calcium- and SNARE-dependent reaction and which therefore express many 
neuronal-specific proteins, enhanced complexin expression reduces secretion of insulin 
(Abderrahmani, Niederhauser et al. 2004).  Finally, addition of sub-micromolar amounts of 
complexin to permeabilized sperm severely inhibits acrosomal exocytosis by blocking release at 
a point where SNAREs are assembled in loose trans complexes.  This block is relieved by 
addition of calcium and the C2B domain of synaptotagmin VI, which is known to be essential for 
the acrosomal reaction (Roggero, De Blas et al. 2007).  Taken together, this evidence suggests 
that complexin is a negative regulator of synaptic vesicle exocytosis and that it may function by 
preventing full zippering of the SNARE complex.   
However, studies of a mouse complexin 1/2 double knockout animals suggest the 
opposite (Reim, Mansour et al. 2001).  Double knockout mice die within hours after birth.  In 
hippocampal autaptic cultures from these mice, there is a 50% reduction in evoked release 
compared to wild type cells at 4 mM extracellular calcium with no detectable defect in the 
readily releasable pool of vesicles, as determined by application of a hypertonic sucrose solution.  
The readily releasable pool of vesicles corresponds to those vesicles that are docked and primed.  
Therefore, the defect in these cultured neurons is in an exocytosis step after priming.  The 
authors also observed that while evoked release was smaller than in wild type animals at medium 
and low levels of external calcium, at high levels of external calcium (>12 mM), the evoked 
response approached that of wild type cells. Therefore, the double complexin knockout has a 
calcium sensing defect very similar to that of a synaptotagmin hypomorphic allele, indicating 
that complexin may promote release during calcium sensing or during fusion after calcium 
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sensing.  While complexins 1 and 2 are the predominant complexins expressed in the brain, there 
is a limited amount of complexin 3 expressed in the brain as well, potentially confounding these 
results.  However, complexin 1/2/3 triple knockouts have a nearly identical set of synaptic 
transmission defects as the complexin 1/2 knockout, and complexin 3 can rescue the defects seen 
in the 1/2 double knockout, indicating that it functions similarly to complexins 1 and 2 (Xue, 
Stradomska et al. 2008).  Complexin 1/2/3 triple knockouts also showed reduced evoked 
responses and reduced spontaneous postsynaptic current frequency in two central nervous system 
synapses, GABAergic synapses in the striatum and in brainstem slice recordings from the pre-
Bӧtzinger complex.  Complexin 4 can also rescue the defect seen in complexin 1/2 double 
knockouts, so the possibility still remains that compensatory effects by the final complexin 
isoform could confound this analysis, although it is not expressed in the central nervous system.  
Also, because the 1/2 double knockout is lethal within hours after birth in mice, central nervous 
system synapses are not mature at the time of the recordings done in this study.  Thus, in vivo 
recordings from mature synapses containing no complexin have not been completed to date, but 
the recordings that have been done in mammalian complexin knockouts argue for a positive role 
of complexin in neurotransmitter release at a post-priming step. 
 Further experiments have explored the mechanism by which complexin regulates the 
SNARE complex to modulate neurotransmitter release.  In cultured cells expressing “flipped” 
SNAREs, or SNAREs tethered to the cell surface membrane by a glycerophosphatidylinositol 
(GPI) anchor, addition of any of the mammalian complexins to the medium restricts fusion of 
cells in a dose-dependent manner (Giraudo, Eng et al. 2006; Giraudo, Garcia-Diaz et al. 2008).  
At the highest concentration of complexin tested (40 µM), cytoplasmic complexin limits fusion 
to 50% of the fusion observed with no complexin added.  Increasing the local concentration of 
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complexin at the membrane by anchoring it with a GPI tether decreases fusion to 3% of normal, 
demonstrating that in in vitro systems complexin is able to restrict fusion as it does in the case of 
overexpression.  This block in fusion is relieved by expression of synaptotagmin and 
physiological levels of calcium.  The block holds the SNARE complex in a conformation that is 
sensitive to Botulinum neurotoxin serotype B (BoNT/B) but insensitive to Tetanus neurotoxin 
(TeNT).  Both of these toxins cleave synaptobrevin at the same site (Schiavo, Benfenati et al. 
1992), but because BoNT/B binds synaptobrevin at a membrane-proximal site closer to the C 
termini of the SNARE complex, whereas TeNT binds it at a membrane-distal site (Pellizzari, 
Rossetto et al. 1996), and because these toxins can only bind and cleave SNAREs in their 
uncomplexed form (Hayashi, McMahon et al. 1994; Pellegrini, O'Connor et al. 1994), this 
indicates that under these experimental conditions complexin holds the SNARE complex in a 
partially-zippered trans conformation (Giraudo, Eng et al. 2006).   
 These conclusions are supported by the observation that Drosophila complexin and 
mouse complexin 4 prevent fusion of reconstituted liposomes containing SNAREs, and that this 
block is relieved by addition of the cytoplasmic domains of synaptotagmin and calcium (Schaub, 
Lu et al. 2006).  Additionally, by separately monitoring mixing of the inner leaflets and outer 
leaflets of liposomes, it was observed that complexin selectively prevents mixing of the inner 
leaflets of liposomes, indicating that fusion is blocked at a hemifused state in which the outer 
leaflets of fusing membranes are fused and the inner leaflets are not fused.  When synaptotagmin 
and calcium are added to liposomes blocked at this stage of fusion, rapid and synchronous fusion 
of liposomes proceeds.  This rapid and synchronous fusion is not observed when synaptotagmin 
is added without calcium or when synaptotagmin and calcium are added to liposomes without 
complexin (Schaub, Lu et al. 2006).   
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 The information thus far about complexin’s molecular mechanism suggests that 
complexin functions as a vesicle fusion clamp by halting fusion at a hemifused state in which the 
SNARE complex is incompletely zippered.  Synaptotagmin then responds to calcium binding by 
overcoming this clamping mechanism through unknown mechanisms and triggering synchronous 
fusion.  In this fusion clamp model, complexin limits spontaneous and slow fusion but promotes 
synchronous and rapid fusion triggered by calcium and synaptotagmin, possibly explaining why 
some experiments produce results arguing for a positive role in neurotransmitter release while 
others produce results arguing for a negative role in neurotransmitter release.   
The functional interplay between complexin and synaptotagmin in this model is well 
supported. Complexin is displaced by synaptotagmin from reconstituted SNARE complexes in 
supported bilayers, and this displacement depends on the concentration of both calcium and 
synaptotagmin (Tang, Maximov et al. 2006).  The range of calcium concentrations required for 
displacement is within the range found at active zones during calcium influx.  Displacement of 
complexin from SNARE complexes in supported bilayers is eliminated in synaptotagmin C2B 
domain mutants that have diminished calcium and phospholipid binding (Dai, Shen et al. 2007).  
Similarly, synaptotagmin VI and calcium release a block by complexin of acrosomal exocytosis 
in sperm and this effect is eliminated in synaptotagmin VI C2B mutants that have diminished 
calcium or phospholipid binding (Roggero, De Blas et al. 2007).  These results are consistent and 
suggest that part of the function of synaptotagmin’s previously identified calcium-dependent 
lipid binding function may be to overcome complexin’s block on vesicle release.  While 
synaptotagmin clearly displaces complexin from SNARE complexes in a calcium-dependent 
manner, in some experimental conditions complexin and synaptotagmin can bind simultaneously 
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to the SNARE complex (McMahon, Missler et al. 1995; Schaub, Lu et al. 2006), so it is unlikely 
that this effect is achieved by direct competition for a SNARE complex binding site.   
 That complexin is displaced from SNARE complexes by synaptotagmin in a calcium-
dependent manner is clear, but there is considerable controversy over the “fusion clamp” model 
of complexin’s function, in which it is proposed to prevent vesicle fusion in the absence of a 
calcium signal and promote synchronous fusion of vesicles.  A competing model proposes that 
complexin promotes vesicle fusion by stabilizing ternary SNARE complexes.  Both models are 
supported by a variety of evidence.  Recordings from dissociated cortical neurons expressing a 
complexin-synaptobrevin fusion construct, which increases the local concentration of complexin 
at sites of release, decreases spontaneous release frequency to about 1/3
rd
 the normal frequency 
(Tang, Maximov et al. 2006).  Evoked responses in neurons expressing this construct are 
decreased by about 80%.  These results argue for an inhibitory role for complexin in release, but 
it is unclear whether these results represent physiological complexin function because of the 
nonphysiological nature of the fusion construct.  Interestingly, overexpression of the fusion 
construct specifically inhibits synchronous release mediated by synaptotagmin and does not 
inhibit asynchronous release, as determined by high frequency stimulation protocols.  This 
phenomenon is similar to recordings from syt1 null mutants, in which synchronous release is 
abolished but asynchronous release remains (Geppert, Goda et al. 1994).  The phenotype 
observed may be due to the fact that high concentrations of complexin prevent binding of 
synaptotagmin to SNARE complexes (Tang, Maximov et al. 2006) and is consistent with the 
idea that complexin bound to the SNARE complex must be removed by synaptotagmin in order 
to trigger fast synchronous release. 
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 Deletion analysis of mammalian complexins revealed that complexin has dual roles in 
neurotransmitter release mediated by separate portions of the protein (Xue, Reim et al. 2007) 
(Figure 6).  The minimal SNARE binding region of complexin (residues 47-75) is necessary but 
not sufficient to rescue the complexin 1/2 null phenotype of decreased evoked responses.  
Therefore, complexin functions through activities of its non-SNARE-binding regions.  Residues 
47-134 partially rescue the null phenotype, whereas residues 27-134 do not rescue at all.  This 
suggests that the accessory alpha helix (residues 30-47) functions to suppress complexin’s 
positive role in neurotransmitter release.  Introduction of a mutation in the accessory alpha helix 
that inhibits its alpha helical conformation without affecting SNARE complex binding eliminates 
this activity, indicating that the alpha helical conformation is necessary for the inhibitory 
function of the accessory alpha helix.  Full length complexin rescues the null phenotype, so 
residues 1-26 are necessary to overcome the inhibitory function of the accessory alpha helix.  
One way to explain these results is that the accessory alpha helix mediates a clamping function 
that requires SNARE binding by complexin.  The N terminus is then responsible for relieving 
this block during calcium-evoked exocytosis by an unknown mechanism.  This model posits that 
complexin’s overall function is to promote release during priming but the accessory helix blocks 
release until calcium influx occurs.  Promotion of release is proposed to occur via stabilization of 
trans SNARE complexes (Xue, Reim et al. 2007).   
 Recent observations of individual liposome fusion events using Total Internal Reflection 
(TIRF) microscopy support complexin’s positive role in vesicle fusion (Yoon, Lu et al. 2008).  
FRET efficiency between vesicles containing acceptor fluorophores and v-SNAREs and vesicles 
containing donor fluorophores and t-SNAREs was used as a measure of fusion.  Within an hour 
of mixing of the two types of vesicles, only a small population of vesicles containing SNAREs 
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alone had fused.  With complexin present over a range of concentrations up to 20 µM, the 
majority of vesicles had a FRET efficiency indicative of fusion.  Addition of 1mM calcium 
enhances this effect and speeds up fusion.  Within several seconds of calcium addition after 
incubation with complexin 25% of vesicles underwent fusion.  This suggests that complexin 
binding alone promotes fusion and confers some calcium sensitivity of fusion.  Notably, the 
authors did not include an analysis of complexin’s function in the presence of synaptotagmin.  It 
has been reported that synaptotagmin enhances the clamping function of complexin (Giraudo, 
Eng et al. 2006).   
Summary of evidence for complexin’s function in the nervous system 
Taken together, the available evidence argues for a dual nature of complexin’s role in 
neurotransmitter release.  The fact that complexin mouse knockouts show decreased EPSCs 
demonstrates a positive role for complexin and this is supported by the finding that complexin 
promotes vesicle fusion in single vesicle fusion assays.  Irrespective of the effects of 
overexpression of complexin, which are subject to caveats regarding their non-physiological 
nature, significant biochemical and molecular evidence exists to support the idea that complexin 
prevents vesicle fusion in the absence of calcium and synaptotagmin, and that this block is 
relieved by synaptotagmin in the presence of calcium.  It is possible that complexin stabilizes an 
intermediate in the SNARE zippering reaction, speeding SNARE formation to that point, but 
also preventing full zippering until calcium influx occurs.  This would have the effect of 
promoting fusion but also synchronizing it.  It is also possible that complexin prevents 
synaptotagmin from triggering fusion in a calcium independent manner.  In any case, one would 
expect a vesicle fusion clamp to present characteristics of both a negative and a positive 
regulator of neurotransmitter release as it both suppresses calcium-independent release and 
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promotes synchronous calcium-dependent release.  However, one would also expect knockout of 
a fusion clamp to produce enhanced spontaneous synaptic vesicle exocytosis, but this has not 
been observed in the mouse knockouts.  It is possible that additional proteins with clamping 
function exist in mammals, including synaptotagmins.  Also, observations from these mouse 
knockouts have several potential caveats, detailed below.   
Caveats of mouse complexin knockout electrophysiology data 
While three of the four complexin isoforms have been knocked out in mice, one isoform that is at 
least partially redundant remains, although this isoform is not known to be expressed in the 
brain.  Also, because mouse knockouts die within hours after birth, recordings from intact 
animals are necessarily done from immature synapses, which is why most of the analysis was 
done in autaptic synapses in the microisland hippocampal primary culture system (Reim, 
Mansour et al. 2001).  Although this system has proven a valuable tool for analysis of synaptic 
function, it is not without its caveats.  The number of release sites from a given recording can 
vary over several orders of magnitude, so the system is less well defined than more standardized 
models such as the Calyx of Held or neuromuscular junction (NMJ).  This necessitates a great 
deal of information processing for quantification of even basic properties of synaptic function 
such as mini frequency or evoked currents.  Indeed, this has proved problematic in at least one 
case, in which elevated mini frequency was observed in NMJ recordings from Drosophila 
synaptotagmin null mutants but not in hippocampal cultures from mouse synaptotagmin null 
mutants (Littleton, Stern et al. 1993; Broadie, Bellen et al. 1994; DiAntonio and Schwarz 1994; 
Geppert, Goda et al. 1994).  It was later discovered in in vivo recordings from mouse 
synaptotagmin 2 mutants and in recordings from primary cortical cultures of synaptotagmin 1 
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knockout mice that in both cases there is indeed a highly elevated mini frequency phenotype 
(Pang, Sun et al. 2006), in accordance with the data from Drosophila neuromuscular junctions.   
As an additional caveat of the complexin knockout recordings, in mice complexin is only 
fully expressed and properly localized to synapses after the animals are several weeks old or in 
hippocampal cultures after growth for between 16 and 28 days (Ono, Baux et al. 1998; Reim, 
Wegmeyer et al. 2005).  This suggests that there is some type of synaptic maturation or 
development that occurs and complexin expression and localization is only necessary after that 
event.  Importantly, there is almost no expression of complexins 1, 2, and 3 in wild type mice on 
postnatal day 0, when recordings from intact triple knockouts or from acute brainstem slices 
from triple knockouts were done (Reim, Wegmeyer et al. 2005; Xue, Stradomska et al. 2008).  
Recordings from hippocampal cultures were done after 10-16 days of growth, when complexin is 
expressed but not yet specifically localized to synapses (Ono, Baux et al. 1998; Reim, Mansour 
et al. 2001; Xue, Stradomska et al. 2008).  Thus, electrophysiology on double and triple 
complexin knockouts has to date only been done at time points when complexin is normally 
either not expressed or not properly localized to synapses.   
Additional features of complexin’s function may be revealed by in vivo 
electrophysiological recordings from a synapse that is highly stereotyped, at a developmental 
stage in which complexin is normally expressed and properly localized, and in a simpler genetic 
system where no residual complexin function can interfere with interpretation of the results.  For 
these reasons, we have completed an analysis of complexin function in Drosophila at the larval 
neuromuscular junction.  This synapse fits the description above and has revealed significant 
evidence that complexin functions as a synaptic vesicle fusion clamp in vivo. 
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Figures 
 
 
Figure 1. The Synaptic Vesicle Cycle. At presynaptic terminals, synaptic vesicles filled with neurotransmitter 
(dark orange) are targeted to and dock at the presynaptic membrane. Docking is followed by priming, in which 
synaptic vesicles are made fusion-competent and may undergo hemifusion. Upon calcium influx, synaptic 
vesicles fuse and release their neurotransmitter cargo into the synaptic cleft.  Synaptic vesicle membrane 
proteins are then endocytosed and synaptic vesicles are recycled into the vesicle pool either directly or through 
endosomal intermediates. Black dashes symbolize clathrin.  
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Figure 2. Example figures from Fatt and Katz 1952 showing variability of minis at th e frog neuromuscular 
junction. (a and b) Examples of low frequency minis. (c) An example of high frequency minis. Recording is from 
same animal as in b. (d) Sample recordings showing the effect of high osmotic pressure on mini frequency. Top 
panel: Minis before application of 50% sucrose solution to muscle. Middle panel:  Recordings of minis after 
application of sucrose solution. Bottom panel:  Recordings of minis after washing the sucrose solution from the 
muscle. Note time and potential scales are not the same for all recordings.  
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Figure 3. Model of intermediates in membrane fusion from Jackson and Chapman 2008. Two apposed 
membranes are brought into close proximity and begin fusion, forming a stalk (top two panels). Stalk widening 
produces a hemifusion intermediate (third panel), followed by fusion pore opening. Modified from Jackson and 
Chapman, Nat Struct Mol Biol 2008. 
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Figure 4. Key differences between calcium evoked synaptic vesicle fusion and constitutive fusion. Left panel: A 
neuron contains both constitutive vesicle traffic and synaptic vesicle exocyt osis. Constitutve vesicle traffic (blue 
circles) occurs throughout the cell, while synaptic vesic les (orange circles) are localized to active zones. The 
active zone is depicted with a T bar, the form of the presynaptic density in Drosophila  neuromuscular junction 
active zones. (a and b) Zoomed-in views of boxed areas in left panel. (a) In constitutive vesicle fusion, vesicles 
constantly traffic between membranes and fuse as soon as they reach their targets. ( b) In synaptic vesicle 
exocytosis, synaptic vesic les wait for calcium influx before fusing and fusion is synchronized. Right panel: 
Representative figures showing the timescales of the two types of fusion. Intracellular vesicle traffic, in this case 
fusion of endosomes, occurs on timescales of minutes. S ynaptic vesicle exocytosis occurs within a millisecond 
after calcium influx. Representative figures were adapted from Kjeken, Egeberg et al Mol Biol Cell 2004 and 
Sabatini and Regehr Biophys J 1998. 
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Figure 5. Structure of the neuronal SNAREs.  (a) Domain structures of the SNAREs. Sequence lengths are based 
on Drosophila  protein sequences. Structured domains are shown as boxes. Unstructured sequence is shown as a 
line. Synaptobrevin (yellow) has one SNARE domain, a transmembrane domain, and short intravesicular tail. 
SNAP-25 (red) has two SNARE domains jo ined by a long flexible linker.  It is palmitoylated at two cysteines in this 
linker region (black wavy lines) to tether it to the presynaptic membrane. Syntaxin (blue) has a long N-terminal 
HABC domain that folds into a series of three alpha helices. Like synaptobrevin, it also has one SNARE domain 
and one transmembrane domain. (b) Three dimensional structure of the SNARE complex. Colors correspond to 
those in (a). Linker regions and transmembrane domains have been added. The N termini of the SNAREs are to 
the right and the C termini are to the left.  Syntaxin is shown in the open conformation. The core SNARE complex 
structure is from Chen et al Neuron 2002. The structure of the HABC domain is from Bracher and Weissenhorn 
BMC Struct Biol 2004. 
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Figure 6. Alignment of complexins from vertebrate and invertebrate species. Primary sequences of complexins 
were aligned for maximal homology using CLC Bio Sequence Analysis software. Residues that are identical in at 
least 50% of species are highlighted in dark blue. Simi lar residues are highlighted in light blue. Similarity groups: 
F,Y,W; I,L,V,M; H,R,K; D,E; G,A; T,S; N,Q. The colored bars highlight important fragments of the sequence. Red 
bar: Fragment crystallized in rat complexin structure (Chen et al  Neuron 2002). Purple bar: Central alpha helix 
responsible for binding to the SNARE complex. Green bar: accessory alpha helix. Yellow bar: N terminal 26 
residues proposed to overcome the inhibitory function of the accessory alpha helix (Xue et al Nat Struct Mol 
Biol 2007). Black box: CAAX motif found in complexins from invertebrate species and mammalian complexins 3 
and 4. Abbreviations: dm, Drosophila melanogaster ; ds, Drosophila simulans; tc, Tribolium castaneum; lp, Loligo 
pealei; hm, Hirudo medicinalis; m, mouse (Mus musculus); h, human (Homo sapiens); ce, Caenorhabditis elegans; 
nj, Narke japonica; xl, Xenopus laevis.  Two splice isoforms of complexin (dmcpxA and dmcpxB) aexpressed in D. 
melanogaster are shown.  They differ in their C terminal sequence.  
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Figure 7. Phylogenic tree showing evolutionary relationships of vertebrate and invertebrate complexins. 
Mammalian complexins 3 and 4 form a subfamily separate from the complexin 1 and 2 subfamily.  
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Figure 8. Three dimensional structure of complexin bound to the SNARE complex (Chen et al Neuron 2002). All 
panels: Green = complexin accessory alpha helix (residues 32 -47); Purple = Complexin central alpha helix 
(Residues 48-72); Blue = syntaxin SNARE motif; Yellow = synaptobrevin SNARE motif; Red = SNAP -25 SNARE 
motifs. For complexin, color scheme corresponds to colored bars in Figure 6. For SNAREs, color scheme 
corresponds to colors in Figure 5. (a-c) N termini of SNAREs are to the left and C termini are to the right.  
Transmembrane domains and synaptic vesicle would be to the right. ( a) Ribbon diagram showing alpha helical 
structures and coiled-coil interactions. (b) Space filling model showing interaction of complexin centra l alpha 
helix with the groove between syntaxin and synaptobrevin. ( c) Close-up of binding site of complexin. For the 
sake of clarity, SNAP-25 helices are not shown as they do not participate in binding. ( d and e) Ribbon diagrams 
showing structure from SNARE C terminal and SNARE N terminal sides, respectively.  
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Introduction 
Intracellular vesicular trafficking is ubiquitous among eukaryotes, with vesicle fusion driven by 
assembly of the SNARE (soluble N-ethlymaleimide-sensitive factor attachment protein receptor) 
complex (Sollner, Whiteheart et al. 1993). Vesicle fusion occurs when vesicle-bound SNAREs 
bind with SNAREs in the target membrane via coiled-coil interactions (Sutton, Fasshauer et al. 
1998), bringing the membranes into close proximity and releasing enough free energy to 
overcome the energy barrier imposed by lipid fusion (Fasshauer, Otto et al. 1997; Rice, 
Brennwald et al. 1997).  While most intracellular trafficking events occur constitutively and on a 
time scale of minutes, synaptic vesicles must wait in a fusion-competent state before fusing, and 
synaptic vesicle exocytosis in response to an action potential occurs synchronously within 
approximately 200 µsec of calcium influx (Llinas, Steinberg et al. 1981; Cope and Mendell 
1982).  Despite these vast differences in kinetics and regulation, synaptic vesicle exocytosis and 
intracellular vesicular trafficking both occur via a common SNARE-driven mechanism (Bennett 
and Scheller 1993).  It is therefore thought that neuronal regulatory proteins have evolved that 
impinge on SNARE function to allow synaptic vesicles to wait for calcium influx before fusing, 
to trigger fusion in the presence of calcium, and to speed the kinetics of fusion (Wojcik and 
Brose 2007).  A thorough understanding of the molecular events leading up to fusion requires 
identification of these regulators and dissection of the molecular mechanisms by which they 
regulate the fusion process.  An effective strategy to achieve this goal has been to identify 
conserved neuron-specific proteins that bind the assembled SNARE complex and then to study 
functions of these proteins using genetic and biochemical methods.  Indeed, synaptotagmin 1 
was identified as the calcium sensor for neurotransmitter release using this strategy. 
 While the calcium sensor for neurotransmitter release has been identified, the identity of 
a vesicle fusion clamp that would prevent exocytosis in absence of a calcium influx has yet to be 
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conclusively found.  Ever since it was demonstrated that synaptic vesicle exocytosis and 
intracellular membrane trafficking occur via a common SNARE-driven mechanism (Bennett and 
Scheller 1993), it has been thought that such a regulator must exist because intracellular vesicle 
fusion events are constitutive, whereas synaptic vesicles wait in a fusion-competent state before 
synaptic vesicle exocytosis is triggered by calcium influx (Bennett and Scheller 1993; Popov and 
Poo 1993; Sollner, Whiteheart et al. 1993).  Indeed, recent evidence demonstrates that in a cell-
free assay using purified synaptic vesicles and proteoliposomes, fusion proceeds constitutively, 
suggesting the presence of cytoplasmic regulators that serve the fusion clamp function (Holt, 
Riedel et al. 2008).  Because synaptic vesicle exocytosis is an essential process, and because a 
fusion clamp would regulate the last stages of fusion, one would expect a fusion clamp to be 
conserved, expressed specifically in neurons, and to function by acting on the SNARE complex. 
Complexins are small, conserved, neuron-specific cytosolic proteins that interact with 
assembled SNARE complexes with a 1:1 stoichiometry (McMahon, Missler et al. 1995; Chen, 
Tomchick et al. 2002).  Alterations in complexin levels in humans have been implicated in a host 
of neurological diseases ranging from schizophrenia (Lee, Song et al. 2005; Sawada, Barr et al. 
2005) to Parkinson’s and Huntington’s Disease (Basso, Giraudo et al. 2004; DiProspero, Chen et 
al. 2004; Zabel, Sagi et al. 2006), suggesting complexin dysfunction may contribute to several 
human neuropathologies.  When either two (Reim, Mansour et al. 2001) or three (Xue, 
Stradomska et al. 2008) of the four mouse complexin genes are removed, the animals die within 
hours after birth.  Evoked neurotransmitter release is decreased in both hippocampal autaptic 
cultures and in the brainstems of knockout mice (Reim, Mansour et al. 2001; Xue, Stradomska et 
al. 2008), while the readily releasable pool of vesicles remains unchanged.  This suggests that 
complexin serves a positive, post-priming role in neurotransmitter release.  However, recent 
66 
 
biochemical evidence demonstrates that complexin can reduce SNARE-mediated fusion in vitro 
in cell-cell (Giraudo, Eng et al. 2006) or liposome (Schaub, Lu et al. 2006) fusion assays, largely 
because of a block in inner-leaflet mixing (Schaub, Lu et al. 2006) and a concomitant block of 
full zippering of the SNARE complex (Giraudo, Eng et al. 2006), suggesting that complexin may 
function as a clamp to stabilize a hemifusion intermediate formed by the SNARE complex.   
In addition to preventing fusion of synaptic vesicles in the absence of calcium, a vesicle 
fusion clamp must be relieved by calcium in order to allow release to proceed.  Indeed, in vitro, 
the fusion block imposed by complexin can be rapidly eliminated by a combination of calcium 
and synaptotagmin to trigger fusion (Giraudo, Eng et al. 2006; Schaub, Lu et al. 2006).  
Synaptotagmin rapidly triggers fusion in vitro in the presence of complexin and calcium by 
displacing complexin from SNARE complexes in a calcium-dependent manner (Tang, Maximov 
et al. 2006).  Thus, biochemically, complexin has the properties necessary to function as a fusion 
clamp, but the electrophysiology data from complexin knockout mice are inconsistent with this 
conclusion because knockout of a vesicle fusion clamp would be expected to dramatically 
enhance spontaneous release of synaptic vesicles and this has not been observed (Reim, Mansour 
et al. 2001; Xue, Stradomska et al. 2008).   
The mouse electrophysiology data have several caveats, however.  First, there are four 
complexins (Reim, Wegmeyer et al. 2005) in mammals and only three have been knocked out 
(Xue, Stradomska et al. 2008), leaving the possibility of compensatory effects by the fourth 
isoform.  This compensatory effect is unlikely to occur, however, because complexin 4 is only 
expressed in the retina (Reim, Wegmeyer et al. 2005) and not in the central nervous system.  
Second, and more importantly, the recordings from brainstem slices and striatum of complexin 
1/2/3 triple knockout mice were done, by necessity, on postnatal day 0, when synapses may not 
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have fully developed and when complexin expression in the central nervous system has not yet 
begun in wild type mice (Reim, Wegmeyer et al. 2005).  Complexin is not fully expressed in the 
central nervous system of mammals until they are several weeks old (Ono, Baux et al. 1998; 
Reim, Wegmeyer et al. 2005).  Additionally, in hippocampal cultures where much of the analysis 
of the synaptic transmission defect in complexin 1/2 knockouts was done, complexin is not 
properly localized to synapses until after day 16 of growth (Ono, Baux et al. 1998), while 
recordings were done on cultures between 10 and 16 days old (Reim, Mansour et al. 2001; Xue, 
Stradomska et al. 2008).  Finally, recent evidence suggests that an enhanced rate of spontaneous 
release can be missed by recordings from autaptic hippocampal cultures.  Synaptotagmin 
knockouts in Drosophila were reported in the early 1990’s to have a spontaneous release 
frequency two to six times the frequency observed in wild type animals (Littleton, Stern et al. 
1993; Broadie, Bellen et al. 1994; DiAntonio and Schwarz 1994).  This was not thought to be 
significant because no such increase in mini frequency was observed in autaptic hippocampal 
recordings from syt1 knockout mice (Geppert, Goda et al. 1994).  Recently however, recordings 
from the Calyx of Held, the neuromuscular junction, and cortical cultures from synaptotagmin 
mouse knockouts showed an increase mini frequency about five times that of the wild type mini 
frequency (Pang, Sun et al. 2006).   
Thus, a greater understanding of complexin’s function in synaptic vesicle exocytosis may 
be gained by an electrophysiological analysis of complexin knockouts at a highly stereotyped, 
mature synapse in a simple genetic background where interpretation of the results are not 
confounded by the presence of additional complexins.  The larval neuromuscular junction in 
Drosophila melanogaster is ideal for such an analysis.  We therefore undertook a study of 
complexin function in this system and found significant evidence that complexin does indeed 
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function as a vesicle fusion clamp in vivo.  Additionally, because there is a massive enhancement 
in mini frequency in complexin mutants, we were able to observe the effects of enhanced mini 
frequency on synaptic plasticity at the neuromuscular junction.  Our observations add strong 
evidence to the growing range of evidence that suggests that minis are not just background noise 
at synapses but may play a significant role in synaptic plasticity and information storage. 
Experimental Procedures 
Drosophila Genetics and Generation of a complexin Null Mutant 
Drosophila were cultured on standard medium at 22°C. The Drosophila genome encodes a 
single gene located on the 3rd chromosome at cytological interval 82A1 encoding the complexin 
protein (also known as synaphin) (Tokumaru, Umayahara et al. 2001), which has been 
previously demonstrated to bind assembled SNARE complexes and reduce SNARE-mediated 
fusion in vitro (Schaub, Lu et al. 2006).  The locus spans 22.5 kb and contains eight exons, with 
the start codon for the ORF located within the third exon.  A second uncharacterized gene, 
CG9780, is contained within intron three of the complexin locus.  A null mutant in complexin 
(cpx
SH1
) was generated by imprecise excision of PKG030233 (Bellen, Levis et al. 2004), a P-
element insertion located 2.7 kb 5’ of the primary complexin translation start site in the first 
intron of the gene.  KG03023 flies are viable and fertile and do not disrupt complexin expression. 
Using PCR analysis of 600 white
– 
excision events, we isolated a 17 kb intragenic deletion within 
complexin (cpx
SH1
) that removed exons 2-4, which contain the start codon and most of the 
coding region for the protein. To confirm that this complexin allele was a null, we performed a 
western analysis on protein extracts from control adults, cpx
SH1
 heterozygotes, and cpx
SH1
 
homozygotes. Complexin immunoreactivity showed reduced protein levels in heterozygotes 
compared to controls, and absent protein in homozygotes. In addition, immunocytochemistry on 
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control and cpx
SH1
 homozygous larvae with anti-complexin antisera confirmed that the cpx 
mutant completely removed expression of the protein. Homozygous cpx
SH1
 mutants and 
cpx
SH1
/Df(3R)ED5021 (Ryder, Blows et al. 2004) (a deletion removing complexin that spans the 
cytological interval 81F6-82A5) animals showed identical phenotypes, indicating cpx
SH1
 behaves 
as a null mutation. Df(3R)ED5021 was used in trans to cpx
SH1
 to remove complexin in 
physiology experiments. Primers used to define the cpx deletion included: 
 
PCR across the P element insertion site 
5’ primer:  GCTATGTGCTTCCGGTCCCGTCTTC 
3’ primer:  GAACGGCCCGAGCTCGAAAGCACGACTG 
Product 1 
5’ primer:  GCTATGTGCTTCCGGTCCCGTCTTC 
3’ primer:  GTCCTGGCGGTCCTGCAATCTTGCC 
Product 2 
5’ primer: CGAGAATTTTCGGACGGCGCTAAAG 
3’ primer: GAACGGCCCGAGCTCGAAAGCACGACTG 
Product 3 
5’ primer: CCGAATGCCACGACCAAGAAAG 
3’ primer: CTGCAGCATCTGTCGAGCGTG 
Product 4 
5’ primer: GTGTCATGCAGTGATATGTCAGTCACC 
3’ primer: GCATTCGAGTGTCATCGTGCCGATTC 
Product 5 
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5’ primer: GCAGGCCAGCATTCCCTATC 
3’ primer: CGCTATTCATGGTCTAGTCATTTGAGCC 
Product 6 
5’ primer: CTCGGCAGGCGCTCTGTCAGCGTATCG 
3’ primer: GTCCATTCCGGTAGCCACATTGGCTG 
 
To confirm that defects in our mutant analysis were due to complexin function in the 
nervous system, we took advantage of the UAS/GAL4 (Brand and Perrimon 1993) system to 
selectively drive transgene expression within neurons.  We subcloned a complexin cDNA 
encoding complexin 7B that spans the ORF into the pUAST vector and generated transgenic flies 
expressing UAS-complexin by standard injection techniques. 
Protein Expression and Antibody Production 
Complexin was amplified by PCR from a Drosophila cDNA library and subcloned into pGEX-
2T (GE Healthcare).  Recombinant complexin fused with GST was expressed in E. coli (BL21) 
and purified using glutathione-sepharose 4B (Amersham Biosciences).  GST was cleaved from 
complexin by incubation with thrombin and further purified by anion exchange chromatography 
on a MonoQ 5/5 column (Amersham Biosciences).  Peak fractions were concentrated and further 
purified by gel filtration on a Superose 12 10/30 column (Amersham Biosciences) in 1X TS (100 
mM Tris base, 100 mM NaCl, pH 7.4). Sample loading and elution was performed on an
 
AKTA 
FPLC (Amersham Biosciences).  Polyclonal antibodies to complexin were generated in rabbits 
(Invitrogen). 
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Immunostaining 
3
rd
 instar larvae were reared at 22°C and dissected in HL3.1 (Stewart, Atwood et al. 1994) (70 
mM NaCl, 5mM KCl, 10 mM NaHCO3, 4mM MgCl2∙6H2O, 5 mM Trehalose, 115 mM Sucrose, 
5 mM HEPES, pH 7.2).  Following washes, larvae were incubated with primary antibody 
overnight at 4 °C, incubated with secondary antibodies for four hours at room temperature, and 
mounted in 80% glycerol for imaging.  The dilutions of primary antibodies were as follows:  
complexin (1:500), anti-HRP (1:10,000), anti-nc82 (1:50), anti-Dlg (1:1000).  The nc82 antibody 
against Bruchpilot developed by Erich Bruchner and the 4F3 antibody against Dlg developed by 
Corey Goodman were obtained from the Developmental Studies Hybridoma Bank developed 
under the auspices of the NICHD and maintained by the University of Iowa, Department of 
Biological Sciences, Iowa City, IA 52242.  Secondary antibodies from Jackson ImmunoResearch 
Laboratories were used at a dilution of 1:250 and were as follows: Cy2-conjugated Goat anti-
Rabbit, Cy2-conjugated Goat anti-Mouse, Rhodamine Red-conjugated Goat anti-Mouse, and 
Rhodamine Red-conjugated Goat anti-Rabbit.  Visualization
 
was performed under light 
microscopy using a 40x oil-immersion
 
lens.  Images were taken with confocal microscopy 
(Axoplan 2; Carl Zeiss MicroImaging, Inc.) using PASCAL software (Carl Zeiss MicroImaging, 
Inc.).  Immunoreactivity for complexin was abolished in null mutants lacking the protein, 
confirming the antisera we generated specifically cross react with complexin. 
Western Blots 
Western blots were performed using standard laboratory procedures by probing nitrocellulose 
membranes with a variety of antibodies.  Blocking was performed in a solution containing four 
parts TBS (10 mM Tris Base pH 7.5, 150 mM NaCl) to one part Odyssey Blocking Buffer (LI-
COR Biosciences).  Antibody incubations were performed in a solution containing four parts 
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TBST (1X TBS with 1% Tween-20) to one part Odyssey Blocking Buffer.  Antiserum dilutions 
were: complexin, 1:10,000; Syt 1, 1:10,000; arginine kinase, 1:10,000; α-SNAP 1:1,000; 
syntaxin, 1:1,000; synaptobrevin, 1:1,000; SNAP-25, 1:1,000; CSP, 1:200; Rab3, 1:500; Rop, 
1:500.  The probes were detected using Alexa Fluor 680-conjugated goat anti-rabbit IgG at a 
dilution of 1:3000 (Invitrogen Molecular Probes) and IRDye 800-conjugated goat anti-mouse 
IgG at a dilution of 1:10,000.  Visualization was done using the LI-COR Odyssey Imaging 
System (LI-COR Biosciences).  
Electrophysiology  
Electrophysiology under current clamp at 3
rd
 instar NMJs was performed as previously described 
(Rieckhof, Yoshihara et al. 2003) at the indicated extracellular calcium concentrations in HL3.1 
saline at muscle fiber 6 of segments A3 to A5.  Elevated temperature recordings were done at 
32ºC.  
 
Electroretinograms:  ERGs were performed at room temperature on adult flies aged two to seven 
days.  The flies were briefly anesthetized on ice and immobilized in clay.  A sharp glass 
electrode was placed in the eye and a reference electrode was placed in the thorax, allowing 
analysis of the on- and off-transients that represent normal synaptic communication between 
photoreceptors and second order neurons in the visual system.  No defects were observed on 
photoreceptor depolarization in response to a light pulse, suggesting specific defects in synaptic 
communication as opposed to membrane excitability.   
 
ERGs and current clamp recordings were done using an Axoclamp-2B amplifier (Axon) and 
digitized with an Instrunet Model 100 digitizer at 10 kHz and analyzed with Superscope 3.0 
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software (GW Instruments).  Mini frequency was quantified in complexin mutants by counting 
discernable individual peaks.  This is certainly an underestimate of mini frequency in the mutant, 
as the massive increase in spontaneous exocytosis leads to an incredible number of fusion events 
that are tightly packed, with compound fusion events on top of each other, generating 
underestimates of the total rate in the mutant due to a failure to clearly separate individual 
events. 
 
Electrophysiology under voltage clamp: Postsynaptic currents were recorded at segments A3 of 
ventral longitudinal muscle 6 in third instar larvae using two-electrode voltage clamp (OC-725, 
Warner Instruments, Hamden, CT) at -80 mV holding potential in a modified HL3 solution 
containing (in mM) 10 NaHCO3; 5 KCl; 4 MgCl2; 5 HEPES; 70 NaCl; 5 Threalose;115 Sucrose, 
pH 7.2. The Ca
2+
 concentration was adjusted to a final concentration required in each condition.  
Data acquisition and analysis were done using Axoscope 9.0 and Clampfit 9.0 software (Axon 
Instruments, Foster City, CA), respectively. Quantal content of nerve-evoked responses was 
estimated by dividing the current integral of individual nerve-evoked currents by the integral of 
the current evoked by the release of an individual quantum, as described (Acharya, Labarca et al. 
1998; Delgado, Maureira et al. 2000).  For stimulation, nerves were cut close to the ventral 
ganglia and sucked into the stimulating pipette. Nerve stimulation was applied at the indicated 
frequencies using a programmable stimulator Master-8 (A.M.P.I., Jerusalem, Israel). 
Electrophysiology Quantification 
Genotypes used for physiological analysis shown in Figure 5 are: control (w
-
; precise 
excision/precise excision); cpx (w
-
; cpx
SH1
/cpx
SH1
); rescue (w
-
, UAS-cpx/C155elav-
Gal4;cpx
SH1
/cpx
SH1
) and cpx over deficiency (w
-
; cpx
SH1
/Df(3R)ED5021). For Figure 5 and 
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Figure 6, cpx
SH1
 homozygotes (Student t-Test, ** = P<0.0001) and cpx
SH1
/deficiency larvae 
(Student t-Test, ** = P<0.0001) have mini frequencies >20-fold higher than controls. Data used 
in the analysis include: Control (Mini Frequency (MF)=3.14±2.9 Hz; Resting Potential (RP)=-
51.1±1.1; n=18); cpx
SH1
 (MF=67.0±4.8 Hz; RP=-48.3±0.9,  n=27); cpx
SH1
/deficiency 
(MF=58.3±2.3 Hz; RP=-48.6±1.3, n=18); Rescue (MF=2.2±0.2, RP=-54.5±1.8, n=25).  Figure 8 
summarizes average EJP amplitude (± s.e.m.) versus extracellular calcium concentration in 
cpx
SH1 
(closed circles) and precise excision (open squares) larvae.  At low calcium concentrations 
(0.15 mM and 0.2 mM), there is no statistically significant difference between mutants and 
controls.  cpx
SH1
 larvae have significantly lower EJPs at higher calcium concentrations of 0.4 
mM (Student t-Test, ** = P<0.001) and 1 mM (Student t-Test, ** = P<0.01) compared to precise 
excision controls.  Data used in the analysis include: 0.15 mM calcium (Control EJP=9.1±0.9 
mV, RP=-57.4±1.7, n=17; cpx
SH1
 EJP=9.8±0.9 mV, RP=-47.4±1.1, n=11); 0.2 mM calcium 
(Control EJP=15.5±3.1 mV; Resting Potential (RP)=-51.1±1.1; n=10), cpx
SH1
 (EJP=13.5±0.8 
mV; RP=-48.3±0.9, n=18), Rescue (EJP=15.9±2.2  mV, RP=-54.5±1.8, n=8); 0.4 mM calcium 
(Control EJP=28.2±3.1 mV, RP=-54.7±1.5, n=9; cpx
SH1
 EJP=19.6±0.9 mV, RP=-56.6±1.2, 
n=15); 1.0 mM calcium (Control EJP=33.1±2.2 mV, RP=-58.7±1.8, n=14; cpx
SH1
 EJP=25.9±1.2 
mV, RP=-60.2±2.6,  n=9). Comparing mini  frequency across a range of extracellular calcium, 
Figure 6 shows that cpx
SH1
 mutants show statistically significant (Student t-Test) elevated 
spontaneous release at 0 mM (** = P<0.0001), 0.15 mM (** = P<0.0001), 0.2mM (** = 
P<0.0001), 0.4 mM (** = P<0.0001) and 1.0 mM (** = P<0.0001) extracellular calcium 
compared to controls. Data used in the analysis include: cpx
SH1
 – 0 mM calcium (MF=83.2 ± 6.5 
Hz, n=10), 0.15 mM (MF=80.8 ± 9.2 Hz, n=6), 0.2 mM (MF=66.9 ± 4.8 Hz, n=27), 0.4 mM 
(MF=75.9 ± 2.3 Hz, n=15) and 1.0 mM (MF=66.35 ± 2.5 Hz, n=10); precise excision control - 0 
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mM calcium (MF=2.86 ± 0.2 Hz, n=19), 0.15 mM (MF=2.7 ± 0.5 Hz, n=7), 0.2 mM (MF=3.1 ± 
0.3 Hz, n=18), 0.4 mM (MF=3.9 ± 0.6 Hz, n=5) and 1.0 mM  (MF=4.0 ± 0.4 Hz, n=16). Figure 
10 shows that complexin overexpression decreases mini frequency and increases evoked 
response amplitude. Genotypes used in this analysis are: complexin overexpression (elav-GAL4; 
UAS-complexin), no driver control (UAS-complexin), and driver alone control (elav-Gal4). 
Recording were done in 0.2 mM extracellular calcium. Animals overexpressing complexin have 
a >2.8-fold reduction in mini frequency compared with controls (Student t-Test, ** = P<0.0001 
compared to UAS-complexin, ** = P<0.0001 compared to elav-GAL4). Data used in the analysis 
include: elav-GAL4; UAS-complexin (Mini Frequency (MF)=0.9 ± 0.09 Hz; n=32), elav-GAL4 
(MF=2.8 ± 0.2 Hz; n=27), UAS-complexin (MF=2.7 ± 0.3 Hz; n=16). Overexpression of 
complexin results in a statistically significant enhancement in average EJP amplitude versus 
controls (Student t-Test, ** = P<0.0001 compared to UAS-complexin; ** = P<0.003 compared to 
elav-GAL4). Data used in the analysis include: elav-GAL4; UAS-complexin (EJP=23.3 ± 1.4 
mV; Resting Potential (RP)=-60.4 ± 1.6; n=18); UAS-complexin (EJP=12.5 ± 1 mV; RP=-60.5 ± 
3, n=8); elav-GAL4 (EJP=17.2 ± 1.5 mV, RP=-58.2 ± 1.3, n=24).  Genotypes used in analysis in 
Figure 11 are: complexin overexpression (ov cpx) (elav-GAL4; UAS-complexin); cpx (w; 
cpx
SH1
/cpx
SH1
); control (w; precise excision/precise excision). 
Morphological Quantification 
To quantify NMJ bouton number, anti-Synaptotagmin 1 (Syt 1) stained varicosities were counted 
at muscle fiber 6/7 of segments A3 and A4 and at muscle fiber 4 of segment A3.  The number of 
Syt 1-positive varicosities was statistically increased compared to controls at muscle fiber 6/7 of 
segment A3 (Student  t-Test, ** = P<0.0001). Data used in the varicosity number analysis 
include: Control (muscle (m) 6/7 segment A3: bouton  #=76.3±2.8, n=32); cpx
SH1
 (m6/7 segment 
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A3: bouton # =140.6±4.9, n=35); Rescue (m6/7 segment A3: bouton # =73.9±4.2; n=16).  For 
active zone quantification, antisera against the active-zone protein bruchpilot (nc82) was used 
and nc82 positive puncta were counted from confocal stacks taken through muscle fiber 6/7 at 
segment A3 as previously described (Dickman, Lu et al. 2006).  The number of nc82-positive 
active zones was statistically increased compared to controls (Student t-Test, ** = P<0.0002). 
Data used in the active zone analysis include: Control precise excision: active zone # per m6/7 
synapse = 990.4 ± 102.1, n= 12; cpx
SH1
: active zone # per m6/7 synapse = 1620.5 ± 111.5, n=11. 
Adult Locomotion Analysis 
Adult climbing assays and spontaneous locomotion were performed on flies aged 6-7 days as 
previously described (Wang, Saraswati et al. 2004).  Briefly, climbing assays were done on flies 
aged 6-7 days, and the time required to climb 5 cm in a plastic vial was recorded, with a cutoff of 
15 min.  Spontaneous locomotion assays were done by introducing 6- to 7-day-old flies into a 
chamber and quantifying the number of times the fly crossed a line bisecting the chamber in a 
four minute period. 
Gradient Centrifugation 
Isolation of Canton-S head homogenates was performed as described
 
previously (Littleton, 
Serano et al. 1999). A post-nuclear extract was layered onto a 10–30% sucrose gradient and 
centrifuged at 50,000 RPM for 1 h in a
 
NVT65 rotor (Beckman Coulter). 1-ml fractions were 
collected
 
beginning from the bottom of the gradient and proceeding to
 
the top. After collection, 
fractions were mixed with an equal
 
volume of 2x SDS-PAGE loading buffer and probed by 
Western analysis. 
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Transmission Electron Microscopy 
EM supplies were obtained from Electron Microscopy Sciences. Wandering third-instar larvae 
were dissected in HL3 (Stewart, Atwood et al. 1994) and fixed in 0.13 M Cacodylate buffer 
containing 4% paraformaldahyde and 1% glutaraldehyde (pH 7.2). Samples were secondarily 
fixed in 1% OsO4 in 0.13 M cacodylate buffer containing 0.26 M sucrose (pH 7.2), stained en 
bloc with 2% uranyl acetate, dehydrated, and embedded in Scipoxy 812 resin (Energy Beam 
Sciences). Serial sections (65–75 nm) were collected on nickel grids and stained with 1% uranyl 
acetate followed by Reynold's lead citrate.  Data were captured with an electron microscope 
(model
 
JEM-1010; JEOL), and images were processed in Photoshop 7 (Adobe)
 
and assembled in 
CorelDRAW 12 (Corel).   
 
Vesicle density is defined as the number of vesicles/bouton midline cross-sectional area in μm2. 
Major vesicle axis is defined as the longest line bisecting a vesicle.  Cisternae density is defined 
as the number of cisternae / bouton midline cross-section area in μm2. For quantification of 
vesicle density, major vesicle axis, and cisternae density, vesicles were counted from 12 boutons 
from 3 different animals per genotype. Major vesicle axes were counted from 100 vesicles at 
random per bouton. For quantification of the number of vesicles within a 250nm radius of the 
active zone and the number of docked vesicles, 10 active zones from 3 different animals per 
genotype were counted.  
Results 
Features of the Drosophila complexin genomic locus and complexin isoforms 
The Drosophila melanogaster genome has a single gene encoding the complexin protein 
(Tokumaru, Umayahara et al. 2001; Smith, Shu et al. 2007; Wilson, Goodman et al. 2008) 
(Figure 1a).  The genomic locus is predicted to encode fourteen different transcripts produced 
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by alternative splicing, most of them differing in the first exon, which contains a large portion of 
the 5’ untranslated region (UTR) (exons are shown by red bars in Figure 1a).  Alternative 
splicing of the first exon is well supported by sequences of expressed sequence tags (ESTs) that 
correspond to sequences in the alternate first exons (see numbers below exons in Figure 1a).  In 
general, the 5’ UTR of mRNA sequences can mediate regulation of both translation initiation 
and mRNA stability (Pickering and Willis 2005), so the wide variety of 5’ UTRs in complexin 
transcripts suggests that the timing, level, and/or location of complexin expression is tightly 
regulated in Drosophila. 
 The complexin locus may encode up to six different protein sequences.  Two complexin 
isoforms, complexin 7a and complexin 7b (cpx7a and cpx7b in Figure 1), are encoded by 
transcripts that were isolated by PCR from a cDNA library generated from adult flies.  These two 
isoforms mainly differ in their C termini, encoded by two alternate seventh exons, 7a and 7b.  
The coding sequence for cpx7a is contained in exons 3, 4b, 5, 6, and 7a.  Complexin 7a contains 
a conserved CAAX box motif (black box in Figure 1b) that, in mammalian complexins 3 and 4, 
is farnesylated for enhanced localization of complexin to the plasma membrane (Reim, 
Wegmeyer et al. 2005).  Presumably farneslyation of Drosophila complexin 7a also occurs, 
although this has not been definitely shown.  Complexin 7b does not contain an N terminal 
CAAX box motif.  This motif is clearly not universally necessary for complexin function, since 
complexins 1 and 2 do not have a CAAX box motif but are still functional.  It is more likely that 
the CAAX box is used as it is in mammals to affect the subcellular localization of complexin.  
There is no support for expression of complexin 7b by ESTs, but it was the first Drosophila 
complexin reported in the literature (Pabst, Hazzard et al. 2000; Tokumaru, Umayahara et al. 
2001) and in this study it was isolated from a Drosophila cDNA library by PCR, so it is 
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expressed under at least some circumstances. Also, the unique exon 7b is highly conserved 
among 10 related Drosophila species.   
Nine of the fourteen transcripts predicted by Flybase (the primary database of Drosophila 
genomic data) encode a single sequence, complexin A (cpxA in Figure 1b), which is named 
after the Flybase annotation of the transcript encoding it.  Expression of complexin A is well 
supported by available EST sequences.  The coding region for this isoform of complexin is 
contained in exons 3, 5, 6, and 7a.  CpxA is nearly identical to cpx7a with the exception of five 
amino acids (19-23) near the N terminus that are encoded by exon 3 in cpxA and exon 4b in 
cpx7a. Alternative splicing of exon 4 may produce several additional complexin isoforms, 
although support for the expression of these isoforms by ESTs is much weaker than for 
complexin A.  Isoform R (named for the encoding transcript) is produced by splicing of exon 4a 
and is identical to complexin A except in its N terminal thirteen residues.  Isoform L is encoded 
by exon 4c and again differs from complexin 7a only its N terminal residues.  Two additional 
exons, 4d and 4e, are predicted to produce an identical complexin sequence, cpxJ/K, that is 
truncated in the SNARE binding region of complexin.  This region is widely reported to be 
necessary for complexin’s function (Pabst, Hazzard et al. 2000; Chen, Tomchick et al. 2002; 
Xue, Reim et al. 2007), so it is unlikely that if cpxJ/K is expressed it is functional.  All 
Drosophila complexin transcripts contain exons five and six, which encode the highly conserved 
accessory and central alpha helices in complexin (green and purple bars in Figure 1b).  Exon 3 
contains the primary complexin translation start site (ATG in Figure 1a).  Exons 4a, 4c, and 
exon 5 contain additional potential translation start sites.    
 The C terminus of complexin is regulated by both post-transcriptional and post-
translational modifications.  Farnesylation of complexin at the C terminus has already been 
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discussed.  Additionally, in Drosophila the transcripts encoding complexin 7a have been shown 
to be modified by RNA editing to produce two amino acid changes: I124M and N129 to S, G, or 
D (orange boxes in Figure 1b) (Hoopengardner, Bhalla et al. 2003).  Editing of RNAs occurs by 
deamination of adenosine to inosine, which is read as a guanosine by the ribosome.  Only a small 
subset of transcripts are known to be RNA edited, and nearly all encode proteins involved in 
rapid neurotransmission (Hoopengardner, Bhalla et al. 2003).  The functional consequences of 
these modifications are currently unclear. 
 Mammalian complexins have been shown to be phosphorylated at two residues in the C 
terminus, Serine 93 and Serine 115 (Hill, Callaghan et al. 2006; Shata, Saisu et al. 2007).  It is 
not clear what purpose this phosphorylation serves, but these amino acids are highly conserved 
among mammalian complexins 1 and 2.  While these phosphorylation sites are not conserved in 
invertebrate species, several other predicted phosphorylation sites in the C terminus are 
conserved among invertebrates (Figure 1b), including predicted phosphorylation sites for PKA, 
PKC, and CaM kinase II (Obenauer, Cantley et al. 2003; Blom, Sicheritz-Ponten et al. 2004).   
Subcellular localization of Drosophila complexin  
To characterize the subcellular localization of complexin, we generated antisera to recombinant 
Drosophila complexin 7b that recognized a 16-kDa protein in brain extracts and is enriched in 
both CNS and peripheral synapses (Figure 2).  The antisera generated recognize both complexin 
7a and 7b in vitro.  Co-staining for complexin and the pan-neuronal marker horseradish 
peroxidase shows high levels of localization of complexin at nerve terminals of the NMJ (small 
arrowhead in Figure 2a), with very little localization to axons (large arrowhead in Figure 2a).  
Co-staining for complexin and the postsynaptic marker discs large (Dlg) (Figure 2b-d) displays 
non-overlapping staining of the two proteins, demonstrating that complexin is localized 
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presynaptically.  Complexin is localized to both type 1b and 1s synapses at the NMJ (Figure 2c), 
which are two of the major types of glutamatergic synapses at Drosophila larval NMJs.  Co-
staining for complexin and the active-zone protein bruchpilot / nc82 demonstrates that complexin 
is expressed diffusely in presynaptic terminals (Figure 2e-f) and is not specifically localized to 
active zones.  To characterize the compartmental localization of complexin, velocity gradient
 
subcellular fractionation experiments using 10–30% sucrose gradients were performed on 
extracts from wild type adult fly heads (Figure 2g) (Adolfsen, Saraswati et al. 2004).  
Subcellular compartments were identified in fractions using the compartmental markers ROP 
(plasma membrane and cytosol) (Salzberg, Cohen et al. 1993), HRS (endosomes) (Lloyd, 
Atkinson et al. 2002) and synaptogyrin (synaptic vesicles) (Robin Stevens, personal 
communication).  While complexin partitions to all fractions, it is most concentrated in the 
cytosolic fractions, similar to the distribution of Rop.  There is also some enhanced concentration 
in the synaptic vesicle fractions.  This experiment suggests that complexin is mainly localized to 
the cytosol, but further experiments with a larger number of compartmental markers would be 
warranted to confirm this conclusion.  Drosophila complexin is localized presynaptically at 
nerve terminals, and is possibly a cytosolic protein, consistent with complexin functioning in 
regulation of neurotransmitter release.   
Generation of a Drosophila complexin null mutant 
To determine the in vivo function of complexin, we generated the first complete knockout of 
complexin in any organism.  A 17-kb intragenic deletion within complexin (cpx
SH1
) that removed 
most of the coding region was generated by imprecise excision of a P element located in the first 
intron of the complexin gene (Figure 3a-c).  A precise excision lacking any deletion was also 
generated, and served as a control for genetic backgrounds in most experiments.  Imprecise 
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excision of the P element was confirmed by a PCR across the P element insertion site in genomic 
DNA from wild type (white), precise excision, and cpx
SH1
 homozygote adult fly heads (Figure 
3b and orange bar in 3a).  The boundaries of the deletion were mapped by PCR of six 500 base-
pair products at locations upstream and downstream of the P element insertion site (Figure 3c 
and green bars in 3a).  The deletion extends from the P element insertion site in the first intron to 
somewhere between exons 7a and 8 (purple bar and dashes in Figure 3a), removing the primary 
translation start site, the additional putative translation start sites, and nearly all of the coding 
region of complexin.  Western analysis (Figure 3d) confirmed the loss of expression of the 
complexin protein in cpx
SH1
 homozygotes, and reduced expression in heterozygotes compared 
with white controls.  Immunocytochemistry (Figure 3e) at third-instar larval NMJs using 
antibodies to complexin and the neuronal marker HRP revealed that, while neuronal connectivity 
with muscles remains in cpx
SH1 
mutants, there is no evidence of expression of complexin in the 
mutant, further confirming that it is a null allele.  Expression levels of many synaptic proteins, 
including arginine kinase, α-SNAP, syntaxin, synaptobrevin, SNAP-25, syt 1, cysteine string 
protein, Rab3, and Rop (sec1/unc-18) do not change in complexin mutants (Figure 3f). 
Null mutants lacking complexin display several striking phenotypes.  The cpx
SH1
 allele is 
semilethal, with most homozygous animals dying before adult eclosion. Escaper adults are 
infertile and show severe motor defects, moving visibly slower than controls, frequently falling 
to the bottom of the vial, and having difficulty righting themselves after falling.  Quantification 
of the motor defect in complexin mutants using a wall climbing assay (Figure 4a) and a 
spontaneous locomotion assay (Figure 4b) confirms these observations, with complexin mutants 
taking 69.9 times longer on average to climb a vial and crossing a chamber a factor of 33.9 times 
fewer than their wild type counterparts.  To determine whether these phenotypes might result 
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from defects in synaptic transmission, electroretinograms detecting synaptic transmission in the 
second order neurons of the retina were performed on controls and null mutants.  These 
demonstrated that complexin null mutants lack the on- and off-transients that represent normal 
synaptic transmission in response to light pulses in the visual system (arrows in Figure 4c), 
suggesting that cpx
SH1
 mutants have a synaptic transmission defect.  Pan-neuronal expression of 
a UAS-complexin7b transgene with the elav-GAL4 neuronal driver rescues the reduced viability, 
motor defects, and abnormal synaptic transmission of cpx
SH1 
mutants (Figure 4a,c), 
demonstrating that these phenotypes are due to lack of complexin expression and not to second-
site mutations.  
Electrophysiological characterization of the Drosophila complexin null mutant cpxSH1 
To analyze the role of complexin in neurotransmitter release, we performed electrophysiological 
recordings at Drosophila third-instar larval abdominal muscle 6 synapses.  cpx
SH1
 mutants 
displayed a profound enhancement in the frequency of miniature excitatory junctional potentials 
(mEJPs or minis) (Figure 5a).  By expanding the time scale of the recordings and attempting to 
distinguish individual minis (arrows in Figure 5b), we quantified the frequency of minis in 
control and mutant larvae.  Mini frequency was enhanced by at least 20 fold at cpx
SH1 
mutant 
synapses (67 ± 4.8 Hz compared to 3.1 ± 0.3 Hz at control synapses), demonstrating continuous 
exocytosis of synaptic vesicles in the absence of any stimulation (Figure 5c).  This is likely to be 
an underestimate of the true mini frequency in cpx
SH1
 mutants because it is difficult to separate 
individual minis in the mutant due to their high frequency.  cpx
SH1
 heterozygous with a 
deficiency that removes complexin (cpx/Df in Figure 5c) also displays a massively enhanced 
mini frequency (58.3 ± 2.3 Hz).  Neuronal expression of a UAS-complexin7B transgene in a 
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homozygous null mutant background rescued the enhanced frequency of spontaneous release 
(2.2 ± 0.2 Hz) (Figure 5).  
There are several possible explanations for the enhanced mini frequency observed in 
complexin mutants.  One is that complexin functions as a vesicle fusion clamp, and without it 
synaptic vesicles are released immediately after priming.  Other explanations are that the minis 
result from aberrant influx of calcium into the nerve terminal, that neurotransmitter is released 
from the nerve terminal extravesicularly, that a morphological defect results from removal of 
complexin that causes enhanced spontaneous release, or that there is a postsynaptic defect in 
complexin mutants, an obvious example of which would be aberrant opening of glutamate 
receptors in the muscle.  We performed a series of experiments to distinguish among these 
possibilities. 
To confirm that the increase in miniature postsynaptic potentials resulted from increased 
spontaneous vesicle fusion, as opposed to non-vesicular dumping of glutamate at the synapse or 
to a postsynaptic defect, we made use of a temperature-sensitive allele of dynamin (shibire
TS1
) 
that blocks endocytosis at 32 ºC (Koenig and Ikeda 1989).  High-frequency stimulation at 32 ºC 
depletes the synaptic vesicle pool in shibire mutants.  If the enhanced mini frequency observed in 
cpx
SH1
 mutants is due to vesicular release from the presynaptic terminal, high frequency 
stimulation would be predicted to eliminate the enhanced spontaneous vesicle fusion in double 
mutants.  Indeed, after a 5-minute 10-Hz stimulation train at 32ºC in shibire
TS1
; cpx
SH1
 double 
mutants, which abolished evoked release, the elevated mini frequency observed at permissive 
temperatures was eliminated (Figure 6a).  To determine whether the enhanced mini frequency 
observed in complexin mutants is due to aberrant influx of calcium into the nerve terminal, we 
quantified mini frequency at control and mutant NMJs over a range of extracellular calcium 
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concentrations from 0mM to 1mM.  The frequency of spontaneous release in cpx
SH1
 mutants 
remained strongly elevated across the range of calcium concentrations, including 0 mM (Figure 
6b), ruling out enhanced calcium influx into the presynaptic nerve terminal as the cause for the 
enhanced spontaneous release.  Thus, the enhanced mini frequency in complexin null mutants is 
due to a large increase in the frequency of spontaneous, calcium-independent release of synaptic 
vesicles from presynaptic nerve terminals.  
These observations suggest that complexin functions as the synaptic vesicle fusion clamp 
in vivo, and with its loss, synaptic vesicles continuously fuse in the absence of stimulation. 
Another possible explanation for the enhanced mini frequency in complexin mutants is that 
synapses in the mutants have a severe morphological defect that causes enhanced mini 
frequency.  By analyzing synaptic structure, we were able to determine whether this might be the 
case.  This experiment also provided us an opportunity to determine the consequences of 
increased mini frequency on synaptic growth.  To analyze synaptic structure, we counted 
synaptic varicosities in age-matched control and cpx
SH1
 third-instar NMJs at three different 
muscle segments.  cpx
SH1
 mutants showed a two-fold overproliferation of boutons at each muscle 
examined (Figure 7a-d), and neuronal expression of a complexin transgene in the mutant 
background reverted the synaptic overgrowth phenotype.  Overgrowth of NMJs resulted in a 
concomitant increase in the total number of active zones present at synapses, with 64% more 
active zones at muscle 6/7 segment A3 in complexin mutants (Figure 7e,g).  There is almost no 
difference in the number of active zones per bouton between wild type (13.0 active zones / 
bouton) and mutant (11.53 active zones / bouton ) synapses (Figure 7f), demonstrating that the 
increase in the total number of active zones in complexin mutants is due to the increase in bouton 
number.  These data eliminate any structural considerations that could account for the enhanced 
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minis, as the 64% increase in the number of active zones is insufficient by far to explain the >20-
fold increase in spontaneous release.  Based on this data, we conclude that complexin functions 
as a vesicle fusion clamp in vivo. 
Loss of the synaptic vesicle fusion clamp in complexin mutants resulted in a defect in 
evoked excitatory junctional potentials (EJPs) at the NMJ (Figure 8).  In high extracellular 
calcium concentrations of 1.0 mM and 0.4 mM, evoked responses in cpx
SH1
 mutants after nerve 
stimulation were significantly reduced compared with controls, whereas in low extracellular 
calcium concentrations of 0.2 mM and 0.15 mM we observed no difference.  Because complexin 
mutant synapses showed a 64% increase in active zone number this indicates that neuromuscular 
junction synapses lacking complexin had a reduction in evoked fusion events per active zone that 
was exacerbated at high calcium levels, where large numbers of synchronous synaptic vesicle 
fusion events are required. This suggests that with loss of the vesicle fusion clamp in complexin 
mutants and uncontrolled release of synaptic vesicles, there is a defect in the number of vesicles 
available for release during evoked responses.  Such a defect might result from fewer docked 
vesicles or fewer primed vesicles.   
 To determine whether there are ultrastructural defects in complexin mutants that could 
account for the observed electrophysiological phenotypes, we performed electron microscopy 
(EM) to image the ultrastructure of mutant and control type 1 NMJ synapses (Figure 9).  
Analysis of images of boutons in control and mutant larvae (Figure 9a,b), showed no significant 
differences in the number of synaptic vesicles per bouton (Figure 9c) or the size of synaptic 
vesicles, as measured by the average length of the major axis of synaptic vesicles (Figure 9d).  
There were also no significant differences in the number of vesicles within 250 nm of active 
zones (presynaptic density in Figure 9f and g) or the number of docked vesicles (Figure 9h and 
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i).  Thus, the defect in evoked potentials in complexin mutants is unlikely to result from a 
decrease in the number of docked vesicles.  The only difference in ultrastructure between mutant 
and control observed was a significant increase in the number of cisternae per bouton in 
complexin mutants (Figure 9e).  Cisternae are large, clear vesicles resulting from bulk 
endocytosis at the synapse that are precursors for synaptic vesicle formation (Koenig and Ikeda 
1989).  They can be found in small numbers in wild type synapses (Zhang, Koh et al. 1998), but 
are observed in greater numbers when large numbers of vesicles must be made, as in the case of 
shibire mutants after depletion of vesicles from the nerve terminal (Koenig and Ikeda 1989).  
This phenotype is consistent with the massive increase in mini frequency observed in complexin 
mutants and suggests a mechanism by which the vesicle pool might be maintained when the rate 
of exocytosis is so elevated.  
 Ultrastructural analysis indicates that complexin mutants do not have a depletion in 
docked vesicles.  It is therefore likely that the reduced EJP amplitude observed at high calcium 
concentrations in the mutant is due to depletion of the readily releasable pool of vesicles.  If this 
is the case, the function of the fusion clamp can be understood to be prevention of spontaneous 
release of vesicles in the readily releasable pool, which consists of those vesicles that are docked 
and primed, conserving them for evoked release.  Overexpression of complexin would then be 
predicted to decrease spontaneous release frequency at the NMJ and enhance the size of the 
readily releasable pool of vesicles, causing an increased amplitude of evoked responses.  To test 
this, a UAS-complexin7b transgene was overexpressed pan-neuronally with the driver elav-Gal4 
(Figure 10).  Immunohistochemistry at NMJs of precise excision, rescue (elav-Gal4,UAS-
cpx7B;cpx
SH1
/cpx
SH1
), and overexpression (elav-Gal4;UAS-cpx7b/UAS-cpx7b) larvae 
demonstrates that the overexpressed complexin is localized to NMJs (Figure 10a).  Western 
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blots on adult heads shows levels of complexin several times higher in overexpression flies 
compared to control flies (Figure 10b).  Overexpression of complexin in larvae significantly 
decreases mini frequency by more than 2.8-fold at NMJs compared to controls (Figure 10c,e) 
(complexin overexpression mini frequency = 0.9 ± 0.09 Hz, elav-GAL4 mini frequency = 2.8 ± 
0.2 Hz; n=27, UAS-complexin mini frequency = 2.7 ± 0.3 Hz, P < 0.0001.).  Overexpression of 
complexin also significantly enhances the average amplitude of evoked potentials by 36.2% 
(Figure 10d,f) (elav-GAL4; UAS-complexin EJP=23.3 ± 1.4 mV, UAS-complexin EJP=12.5 ± 1 
mV, elav-GAL4 EJP=17.2 ± 1.5 mV, P < 0.0001).  These observations support the idea that 
complexin functions to keep primed vesicles from fusing prematurely, holding them for evoked 
release.  In addition, these observations suggest that complexin does not saturate SNARE 
complexes at the NMJ because overexpression of complexin is able to decrease mini frequency 
from that observed at wild type synapses.  If normal complexin expression levels were sufficient 
to saturate SNARE complex binding at the synapse, overexpression of complexin would be 
predicted to have little or no effect on mini frequency.  
 To further test the idea that complexin prevents vesicles in the readily releasable pool 
(RRP) from fusing prematurely, we tested the effect of high frequency stimulation (HFS) on 
evoked responses in control, mutant, and overexpression larvae under voltage clamp (Figure 
11).  Short term synaptic depression due to (HFS) at high calcium concentrations results from 
rapid depletion of the RRP.  If complexin mutants have a depleted RRP, this will be reflected in a 
decrease in depression compared to wild type during HFS because the initial train of evoked 
responses will have low amplitudes at the outset, while the recycling pool should not be affected.  
Under voltage clamp, cpx
SH1
 displays a large increase in mini frequency compared to controls, 
just as it does under current clamp (Figure 11a).  During a HFS of 10Hz stimulation for 150 
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seconds at 2.0 mM extracellular calcium, control responses rapidly undergo depression as the 
RRP depletes (Figure 11b).  After depletion of the RRP, the recycling pool sustains evoked 
responses.  In complexin mutants, initial responses have smaller amplitudes compared to the 
control and the initial depression phase is specifically abolished, leaving the sustained response 
of the recycling pool intact.  In contrast, overexpression of complexin increases the depression 
effect, with increased initial responses, indicating that in overexpression larvae the RRP size is 
enhanced.   
 Calcium influx into nerve terminals triggers synaptic vesicle exocytosis in a fast 
synchronous phase of release and a slow, asynchronous phase (Figure 11c, left panel).  The two 
phases have distinct kinetics of release and only synchronous release requires calcium sensing by 
synaptotagmin 1 (Geppert, Goda et al. 1994; Yoshihara and Littleton 2002).  In complexin 
mutants, as in syt1 mutants, the synchronous phase is specifically affected.  When EPSCs are 
normalized to the number of active zones present at NMJs in control and mutant larvae, the 
amplitude of the synchronous phase of release in complexin mutants is reduced compared to 
controls, while the kinetics of asynchronous release are unaffected (Figure 11c, right panel).  In 
contrast, overexpression of complexin reduces the asynchronous phase of release.  Taken 
together, these data suggest that complexin assists in synchronizing release by holding vesicles in 
the readily releasable pool of vesicles, preventing them from fusing prematurely with the 
presynaptic membrane. 
Discussion 
Our analysis demonstrates that the interaction of complexin with the SNARE complex provides a 
molecular fusion clamp to prevent spontaneous release from the readily releasable pool of 
vesicles at synapses in the absence of stimulation.  These in vivo observations match well with 
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the predicted fusion clamp model based on the in vitro reduction of SNARE-mediated fusion by 
complexin (Giraudo, Eng et al. 2006; Schaub, Lu et al. 2006). Although analysis of cultured 
hippocampal autaptic neurons lacking three of the four mouse complexin genes (Reim, 
Wegmeyer et al. 2005) showed reduced neurotransmitter release (Reim, Mansour et al. 2001) 
(Xue, Stradomska et al. 2008), which matches the observations in Drosophila, mini frequency in 
the mouse system was reported to be unchanged.  It is unclear what underlies the discrepancy in 
mini frequency between models, but one potential explanation is that in mouse either complexin 
4 or other unknown components of the fusion clamp machinery compensate for the loss of 
complexin.  Another potential explanation is that recordings from mice or hippocampal cultures 
from mice were done at P0 or days 10 to 16 of growth, when complexin is either not expressed 
or is not localized to synapses in wild type cells (Ono, Baux et al. 1998; Reim, Wegmeyer et al. 
2005).  It is possible that this reflects a maturation process at synapses and only after this is 
complete is complexin required.  If this is the case, recording from synapses early in 
development may not reveal all aspects of complexin’s function at the synapse.  In this study, we 
have generated the first complete knockout of complexin in any organism and recorded from 
mutant synapses that are developmentally mature and highly stereotyped, revealing a new aspect 
of complexin’s function in vivo that provides a fusion clamp mechanism for synaptic vesicle 
exocytosis.   
It has long been known that minis represent single vesicle fusion events, but their 
underlying function has remained unclear.  Our results unexpectedly uncovered a marked effect 
on synaptic growth at the Drosophila NMJ in complexin mutants.  Although previous studies in 
hyperexcitable Drosophila mutants have demonstrated that increased neuronal activity promotes 
synaptic growth (Guan, Saraswati et al. 2005), the contributions of spontaneous versus evoked 
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signaling are unknown.  Activity-dependent retrograde signaling by the postsynaptic calcium 
sensor Synaptotagmin 4 has also been shown to transiently increase mini frequency 100-fold and 
trigger enhanced synaptic growth at Drosophila embryonic NMJs (Yoshihara, Adolfsen et al. 
2005).  It is tempting to speculate that regulation of complexin during retrograde signaling 
underlies activity-dependent enhancement of spontaneous fusion and synaptic growth.  There is 
at present little evidence that the increased minis cause the morphological overgrowth, and 
further studies will be required to dissect the mechanism by which complexin mutants enhance 
synaptic growth.  Recent work in mammals suggests that spontaneous release can regulate 
dendritic spine morphogenesis (McKinney, Capogna et al. 1999) and dendritic protein synthesis 
(Sutton, Wall et al. 2004).  Complexin dysfunction has also been implicated in human diseases, 
including schizophrenia (Sawada, Barr et al. 2005), indicating that abnormal spontaneous fusion 
may contribute to certain neurological diseases.   
Given that complexin and the synaptic vesicle calcium sensor Synaptotagmin 1 compete 
for binding to SNARE complexes (Tang, Maximov et al. 2006), an attractive model for synaptic 
vesicle exocytosis is the following:  During priming, complexin stabilizes a hemifused 
intermediate by preventing full zippering of the SNARE complex, by preventing synaptotagmin 
1 from triggering vesicle fusion, or possibly via both mechanisms.  Upon calcium activation of 
synaptotagmin 1, the clamp is relieved, perhaps by removal of complexin from the SNARE 
complex.  Synaptotagmin 1 is then free to drive fusion and synaptic vesicles proceed from a 
hemifused state to full fusion.  Our results demonstrate that, together with synaptotagmin 1, 
complexin functions in vesicles fusion by acting as a key neuronal modulator of the SNARE 
complex that adapts the ubiquitous membrane trafficking machinery for synaptic vesicle fusion. 
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Figure 1. Features of the Drosophila complexin  locus and its protein products. (a) Drosophila complexin  is 
diagrammed. Red and black bars represent exons. Black portions of exons indicate protein coding regions, while 
red portions indicate untranslated regions. Lines connecting exons represent splice junctions. Exon numbers are 
labeled below diagrammed exons. Exons 1, 4, and 7 are predicted to be alternatively splice d. Exon 1 alternative 
splicing produces many different 5' UTRs, suggesting tight regulation of complexin expression. Exon 4 alternative 
splice junctions are shown in several different colors for the sake of clarity. Exon 4 alternative splicing is 
predicted to produce several protein sequence variants differing in the N terminal region of complexin (panel b). 
Exon 7 alternative splicing produces two sequence variants, "cpx7a" and "cpx7b", that mainly differ in their C 
terminal sequences. Two versions of exon 5 are shown that are identical in sequence, but the top exon 5 
highlights the putative translation start site for cpxJ/K (panel b). For alternatively spliced exons, the number of 
ESTs whose sequences map to those exons is indicated to show the extent to w hich the predicted splice variants 
have been experimentally verified. Protein sequence complexin A is produced by the majority of predicted 
transcripts and is most supported by EST data. However, only transcripts encoding complexins 7a and 7b have 
been isolated from cDNA libraries. The primary translation start site (ATG) for the locus is present in exon 3, but 
there are 3 additional predicted alternative start sites. CG9780 (blue arrow pointing left) is a gene of unknown 
function located in the intron between exons 4 and 5. Transcript sequences, EST sequences, translation start site 
predictions, and annotations are based on the sequence of the Drosophila melanogaster  genome revision 5.1 
and were downloaded from Flybase (http://flybase.org) (Smith et al Science 2007; Wilson et al Nucleic Acids 
Research 2008) and analyzed using CLC Bio DNA Analysis software. ( b) Alignment of six Drosophila melanogaster  
complexins (7a, 7b, A, L, R, and J/K) with complexins from other invertebrate species. The six D. melanogaster 
complexin isoforms are separated from the other invertebrate complexins by a black line in the alignment. The 
alternative exons that encode the different complexin isoforms are labeled in panel a according to the isoform 
they encode. cpxA, cpxL, cpxR, and cpxJ/K are named for the annotations of the transcripts that produce them 
and differ from dmcpx7a in their N terminal sequence. Complexins L, R, and J/K are encoded by alternate exons 
4c, 4a, and 4e and 4d, respectively. cpxJ/K is encoded by two different fourth exons (4e and 4d) differing in their 
untranslated regions that have identical coding sequences with the putative translation start site in exon 5. 
cpxJ/K is an N-terminal truncation of cpx7a. Complexins 7a and 7b have distinct C termini encoded by  exons 7a 
and 7b. Only cpx7a and cpx7b have been definitively shown to be expressed in vivo. Primary sequences of 
complexins were aligned for maximal homology using CLC Bio Analysis software. Residues that are identical in at 
least 50% of sequences are highlighted in dark blue. The colored bars highlight important fragments of the 
sequence. Red bar: Fragment crystallized in rat complexin structure (Chen et al Neuron 2002). Purple bar: 
Central alpha helix responsible for binding to the SNARE complex. Green b ar: accessory alpha helix. Yellow bar: 
N terminal 26 residues proposed to overcome the inhibitory function of the accessory alpha helix (Xue et al Nat 
Struct Mol Biol 2007). Black box: CAAX motif found in complexins from invertebrate species and mammalian 
complexins 3 and 4. Abbreviations: dm, Drosophila melanogaster ; dp, Drosophila pseudoobscura ; ds, Drosophila 
simulans; dv, Drosophila virilis ; tc, Tribolium castaneum; lp, Loligo pealei; am, Apis mellifera;  hm, Hirudo 
medicinalis. mRNAs that encode cpx7a, cpxA, cpxL, cpxR, and cpxJ/K are edited at cpx7a sites I124 to M and 
N129 to serine, glycine, or aspartic acid (highlighted by orange boxes) (Hoopengardner et al Science 2003). 
Complexin is predicted to be phosphorylated at several sites (*). Phosphorylati on predictions were implemented 
using two phosphorylation prediction programs, NetphosK (http://www.cbs.dtu.dk/services/NetPhosK/) (Blom et 
al Proteomics 2004) and Scansite (http://scansite.mit.edu) (Obenauer et al Nucleic Acids Res  2003). Predicted 
phosphorylation sites and corresponding kinases marked by asterisks from left to right: T101, PKA and PKC; T118 
and T119, PKC; T126, casein kinase 2; S126, PKC and PKA. Numbering is relative to dmcpx7b if site is present in 
dmcpx7b; otherwise numbering is relative to dmcpx7a. 
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Figure 2. Subcellular localization of Drosophila complexin.  (a-f) Third instar larval NMJs stained with antisera 
against complexin and (a) the neuronal tissue marker Horseradish Peroxidase (HRP), (b-d) The postsynaptic 
marker Discs large (Dlg), and (e-f) the active zone marker Bruchpilot/nc82. (a) Complexin (magenta) is enriched 
in nerve terminals. HRP (green) shows immunoreactivity to both axons (arrowhead) and nerve term inals. 
Complexin immunoreactivity is low in axons but high in nerve terminals. ( b) Dlg staining (magenta) and 
complexin staining at the NMJ do not overlap, showing that complexin is expressed presynaptically. ( c) 
Complexin is expressed at two of the major types of excitatory glutamatergic synapes at NMJs, types 1b and 1s. 
(d) Magnified view of complexin and dlg costaining showing complexin's presynaptic expression. ( e-f) Images of 
nc82 (magenta) and complexin (green) at (e) an NMJ or (f) individual NMJ boutons. Complexin is not enriched at 
active zones but is present throughout the nerve terminal. ( g) Complexin primarily localizes to cytosolic 
fractions on a sucrose gradient of post-nuclear adult fly head extracts. Post-nuclear fractions of Canton S head 
extracts were separated on 10-30% sucrose gradients. Isolated fractions were probed for subcellular markers by 
Western analysis, including antisera against ROP / unc18, which localizes to the plasma membrane (left -most 
fractions). Synaptic vesicle fractions were identified using the synaptogyrin antibody, cytosolic fractions were 
indicated by immunostaining for ROP, and endosomal fractions by staining for HRS (Lloyd et al. Cell 2002). The 
last collected fraction (right-most lane) often contained contaminants f rom the residual membrane debris 
extracted from the tube sides in the final step.  
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Figure 3. Generation of a complexin  null mutant in Drosophila. (a) The complexin genomic locus is diagrammed. 
A deletion mutant was produced by imprecise excision of a P -element (yellow triangle) located in the first intron 
of complexin, 2.7 kb upstream of the primary translation start site (ATG) in exon 3. Orange and green bars 
represent diagnostic PCR products used in deletion mapping. ( b) PCR spanning the P-element insertion site 
(orange bar in panel a) on genomic DNA from white (positive control), precise excision , and cpx
SH1
 flies reveals 
lack of the genomic PCR product in the null mutant. (c) PCR mapping of ~500 base pair stretches of genomic DNA 
at defined locations upstream and downstream of the P-element in white (control) and cpx
SH1
 animals reveals an 
intragenic complexin deletion removing the region between the P element insertion site in the first exon to a 
location between exons 7a and 8 defined by PCR products 2 -4. Numbers refer to green bars in panel a. Purple 
bar in panel a shows extent of deletion in cpx
SH1
 mutants. (d) Western analysis of control, heterozygotes and 
cpx
SH1
 mutants with an anti-complexin antibody shows reduced expression in heterozygotes and loss of the 
protein in the null mutant. Syt 1 immunoreactivity (top lanes) was used as a loading control. ( e) 
Immunohistochemistry at larval NMJs confirms the absence of complexin in the cpx
SH1
 mutant compared to 
control. Anti-HRP (green) was used to mark axons and varicosi ties at the NMJ. Complexin staining in the white 
control (top panels) is present, but is absent in the mutant (bottom panels). ( f) Expression levels of many 
synaptic proteins are not altered in complexin mutants compared to precise excision  controls. Proteins analyzed 
by Western Blot include: arg. kinase (arginine kinase), α -SNAP (soluble N-ethylmaleimide-sensitive fusion 
protein (NSF)-attachment protein), syntaxin, n-syb (synaptobrevin); SNAP-25 (synaptosome-associated protein 
of 25000 daltons), syt1 (synaptotagmin 1); CSP (cysteine string protein); Rab3; Rop (sec1/unc -18). 
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Figure 4. Complexin  null mutants have severe defects in motor coordination and synaptic transmission. (a) 
cpx
SH1
 escaper adults show severe motor defects compared to precise excision  controls and rescue animals in a 
wall climbing assay. The numbers of animals assayed were: precise excision , n=15; cpxSH1, n=7; rescue (w-, UAS-
cpx/C155elav-Gal4; cpx
SH1
 / cpx
SH1
), n=14. (b) cpx
SH1
 escaper adults are deficient in spontaneous locomotion, 
crossing an enclosure significantly fewer times than controls. The numbers of animals assayed were: precise 
excision, n=10; cpx
SH1
, n=7.  Error bars for a and b are s.e.m. and statistical significance was determined by the 
Mann-Whitney U test (** = P<0.0001). (c) On/off transients (arrows) in electroretinogram recordings are absent 
in cpx
SH1
 mutants, compared with control white lines and rescue animals, indicating a disruption of synaptic 
transmission between photoreceptors and second order neurons in the visual system.  
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Figure 5. Complexin mutants show a massive increase in mini frequency at third-instar larval NMJs. (a-c) The 
genotypes analyzed are: control (w-; precise excision/precise excision ); cpx (w-; cpx
SH1
/ cpx
SH1
); rescue (w-, UAS-
cpx/C155elav-Gal4; cpx
SH1
/ cpx
SH1
) and cpx/Df (w-; cpx
SH1
/Df(3R)ED5021). (a) Sample traces of mEJPs in precise 
excision, cpx
SH1
 and rescue larvae. cpx
SH1
 mutants show massive spontaneous exocytosis compared to controls. 
(b) Sample traces with expanded timescale showing individual minis labeled with  arrows in the top trace from 
the indicated genotypes. (c) Quantification of average mini frequency (Hz ± s.e.m.) in precise excision , cpx
SH1
, 
cpx
SH1
/Df, and rescue animals in 0.2 mM extracellular calcium. cpx
SH1
 homozygotes (Student t-Test, ** = 
P<0.0001) and cpx
SH1
/Df larvae (Student t-Test, ** = P<0.0001) have mini frequencies >20-fold higher than 
controls. Data used in the analysis include: Control (Mini Frequency (MF)=3.14±2.9 Hz; RP= -51.1±1.1; n=18), 
cpx
SH1
 (MF=67.0±4.8 Hz; RP=-48.3±0.9, n=27), cpx
SH1
/Df (MF=58.3±2.3 Hz; RP=-48.6±1.3, n=18), Rescue 
(MF=2.2±0.2, RP=-54.5±1.8, n=25).  
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Figure 6. Enhanced mini frequency in complexin mutants is due to spontaneous vesicle release from the 
presynaptic terminal and does not require calcium influx. (a) Recordings at 20°C and at 32°C (following a 5 min 
10 Hz stimulation) in shibire
TS1
; cpx
SH1
 double mutants. In the double mutant, no minis are observed at the 
restrictive temperature after stimulation, demonstrating that the mEJPs observed in the mutant are due to 
spontaneous synaptic vesicle release from the presynaptic terminal. (b) cpx
SH1
 mutants show statistically similar 
(Student t-Test) elevated spontaneous release at 0 mM (** = P<0.0001), 0.15 mM (** = P<0.0001), 0.2 mM (** = 
P<0.0001), 0.4 mM (** = P<0.0001) and 1.0 mM (** = P<0.0001) extr acellular calcium compared to controls. 
Data used in the analysis include: cpx
SH1
 - 0 mM calcium (MF=83.2 ± 6.5 Hz, n=10), 0.15 mM (MF=80.8 ± 9.2 Hz, 
n=6), 0.2 mM (MF=66.9 ± 4.8 Hz, n=27), 0.4 mM (MF=75.9 ± 2.3 Hz, n=15) and 1.0 mM (MF=66.35 ± 2.5 Hz, 
n=10); precise excision  control - 0 mM calcium (MF=2.86 ± 0.2 Hz, n=19), 0.15 mM (MF=2.7 ± 0.5 Hz, n=7), 0.2 
mM (MF=3.1 ± 0.3 Hz, n=18), 0.4 mM (MF=3.9 ± 0.6 Hz, n=5) and 1.0 mM  (MF=4.0 ± 0.4 Hz, n=16).  
  
106 
 
 
107 
 
Figure 7. Quantification of synaptic overgrowth at complexin  mutant NMJs. (a) Anti-syt 1 staining of third-
instar larval muscle 6/7 NMJs from segment A3 showing synaptic overgrowth in cpx
SH1
 compared to precise 
excision and rescue animals. Top panels: green = Syt 1 to label varicosities; magenta = Texas -Red phalloidin to 
label muscle actin. Bottom panels: Syt 1 staining alone. ( b-d) Quantification of synaptic overgrowth ± s.e.m. at 
three NMJs in precise excision , cpx
SH1
, and rescue animals. The number of Syt 1-positive varicosities in cpx
SH1
 
mutants was statistically increased compared to controls at ( b) muscle fiber 6/7 of segment A3 (Student t -Test, 
** = P<0.0001), (c) muscle fiber 6/7 of segment A4 (Student t -Test, ** = P<0.0001), and (d) muscle fiber 4 of 
segment A3 (Student t-Test, ** = P<0.0001). Data used in the analysis include: Control (muscle (m) 6/7 segment 
A3: bouton # = 76.3±2.8, n=32; 6/7 segment A4: bouton # = 54.8±2.2; m4 segment A3: bouton # =27.2±1.4; 
n=32), cpx
SH1
 (m6/7 segment A3: bouton # = 140.6±4.9, n=35; m6/7 segment A4: bouton # =101.6±3.5; m4 
segment A3: bouton # =45.6±1.6; n=35), Rescue (m6/7 segment A3: bouton # = 73.9±4.2, n=16; m6/7 segment 
A4: bouton # =51.4±4.9; m4 segment A3: bouton # =28.5±2.0; n=16). (e) Quantification of active zone number ± 
s.e.m. at muscle 6/7 NMJs of segment A3. **P=0.01. Data used in the active zone analysis include: Control 
precise excision: active zone # per m6/7 synapse = 990.4 ± 102.1, n= 12; cpx
SH1
: active zone # per m6/7 synapse 
= 1620.5 ± 111.5, n=11. (f) Number of active zones per bouton at muscle 6/7 NMJs of segment A3. Values were 
generated by dividing the mean number of active zones in a given genotype by the mean number of boutons. 
Data used in the analysis include: Control precise excision: mean number of active zones per m6/7 synapse = 
990.4, mean number of boutons per m6/7 synapse = 76.3, number of active zones per bouton = 13.0; cpx
SH1
: 
mean number of active zones per m6/7 synapse = 1620.5 mean number of b outons per m6/7 synapse = 140.6, 
number of active zones per bouton = 11.53. (g) Staining of third-instar larval muscle 6/7 NMJs from segment A3 
with antibodies to horseradish peroxidase (HRP) and bruchpilot (nc82), showing increased active zone number 
and enhanced synaptic proliferation in cpx
SH1
 mutants. 
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Figure 8. Complexin mutants have significant defects in EJP amplitude at elevated calcium concentrations.  (a) 
Sample traces of EJPs from precise excision, cpx
SH1
 and rescue larvae at 0.2 mM extracellular calcium. (b) 
Quantification of evoked response ± s.e.m. at 0.2 mM extracellular calcium. cpx
SH1
 mutants show no statistically 
significant difference (Student t-Test) in average EJP amplitude at this ca lcium concentration. Data used in the 
analysis include: Control (EJP=15.5±3.1 mV; Resting Potential (RP)= -51.1±1.1; n=10), cpx
SH1
 (EJP=13.5±0.8 mV; 
RP=-48.3±0.9, n=18), Rescue (EJP=15.9±2.2 mV, RP=-54.5±1.8, n=8). (c) Summary of average EJP amplitude (± 
s.e.m.) versus extracellular calcium concentration in cpx
SH1
 (closed circles) and precise excision  (open squares) 
larvae. At low calcium concentrations (0.15 mM and 0.2 mM), there is no statistically significant difference 
between mutants and controls. cpx
SH1
 larvae have significantly lower EJPs at higher calcium concentrations of 
0.4 mM (Student t-Test, ** = P<0.001) and 1 mM (Student t -Test, ** = P<0.01) compared to precise excision  
controls. Data used in the analysis include: 0.15 mM calcium (Control EJP=9 .1±0.9 mV, RP=-57.4±1.7, n=17; 
cpx
SH1
 EJP=9.8±0.9 mV, RP=-47.4±1.1, n=11); 0.2 mM calcium (see B); 0.4 mM calcium (Control EJP=28.2±3.1 mV, 
RP=-54.7±1.5, n=9; cpx
SH1
 EJP=19.6±0.9 mV, RP=-56.6±1.2, n=15); 1.0 mM calcium (Control EJP=33.1±2.2 mV, 
RP=-58.7±1.8, n=14; cpx
SH1
 EJP=25.9±1.2 mV, RP=-60.2±2.6, n=9).  
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Figure 9. Ultrastructural analysis of complexin mutants. (a and b) Electron Micrographs of Type I boutons of complexin precise 
excision controls (a) and complexin null mutants (b). (c-e) Quantification of vesicle density (c), major vesicle axis (d), and 
cisternae density (e) in control and complexin mutant boutons. Vesicles were counted from 12 boutons from 3 different animals 
per genotype. The vesicle densities between two genotypes are not significantly different (P>0.05). Major vesicle axes were 
counted from 100 vesicles at random per bouton. Vesicle axes were measured from 12 boutons from 3 animals per genotype. 
The major vesicle axes between the two genotypes are not significantly different (P>0.05). Cisternae were counted from at least 
12 boutons from at least 3 animals per genotype. Cisternae densities in the different genotypes are significantly different 
(P<0.05). Error bars indicate s.e.m. (f and g). Electron micrographs of active zones in control (f) and complexin mutant (g). (h-i). 
Quantification of vesicles within 250nm radius of the active zone and docked vesicles. Vesicles (h) and docked vesicles (i) within 
250 nm radius from the T bar were counted from 10 active zones from 3 different animals per genotype. Average number of 
vesicles and docked vesicles within the 250nm radius from the T bar between the two genotypes are not significantly different 
(P>0.05). Error bars indicate s.e.m. 
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Figure 10. Complexin overexpression reduces spontaneous mini frequency and enhances evoked release. (a) 
Complexin staining at NMJs in control (precise excision), rescue (elav-Gal4,UAS-cpx; cpx
SH1
/cpx
SH1
), and 
overexpression (elav-Gal4; UAS-cpx) larvae shows that overexpressed complexin is localized to NMJs. ( b) A 
Western blot of protein extracts from adult heads in control and overexpression flies shows a several -fold 
overexpression of complexin compared to the control. A blot for arginine kinase serves as an inter nal loading 
control. (c) Sample traces of mEJPs in 3rd instar larvae overexpressing complexin ( elav-GAL4; UAS-complexin) 
versus control animals (UAS-complexin; no driver) at muscle 6 NMJs. Individual minis are labeled with arrows in 
traces from each genotype. (d) Sample traces of EJPs from 3rd instar larvae overexpressing complexin ( elav-
GAL4; UAS-complexin) versus control animals (UAS-complexin; no driver) at muscle 6 NMJs in 0.2 mM 
extracellular calcium. (e) Quantification of average mini frequency (Hz ±SEM) in larvae overexpressing complexin 
(elav-GAL4; UAS-complexin) versus control animals (UAS-complexin or elav-GAL4) in 0.2 mM extracellular 
calcium. Animals overexpressing complexin have a >2.8 -fold reduction in mini frequency compared with controls 
(Student t-Test, ** = P<0.0001 compared to UAS-complexin, ** = P<0.0001 compared to elav-GAL4). Data used in 
the analysis include: elav-GAL4; UAS-complexin  (Mini Frequency (MF)=0.9 ± 0.09 Hz; n=32),  elav-GAL4 (MF=2.8 ± 
0.2 Hz; n=27), UAS-complexin (MF=2.7 ± 0.3 Hz; n=16). (f) Quantification of evoked response ± SEM at 0.2 mM 
extracellular calcium. Overexpression of complexin results in a statistically significant enhancement in average 
EJP amplitude versus controls (Student t-Test, ** = P<0.0001 compared to UAS-complexin; ** = P<0.003 
compared to elav-GAL4). Data used in the analysis include:  elav-GAL4; UAS-complexin (EJP=23.3 ± 1.4 mV; 
Resting Potential (RP)=-60.4 ± 1.6; n=18); UAS-complexin (EJP=12.5 ± 1 mV; RP=-60.5 ± 3, n=8); elav-GAL4  
(EJP=17.2 ± 1.5 mV, RP=-58.2 ± 1.3, n=24).  
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Figure 11. Complexin is required for maintenance of a readily releasable pool and synchronizes synaptic 
vesicle exocytosis. (a) cpx
SH1
 mutants show enhanced spontaneous release under voltage clamp, the same 
phenotype seen under current clamp. Shown are recordings of postsynaptic currents in control and cpx synapses 
in the presence of 0.1 mM external Ca
2+
. (b) Complexin regulates the early phase of short-term synaptic 
plasticity. Representative nerve evoked EPSCs elicited during 150s of 10Hz stimulation in cont rol, cpx
SH1
 (cpx) 
and complexin overexpression (ov cpx). The left panel shows the total events aligned at the time of the nerve 
stimulus. The right panel shown continuous recording in control, cpx and ov cpx. The central panel displays five 
stimuli of the train in each condition. Stimulus artifact was removed digitally for clarity. The behavior observed 
in the EPSCs during high frequency stimulation was reproduced in 3 different larvae tested for each phenotype. 
The external Ca
2+
 concentration in the bath solution was 2.0 mM. (c) Complexin modulates synchronous evoked 
release. Absolute EPSCs are plotted in a semi logarithmic graph to investigate their components. The fast and 
slow components are easily distinguished during the first 15 and last 20 ms respect ively. Normalized currents by 
the average number of active zones in each genotype (990.4 in control and 1620.5 for cpx
SH1
) are displayed in 
the right panel assuming the same number of active zones in complexin overexpression and controls. As can be 
seen, the asynchronous component in cpx
SH1
 is the same as in control synapses and dramatically diminished in 
ov cpx, while the synchronous component in cpx
SH1
 is reduced. The external calcium concentration in the bath 
solution was 2.0 mM. 
 
  
116 
 
  
117 
 
 
 
 
 
 
 
Chapter 3 
A Functional Analysis of Complexin’s Role in Exocytosis and Synaptic Plasticity 
 
 
 
Sarah Huntwork-Rodriguez1, Lauren Barr1, Dina Volfson1, Amanda 
Hartman, Krys Foster, and J. Troy Littleton1 
 
 
1
Picower Institute for Learning and Memory, Department of Biology, Massachusetts Institute of Technology, 
Cambridge, MA 02139 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The majority of the work described in these studies was performed by Sarah Huntwork-
Rodriguez.  Lauren Barr and Dina Volfson performed the in vitro kinase assays. Amanda 
Hartman and Krys Foster assisted in the mutagenesis screen. Electrophysiology was performed 
in large part by J. Troy Littleton.  
  
118 
 
Introduction 
The role of minis in modulation of synaptic function and synaptic growth 
Since Fatt and Katz published the first seminal papers describing synaptic transmission at the 
neuromuscular junction (Fatt and Katz 1951; Fatt and Katz 1952), it has been known that 
neurotransmitter release occurs in discrete packets, or quanta.  Quantal release occurs in two 
different modes at the synapse: individual quanta can spontaneously release from the synapse to 
elicit miniature postsynaptic potentials (minis), or multiple quanta can release synchronously in 
response to an action potential, producing an evoked postsynaptic potential.   
Evoked responses are well known to be altered during synaptic plasticity, as in the case 
of LTP or LTD.  In contrast, minis have long been thought to represent background noise at 
synapses.  This perception has recently begun to change due to studies demonstrating that mini 
frequency can play critical roles in maintaining dendritic spine density in CA1 pyramidal cells in 
the hippocampus (McKinney, Capogna et al. 1999), in suppressing dendritic protein synthesis 
(Sutton, Wall et al. 2004), and in regulation of spike frequency in pyramidal cells of the 
hippocampus in response to nicotine application (Sharma and Vijayaraghavan 2003). 
In addition to these examples of the roles that minis may play in the mammalian central 
nervous system, mini frequency at the Drosophila embryonic neuromuscular junction (NMJ) is 
upregulated by over 100-fold after high frequency stimulation (Yoshihara, Adolfsen et al. 2005) 
(Figure 1).  This upregulation of mini frequency lasts for several minutes and requires the 
function of a pathway that is activated by postsynaptic calcium influx through glutamate 
receptors in the muscle.  This calcium influx is sensed by synaptotagmin 4 in the postsynaptic 
compartment, triggering postsynaptic fusion of vesicles and releasing an unknown retrograde 
signal into the synaptic cleft.  Retrograde signaling upregulates cAMP in the presynaptic 
compartment, activating Protein Kinase A (PKA), which in turn acts on an unknown downstream 
119 
 
effector to enhance mini frequency.  In addition to regulating mini frequency at the NMJ, this 
pathway is critical for normal synaptic growth, and overexpression of synaptotagmin 4 or a 
constitutively active form of PKA causes synaptic overgrowth at third-instar larval NMJs.  It is 
currently unclear how upregulation of mini frequency may be tied to activity-dependent synaptic 
growth, but one attractive model is that enhanced mini frequency “tags” a synapse for plasticity, 
allowing local regulation of synaptic morphology.   
 In the complexin null mutant, we had the opportunity to study a situation where there was 
a large enhancement in mini frequency with largely normal evoked responses.  Interestingly, we 
observed a large and significant increase in synaptic plasticity at larval NMJs, suggesting that the 
increase in minis is driving synaptic plasticity.  It is also possible that the increased synaptic 
growth observed is due to a developmental defect specific to complexin mutants or to 
compensation for the reduced EJP amplitudes observed at complexin mutant NMJs.  The fact that 
complexin null mutants display a large enhancement in mini frequency with a concomitant 
increase in synaptic growth suggests it could be modulated in vivo to cause the PKA-dependent 
rise in mini frequency observed at embryonic NMJs, possibly by being a phosphorylation target 
of PKA.  Complexin is phosphorylated in vivo in mammalian systems (Hill, Callaghan et al. 
2006; Shata, Saisu et al. 2007), and there are two conserved potential phosphorylation sites in the 
C terminal portion of Drosophila that might be phosphorylated by PKA, T101 and S126.  Here, 
we test the hypotheses that modulation of mini frequency contributes to synaptic plasticity and 
that complexin is the downstream target of PKA to drive synaptic growth at the larval NMJ. 
Synaptotagmin / complexin dynamics during neurotransmitter release 
The idea that complexin functions as a vesicle fusion clamp at the nerve terminal is supported 
both by our results at the Drosophila NMJ and by biochemical evidence.  Mechanistically, some 
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biochemical evidence suggests that complexin functions at least in part by preventing full 
zippering of the SNAREs (Giraudo, Eng et al. 2006; Roggero, De Blas et al. 2007).  
Additionally, several recent studies have demonstrated that synaptotagmin and complexin 
function together during the last moments before fusion to trigger synchronous release (Giraudo, 
Eng et al. 2006; Tang, Maximov et al. 2006; Roggero, De Blas et al. 2007).  These studies 
suggest a model of complexin function in which complexin prevents fusion of vesicles until 
calcium influx occurs, at which point calcium binding by synaptotagmin allows it to compete 
with complexin for SNARE binding, creating a switch mechanism during synchronous evoked 
fusion (Tang, Maximov et al. 2006).  Given that synaptotagmin and complexin are both 
intimately involved in regulating synaptic vesicle exocytosis during the last few moments before 
fusion, a complete understanding of the process of synaptic vesicle exocytosis inherently 
requires an understanding of how these two proteins function together in triggering evoked 
neurotransmitter release.   
Two potential models for how complexin and synaptotagmin may function in vesicle 
exocytosis are shown in Figure 2.  In the first (left panel in Figure 2), complexin functions 
independently of synaptotagmin, preventing vesicle fusion by its action on the SNARE complex 
until synaptotagmin binds calcium and triggers fusion.  In the second (right panel in Figure 2), 
complexin functions by preventing synaptotagmin from triggering release until calcium influx 
occurs.  There is biochemical evidence supporting both models.  For example, in vitro, 
complexin appears to prevent full zippering of SNAREs until synaptotagmin binds calcium, 
which then releases the block on fusion.  This argues for the first model.  On the other hand, in 
vitro liposome reconstitution experiments incorporating the SNAREs and v-SNARE-bound 
synaptotagmin have demonstrated that synaptotagmin can increase the rate of fusion in the 
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absence of calcium, suggesting that synaptotagmin has some calcium-independent fusogenic 
activity (Mahal, Sequeira et al. 2002).  If this represents in vivo activity of synaptotagmin, a 
mechanism would be required to prevent synaptotagmin from triggering fusion in the absence of 
calcium, arguing for the second model.  The two models are not mutually exclusive and could 
both occur at the synapse.  Here, we begin to investigate the dynamics of complexin-
synaptotagmin function in synaptic vesicle exocytosis genetically by making a series of 
synaptotagmin 1; complexin double mutants designed to test the two models.   
Experimental Procedures 
Drosophila Genetics 
Drosophila were cultured on standard medium at 22°C.  Putative complexin mutants were 
generated by feeding ethane methylsulfonate (EMS) to Canton S males as described (Lewis and 
Bacher 1968). These males were crossed to Tm3Sb,Ser/Tm6, a line containing two 3
rd
 
chromosome balancers.  Individual males or virgin female progeny with the Sb, Ser dominant 
markers (CS*/Tm3Sb,Ser) were crossed to cpx
SH1
/Tm3Sb.  Chromosomes that failed to 
complement cpx
SH1 
were recovered to establish CS*/Tm3Sb strains.  Individual strains were 
recrossed to cpx
SH1 
to confirm non-complementation.  Dominance or recessiveness of the 
phenotypes of the EMS mutants was determined by crossing the mutant lines to Canton S and 
visually inspecting the progeny for the mutant phenotypes.  Complexin protein expression in the 
mutants was determined, where applicable, by Western blots on adult head extracts.  Line #2016 
contains an uncharacterized null allele of complexin and a second-site lethal mutation.  Line 
#572 contains a hypomorphic allele of complexin resulting in reduced protein expression, 
truncation of the protein at position 114, and point mutation of residues 110-114.  For 
electrophysiology studies of mutant line # 572, recordings were done on 572/Df(3R)ED5021 
122 
 
larvae.  Df(3R)ED5021 is a deletion removing complexin that spans the cytological interval 
81F6-82A5 (Ryder, Blows et al. 2004). Other mutant lines have not been fully characterized. 
 
For rescue studies, we took advantage of the UAS/GAL4 (Brand and Perrimon 1993) system to 
selectively drive transgene expression within neurons in the complexin null mutant background.  
Point mutants UAS-complexin 7b T101A, UAS-complexin 7b T101D, and UAS-complexin 7b 
R64H were produced by site directed mutagenesis of pSH3A, a pUAST vector containing a 
subcloned complexin cDNA encoding complexin 7B.  Site directed mutagenesis was carried out 
using the QuikChange XL Site Directed Mutagenesis kit (Stratagene).  For RNAi of complexin 
and synaptotagmin 1, UAS-cpxRNAi and UAS-syt1RNAi lines were obtained from the Vienna 
Drosophila RNAi Center (Dietzl, Chen et al. 2007) (http://www.vdrc.at, stock numbers 21477 
and 8876, respectively).   
 
syt1 single mutants and syt1; cpx double mutants were cultured by crossing flies of desired 
genotypes and allowing females to lay eggs on grape juice plates (2.2% agar, 1.2% sucrose, 25% 
grape juice concentrate, 0.2% Tegosept, 0.5% 1X Penicillin/Streptomycin antibiotic mix 
(Invitrogen catalog number 15070-063)) at 25 °C for 24 hours.  1
st
 instar single or double 
mutants were transferred to new grape juice plates with yeast paste and kept at 25°C in a humid 
chamber until the third-instar stage was reached, followed by electrophysiology and 
immunohistochemistry.   
Protein Expression 
Complexin 7a and 7b were amplified by PCR from a Drosophila cDNA library and subcloned 
into pGEX-2T and pGEX-5X-1, respectively (GE Healthcare).  Recombinant complexin fused 
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with GST was expressed in E. coli (BL21) and purified using glutathione-sepharose 4B 
(Amersham Biosciences).  GST was cleaved from complexin by incubation with thrombin. 
In Vitro Kinase Assays 
10 μg of complexin fused with GST was incubated with 1 μl PKA (New England Biolabs, 2,500 
Units/ μl) in kinase buffer (30 mM HEPES [pH 7.2], 10 mM MgCl2, 5 mM MnCl2, 1 mM DTT) 
supplemented with 100 μM cold ATP and 5 μCi [32P]γATP (Perkin Elmer) in a final volume of 
35 μl for 45 min on ice. The reaction was terminated by the addition of 35 μl of 2× sample 
buffer. Samples were separated by SDS-PAGE and [
32P]γATP incorporation was assessed by 
autoradiography. 
Immunostaining 
3
rd
 instar larvae were reared at 22°C and dissected in HL3.1 (Stewart, Atwood et al. 1994) (70 
mM NaCl, 5mM KCl, 10 mM NaHCO3, 4mM MgCl2∙6H2O, 5 mM Trehalose, 115 mM Sucrose, 
5 mM HEPES, pH 7.2).  Following washes, larvae were incubated with primary antibody 
overnight at 4 °C, incubated with secondary antibodies for four hours at room temperature, and 
mounted in 80% glycerol for imaging.  The dilutions of primary antibodies were as follows:  
complexin (1:500), anti-Dlg (1:1000).  The 4F3 antibody against Dlg developed by Corey 
Goodman was obtained from the Developmental Studies Hybridoma Bank developed under the 
auspices of the NICHD and maintained by the University of Iowa, Department of Biological 
Sciences, Iowa City, IA 52242.  Secondary antibodies from Jackson ImmunoResearch 
Laboratories were used at a dilution of 1:250 and were as follows: Cy2-conjugated Goat anti-
Mouse and Rhodamine Red-conjugated Goat anti-Rabbit.  Visualization
 
was performed under 
light microscopy using a 40x oil-immersion lens.  Images were taken with confocal microscopy 
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(Axoplan 2; Carl Zeiss MicroImaging, Inc.) using PASCAL software (Carl Zeiss MicroImaging, 
Inc.).   
SNARE Complex Binding Assays 
GST-fused proteins were expressed in BL21 cells and purified using glutathione-sepharose beads 
(Amersham Biosciences).  5 mL of Canton S flies were frozen in liquid nitrogen and vortexed.  
Heads were isolated using a sieve, homogenized on ice in homogenate buffer plus protease 
inhibitors (1X TS, 0.2mM EGTA, 1mM PMSF, 2µg/mL aprotinin, 1µg/mL leupeptin, and 1 
µg/mL pepstatin), and solubilized in homogenate buffer with 1.25% Triton X-100 for 30 min.  
Following solubilization, cell debris and head cuticle were removed by centrifugation in a 
microcentrifuge at maximum speed for 10 min.  200 µL head extract was then added to each tube 
containing the desired concentration of beads plus homogenate buffer and 1.25% Triton X-100 
and incubated with shaking at 4 °C for two hours.  For T101 binding assays, heat shocked 
samples were incubated at 100 °C for 3 min and Protein Kinase A inhibitor amide 6-22 (EMD 
Biosciences) was added to samples at a concentration of 68 nM.  Beads were washed 5 times in 
cold 1X TS, boiled in 2X reducing sample buffer, and analyzed by Western blotting.   
Western Blots 
Western blots were performed using standard laboratory procedures.  Blocking of nitrocellulose 
membranes was performed in a solution containing four parts TBS (10 mM Tris Base pH 7.5, 
150 mM NaCl) to one part Odyssey Blocking Buffer (LI-COR Biosciences).  Antibody 
incubations were performed in a solution containing four parts TBST (1X TBS with 1% Tween-
20) to one part Odyssey Blocking Buffer.  Antiserum dilutions were: complexin, 1:10,000; 
arginine kinase, 1:10,000; syntaxin, 1:1,000; synaptobrevin, 1:1,000; anti-GST 1:10,000.  The 
probes were detected using Alexa Fluor 680-conjugated goat anti-rabbit IgG at a dilution of 
125 
 
1:3000 (Invitrogen Molecular Probes) and IRDye 800-conjugated goat anti-mouse IgG at a 
dilution of 1:10,000.  Visualization was done using the LI-COR Odyssey Imaging System (LI-
COR Biosciences).  
Electrophysiology  
Electrophysiology at 3
rd
 instar NMJs was performed as previously described (Rieckhof, 
Yoshihara et al. 2003) at the indicated extracellular calcium concentrations in HL3.1 saline at 
muscle fiber 6 of segments A3 to A5.  Recordings were done using an Axoclamp-2B amplifier 
(Axon) and digitized with an Instrunet Model 100 digitizer at 10 kHz and analyzed with 
Superscope 3.0 software (GW Instruments).  Mini frequency was quantified in complexin and 
synaptotagmin mutants by counting discernable individual peaks.   
Electrophysiology Quantification 
Genotypes used for physiological analysis shown in Figure 9 are: control (w
-
; precise 
excision/precise excision); cpx (w
-
; cpx
SH1
/cpx
SH1
); syt 1; cpx (w-; syt1
AD4
/syt1
N13
; cpx
SH1
/cpx
SH1
); 
and syt 1 (w-; syt1
AD4
/syt1
N13
). cpx
SH1
 homozygotes have mini frequencies >20-fold higher than 
controls and ~10-fold higher than syt 1; cpx double mutants (Student t-Test, ** = P<0.0001). syt 
1; cpx mutants have a mean mini frequency significantly higher than controls (Student t-test, ** 
= P<0.0001). Data used in the analysis include: Control (Mini Frequency (MF)=3.14±0.3 Hz; 
n=18); cpx
SH1
 (MF=66.9±4.8 Hz; n=27); syt 1; cpx (MF=6.57±0.44 Hz, n=7); syt 1 
(MF=3.98±0.35 Hz, n=9). Genotypes used for physiological analysis shown in Figure 11 are: 
control (w
-
; precise excision/precise excision); cpx (w
-
; cpx
SH1
/cpx
SH1
); and 572/Df 
(572/Df3R5021). Data used in the analysis include: Control (Mini Frequency (MF)=3.14±0.3 Hz; 
n=18); cpx
SH1
 (MF=66.9±4.8 Hz; n=27); 572/Df (MF=79.75±2.69, n=6). 
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Morphological Quantification 
To quantify NMJ bouton number, anti-complexin or anti-HRP stained varicosities were counted 
at muscle fiber 6/7 of segments A3 and A4.  For syx
3-69
, the number of cpx-positive varicosities 
was statistically increased compared to controls at muscle fiber 6/7 of segment A3 (Student t-
Test, ** = P=0.0004). Data used in the varicosity number analysis include: Control (Canton S) 
(bouton # =71.44±4.45, n=9); syx
3-69
 (bouton # =128.8±11.8, n=10).  For para
ts1
; cpx
SH1
 double 
mutant analysis, the number of HRP-stained boutons in cpx
SH1
 was statistically increased 
compared to precise excision controls and para
ts1
; cpx
SH1
 double mutants at m6/7 segments A3 
and A4 (Student t-Test, * = P <.05, ** = P < .001).  Data used in the para
ts1
; cpx
SH1
 double 
mutant analysis include: Precise excision (m6/7 segment A3 bouton # = 64.125±3.36, n=8; m6/7 
segment A4 bouton # = 44.36±3.0, n=13), cpx
SH1
 (m6/7 segment A3 bouton # = 103.5±15.98, 
n=4; m6/7 segment A4 bouton # = 83.0±8.66, n=6), para
ts1
; cpx
SH1
 (m6/7 segment A3 bouton # 
= 73.5±8.75, n=6; m6/7 segment A4 bouton # = 56.9±4.64, n=9). 
Adult Locomotion Analysis 
Adult climbing assays were performed on flies aged 6-7 days as previously described (Wang, 
Saraswati et al. 2004).  Climbing assays were done on flies aged 6-7 days, and the time required 
to climb 5 cm in a plastic vial was recorded, with a cutoff of 15 min.   
Results 
Enhanced mini frequency in a temperature sensitive allele of syntaxin drives 
synaptic overgrowth 
To investigate the role that mini frequency plays in synaptic plasticity, we took advantage of a 
temperature sensitive allele of syntaxin, syx
3-69
, that was previously identified in a screen for 
temperature sensitive paralytic mutants (Littleton, Chapman et al. 1998).  This mutant is the only 
other Drosophila mutant known to display a greatly enhanced mini frequency on the same scale 
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as complexin mutants (Figure 3a), with a mini frequency approximately 7-fold higher than wild 
type flies (Lagow, Bao et al. 2007).  If enhanced mini frequency can drive synaptic growth, one 
would expect that, like complexin mutants, syx
3-69
 mutants would display enhanced synaptic 
growth.  Indeed, bouton counting at syx
3-69
 larval NMJs shows that there is a large and significant 
increase in the number of varicosities over wild type controls (Figure 3b).  Adult syx
3-69
 flies 
have normal evoked potentials (Lagow, Bao et al. 2007), eliminating the possibility of 
compensatory effects causing enhanced synaptic overgrowth that could potentially confound the 
interpretation of the overgrowth in complexin mutants.   
 The enhanced mini frequency phenotype observed in syx
3-69 
mutants led us to hypothesize 
that the mutation in these mutants impairs the ability of complexin to bind syntaxin, producing a 
phenotype similar to that of complexin mutants.  syx
3-69
 mutants contain a T254I point mutation 
that reportedly alters SNARE complex formation in vitro.  Molecular modeling suggests that this 
alteration is caused by a stronger zippering reaction in the mutant, with subsequent enhancement 
in mini frequency.  Analysis of the three dimensional structure of the squid complexin-SNARE 
complex (Figure 3c) (Bracher, Kadlec et al. 2002) shows that T254 in syntaxin is located in the 
C-terminal portion of the SNARE domain of syntaxin, placing it in close proximity to the 
transmembrane domains of the SNAREs during the fusion reaction.  Further analysis has shown 
that this residue is on a hydrophobic surface of syntaxin in the +7 layer (Lagow, Bao et al. 2007).  
The closest side chain in proximity to T254 is K79 of SNAP-25, and their Van der Waals 
surfaces are close enough to suggest that these two residues bind during SNARE complex 
formation (Figure 3c).  This does not explain why the T254I mutation would enhance SNARE 
zippering, since the putative binding partner of T254 is a charged lysine residue.  In any case, 
T254 is far from the binding site of complexin with the SNARE complex, although this does not 
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necessarily preclude an effect on complexin binding, which could occur indirectly through 
changes in the coiled-coil interactions of the SNARE complex or through interactions with 
complexin outside the fragment of complexin that was crystallized. 
 To test whether syx
3-69
 alters binding of complexin with syntaxin, we used recombinant, 
GST-fused wild type syntaxin and mutant syx
3-69
 to perform binding assays with native 
complexin from adult fly head protein extracts (Figure 3d).  Protein extracts were incubated 
with GST-fused syntaxins bound to glutathione beads over a range of GST-syntaxin protein 
concentrations from 0.0125 mg/mL to .4 mg/mL.  No major changes in the complexin binding 
affinity of syx
3-69
 were observed, suggesting that the syx
3-69
 T254I mutation does not alter the 
complexin – syntaxin binding affinity.  However, this assay does not test binding of complexin 
with the assembled SNARE complex, it only tests binding of monomeric syntaxin, potentially 
confounding interpretation of the results.  To definitively determine whether complexin’s 
SNARE complex binding affinity is altered in syx
3-69
 mutants, the best experiment would be to 
perform the head extract binding assay using recombinant complexin to bind assembled SNARE 
complexes in the fly CNS.  This would test binding of assembled SNARE complexes as opposed 
to monomeric syntaxin.  Based on these results, it is unlikely that the large enhancement in mini 
frequency in syx
3-69 is due to a change in syntaxin’s complexin binding affinity.  However, the 
large increase in the number of varicosities at syx
3-69 
NMJs strongly supports the idea that minis 
can drive synaptic growth. 
Enhancement of synaptic growth in complexin mutants is suppressed by decreased 
neuronal activity 
In order to determine how evoked potentials and minis might interact at the NMJ to regulate 
synaptic morphology and synaptic growth, we crossed the cpx
SH1
 allele with a temperature 
sensitive allele of the major sodium channel in the nervous system, para
TS1
 (Loughney, Kreber et 
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al. 1989), to make a double mutant.  para
TS1 
 mutants paralyze and action potentials cease at the 
restrictive temperature of 37 °C (Wu and Ganetzky 1980; Ganetzky 1984).  para
TS1
;cpx
SH1
 
double mutants display similar behavioral defects to complexin null mutants alone.  Interestingly, 
even when larvae are grown at the permissive temperature of 25 °C, para
TS1
 suppresses the 
synaptic overgrowth phenotype of cpx
SH1
 mutants (Figure 4).  This effect is observed at two 
different body wall muscle segments (6/7 A3 and A4).  While the average number of boutons at 
para
TS1
;cpx
SH1
 double mutant synapses is higher on average than precise excision controls, this 
difference is not significant.  Interpretation of these results would benefit from two 
improvements to the experiment.  First, varicosity number can depend to some extent on the 
genetic background of the animals, and the precise excision control is in a white- background, 
while the two mutant lines are in a white+ background.  For proper comparison, especially 
comparison of the double mutant to the control, the precise excision control should be put into 
the same red-eyed background that the mutants are in.  Secondly, it is unclear from this 
experiment whether the overgrowth phenotype of complexin mutants is completely suppressed 
by para
TS1
 or whether there is still some overgrowth.  To determine this, bouton counts of 
para
TS1
 larvae grown at 25 °C should be completed.  Thus, preliminary experiments demonstrate 
that decreased neuronal activity suppresses the synaptic overgrowth phenotype observed in 
complexin mutants, but the extent of this effect is currently unclear and requires further 
experiments. 
The role of complexin phosphorylation in regulating mini frequency and synaptic 
growth 
Studies at Drosophila embryonic NMJs have revealed that an activity-dependent signaling 
cascade requiring postsynaptic synaptotagmin 4 and presynaptic PKA function regulates synaptic 
growth and mini frequency (Yoshihara, Adolfsen et al. 2005) (Figure 1).  In response to high 
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frequency stimulation, mini frequency at embryonic NMJs is increased by over 100-fold, and the 
pathway required for this upregulation is also required for normal synaptic plasticity. Given that 
complexin null mutants display large increases in both mini frequency and synaptic proliferation, 
and given that there are several predicted phosphorylation sites in the C terminus of complexin, 
we hypothesized that complexin is phosphorylated by PKA in this pathway to mediate the 
increase in mini frequency (Figure 5a).  According to our hypothesis, prior to high frequency 
stimulation (left panel in Figure 5a), complexin is bound to SNARE complexes and fully 
functional, producing a low mini frequency state.  During high frequency stimulation (middle 
panel), complexin is phosphorylated by PKA in the presynaptic terminal in response to a 
synaptotagmin-4–dependent retrograde signal from the muscle.  Because of this phosphorylation, 
complexin’s vesicle fusion clamp function is impaired, possibly because of decreased binding 
affinity for the SNARE complex.  This would produce a high mini frequency state (right panel).   
 In order to test this hypothesis, we first wanted to determine whether complexin can be 
phosphorylated in vitro by PKA, and if so, at which sites.  One attractive candidate site for PKA 
phosphorylation is T101 (orange box in Figure 5b).  T101 is the third residue in a four-residue 
consensus PKA phosphorylation motif, KKTP, that is 100% conserved in all invertebrate 
complexins examined so far and is present in all isoforms of Drosophila complexin.  To 
determine whether this residue is phosphorylated by PKA in vitro, we mutated T101 in 
complexin 7b to a phospho-incompetent alanine residue, and performed kinase assays on GST-
tagged recombinant mutant and wild type complexins (Figure 5c).  Expressed recombinant 
proteins were incubated with PKA and ATP-γ-32P, reactions were stopped with sample buffer, 
and proteins were separated by SDS-PAGE.  Phosphorylation of complexin was detected by 
autoradiography.  Phosphorylation of complexin was observed, whereas no phosphorylation 
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could be detected in GST alone controls or samples with no enzyme added.  A positive control 
reaction with the kinase Cdk5 was successful, although it did not produce phosphorylated protein 
at the high level that the PKA / complexin reaction did.  Thus, complexin 7b is highly 
phosphorylated in vitro by PKA.  However, the T101A mutant was also highly phosphorylated 
by PKA, demonstrating that, at least in vitro, T101 is not the site of phosphorylation by PKA.   
 To determine whether phosphorylation of the T101 site might change complexin’s 
SNARE complex binding affinity, we performed SNARE binding assays using recombinant wild 
type complexin 7b and two point mutants, complexin T101A (phospho-incompetent), and 
complexin T101D (phospho-mimetic) (Figure 5d).  A third point mutant, complexin R64H, had 
previously been reported to be unable to bind SNARE complexes in mammalian systems 
(Archer, Graham et al. 2002) and was therefore used as a negative control for SNARE binding.  
To detect SNARE binding, recombinant proteins fused to GST and bound to glutathione beads 
were incubated with adult fly head protein extracts.  To detect both monomeric syntaxin binding 
and SNARE complex binding, recombinant proteins were also incubated with head extracts that 
had been heat-shocked to melt SNARE complexes into their monomeric components.  Under 
these conditions, complexin should only detectably bind syntaxin since that is the only 
monomeric binding partner it interacts with.  Finally, to control for the possibility that PKA in 
the head extracts might phosphorylate wild type complexin or the complexin point mutants 
during the incubation step, a PKA inhibitor cocktail was added to head extracts to determine 
whether blocking phosphorylation of complexin by PKA in the test tube might cause a detectable 
change in SNARE complex binding affinity.  Under all conditions tested, there was no decrease 
in binding affinity of the T101A and T101D point mutants for syntaxin, and if anything both 
showed a slight increase in binding affinity (bottom blot, Figure 5d). A GST alone control did 
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not detectably bind syntaxin, and as predicted the R64H mutant did not bind syntaxin either.  No 
detectable synaptobrevin was bound under any conditions, so the binding assay failed to detect 
SNARE complex binding and instead measured only monomeric syntaxin binding.  It is unclear 
why complexin failed to bind assembled SNARE complexes in protein extracts because SNARE 
complexes are remarkably stable.  They are resistant to proteolysis and are highly thermally 
stable (Hayashi, McMahon et al. 1994).  Still, a negative control with very weak or nonexistent 
SNARE complex binding did not bind any monomeric syntaxin, demonstrating that a change in 
binding affinity for the SNARE complex will in all probability be reflected in a change in 
binding affinity for monomeric syntaxin.  Thus, it is likely based on these results that it is not 
T101 that is phosphorylated by PKA.  Consistent with this conclusion is the fact that pan-
neuronal expression of UAS-T101A and UAS-T101D point mutants in the complexin null 
mutant background fully rescues the lethality and behavioral defects of complexin null mutants.   
 Our results thus far show that complexin 7b is highly phosphorylated by PKA in vitro but 
not at the T101 position.  In addition to T101, S126 in complexin 7b is predicted to be 
phosphorylated by PKA.  We therefore performed a PKA phosphorylation assay using wild type 
complexin 7b and an S126A point mutant (Figure 6a).  This mutation removed nearly all of the 
phosphorylation of complexin 7b, demonstrating that S126 is the major phosphorylation target of 
PKA in vitro.   
 The S126 residue is only present in complexin 7b and is not present in complexin 7a or 
any of the other splice isoforms of complexin.  We therefore performed a kinase assay to 
determine whether complexin 7a is phosphorylated by PKA (Figure 6b).  We observed a small 
amount of phosphorylation of complexin 7a, but not nearly to the extent that complexin 7b is 
phosphorylated.  In fact, complexin 7a phosphorylation occurs at about the same level as the 
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complexin 7b S126A mutant, suggesting that complexin 7a lacks a major PKA phosphorylation 
site.   
 In addition to PKA, complexin is also predicted to be phosphorylated by PKC at T101.  
We therefore tested whether it is phosphorylated by PKC in vitro (Figure 6c).  Phosphorylation 
of both complexin 7a and 7b by PKC occurred at very low levels and this phosphorylation was 
not eliminated by mutation of T101 to alanine, so this site is not phosphorylated by PKC in vitro.  
Thus, the only major phosphorylation target in complexin detected thus far is S126, which is 
highly phosphorylated by PKA in vitro.  Further studies will determine whether phosphorylation 
of this site occurs in vivo and whether phosphorylation is required for establishing and storing 
memories in Drosophila or for normal synaptic development. 
R64H point mutants in complexin rescue behavioral defects in complexin null 
mutants 
We generated a point mutant in complexin 7b, R64H, that in mammalian complexins has been 
reported to be deficient in SNARE binding (Archer, Graham et al. 2002) and does not detectably 
bind syntaxin in a head extract binding assay (Figure 5d).  Point mutants in complexin lacking 
SNARE binding activity have been used to demonstrate that the proposed functions of 
complexin require SNARE binding.  These experiments have established that any effects of 
genetic or biochemical manipulations in experiments are specific to complexin’s normal in vivo 
function via SNARE binding and are not non-specific artifacts of the experimental system 
(Archer, Graham et al. 2002; Xue, Reim et al. 2007; Giraudo, Garcia-Diaz et al. 2008; Yoon, Lu 
et al. 2008).  Following this line of reasoning, we decided to test whether the R64H mutant can 
rescue the behavioral defects observed in complexin mutants.  R64 in Drosophila complexin 
corresponds to R59 in mammalian complexins and is a 100% conserved residue from 
invertebrates to vertebrates located in the central alpha helix of complexin responsible for 
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SNARE binding (orange box in Figure 7a).  It interacts via hydrogen bonds with syntaxin 
residue N57 to mediate binding to the SNARE complex (Figure 7b).  In order to determine 
whether the R64H point mutant is capable of rescuing the behavioral defect in complexin null 
mutants, we expressed a wild type complexin transgene and two different R64H point mutant 
transgenes (R64H 2C and R64H 3A) pan-neuronally in the null mutant background (Figure 7c).  
Western blotting showed that the rescuing transgenes are expressed in adult fly heads at levels 
equal to or greater than a driver alone control (C155) or a precise excision control.   
To our surprise, R64H point mutants rescued the behavioral defect to a large degree.  
This rescue was quantified in a wall climbing assay (Figure 7d).  Precise excision flies climb the 
wall of a vial quickly and with very little variation in the length of time required (2.0 ± 0.174 
sec.)  In comparison, complexin null mutants can take up to 15 minutes to climb a vial and are 
highly variable in how quickly they climb (405 ± 97.8 sec.)  Complexin 7b largely rescues the 
null motor defect, but complexin 7b rescue animals still take significantly longer to climb the 
vial and display greater variability than precise excision flies (5.43 ± 0.53 sec., P < 0.0000005 
compared to precise excision, P < 0.000005 compared to complexin null mutants).  This is not 
surprising given that there are several predicted complexin splice variants differing in both 
protein sequence and 5’ UTRs, so rescuing with one variant pan-neuronally likely does not fully 
reproduce the expression pattern of complexin in the nervous system.  While R64H rescues did 
take nearly three times longer on average than wild type rescues to climb the vial (14.33 ± 0.667 
and 14.83 ± 3.40 sec., P < 0.005), indicating some function is indeed lost in this point mutant, 
complexin function for the most part remains when climbing capability is compared with null 
mutants.  Recently it has been reported that R59 point mutants in mammalian complexins retain 
some SNARE binding capability (Xue, Reim et al. 2007).  To completely abolish SNARE 
135 
 
binding, several pairs of double point mutants can be employed, all of which alter highly 
conserved residues in the central alpha helix of complexin responsible for SNARE binding (Xue, 
Reim et al. 2007).  The mostly likely explanation for our results is that, like in mammalian 
complexins, R64H mutants in Drosophila retain some SNARE binding ability, although it was 
not detected in our binding assay.  For this reason, we are generating double point mutants in 
complexin that completely eliminate SNARE binding in order to more definitively demonstrate 
that complexin’s native function in vivo is as a vesicle fusion clamp for neurotransmitter release. 
Double mutant analysis of complexin / synaptotagmin 1 dynamics during 
neurotransmitter release 
Synaptotagmin 1 and complexin both function during the moments before neurotransmitter 
release to synchronize calcium-triggered exocytosis.  A complete understanding of the molecular 
events leading up to neurotransmitter release will require an understanding of how these two 
proteins work together during synchronous release.  We propose two possible models for how 
complexin may function as a vesicle fusion clamp (Figure 8a).  One possibility is that complexin 
prevents fusion of synaptic vesicles by directly inhibiting the fusion activity of the SNARE 
complex (left panel).  This activity would be independent of synaptotagmin function.  The 
second possibility is that complexin functions by preventing synaptotagmin from triggering 
vesicle fusion in the absence of calcium (right panel).  In both cases, synaptotagmin triggers 
fusion after calcium influx by removing complexin from the SNARE complex.  These two 
models might be distinguished by testing the properties of a double mutant of synaptotagmin and 
complexin.  In the first model, the enhanced mini frequency observed in complexin mutants 
would persist in a complexin; synaptotagmin double mutant.  In the second model, the enhanced 
mini frequency would depend on the presence of synaptotagmin and would be eliminated in a 
complexin; synaptotagmin double mutant.  In order to test these two models, we made a series of 
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complexin; synaptotagmin double mutants utilizing a variety of synaptotagmin alleles 
(summarized in Figure 8b and diagrammed in Figure 8c).  In the double null mutant, 
homozygous cpx
SH1
 is crossed with two different null alleles of synaptotagmin, syt1
N13
 (Littleton, 
Stern et al. 1994) and syt1
AD4
 (DiAntonio, Parfitt et al. 1993; DiAntonio and Schwarz 1994).  In 
addition, the complexin null allele was crossed with several different types of synaptotagmin 
hypomorphic alleles.  syt1
T41
 has a wild type protein sequence but very low expression of 
synaptotagmin (Littleton, Stern et al. 1993).  syt1
AD1
 contains a stop codon between the two C2 
domains of synaptotagmin that completely removes the C2B domain (DiAntonio and Schwarz 
1994) and eliminates the fourth-order cooperativity of synchronous release (Yoshihara and 
Littleton 2002).  syt1
AD3
 contains a Y364N point mutation that disrupts calcium-dependent 
conformation changes of synaptotagmin and displays very low amplitude EJPs but leaves 
calcium cooperativity intact (DiAntonio and Schwarz 1994; Yoshihara and Littleton 2002).  In 
addition to using these well characterized alleles of synaptotagmin and complexin, we also 
employed fly lines containing transgenic RNAi expression constructs against both synaptotagmin 
and complexin.  By using these different alleles, we hope to gain mechanistic insight into how 
complexin and synaptotagmin function together in neurotransmitter release.   
Although synaptotagmin 1 single mutants under normal growth conditions die during or 
before the first-instar stage, they can be grown to the third-instar stage for electrophysiological 
recordings fairly easily by careful culturing on grape juice-agar medium.  We used the same 
culturing technique to attempt to grow synaptotagmin; complexin double mutants to the third-
instar stage for analysis.  Of the different double mutant stocks generated, we have thus far 
attempted to culture three combinations to third-instar stage for electrophysiology experiments:  
syt1
N13
/syt1
AD4
; cpx
SH1
/cpx
SH1
 (double null), syt1
T41
/syt1
AD1
; cpx
SH1
/cpx
SH1
 (synaptotagmin 
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hypomorphic alleles with complexin null allele), and C155, UAS-dicer;UAS-syt1RNAi/+; 
cpx
SH1
/cpx
SH1
 (synaptotagmin RNAi expressed pan-neuronally with complexin null allele).  We 
found that even when these double mutants were cultured on grape juice plates, the vast majority 
of animals died before reaching the third-instar stage.  This was true for all three genotypes tried.  
In only one case have we been able to successfully grow a double mutant to third instar stage.  
Staining this double null mutant for complexin and Dlg confirmed it was a complexin mutant 
(Figure 9a).  The motor behavior of the larva (uncoordination and body wall contraction waves 
lasting three to four seconds) was very similar to that of synaptotagmin 1 single mutants.  In 
addition, evoked responses from the double mutant showed no synchronous release with highly 
elevated asynchronous release, typical of synaptotagmin 1 null mutants (Yoshihara and Littleton 
2002) (Figure 9b, left panel).  Finally, the double mutant displayed a high degree of paired pulse 
facilitation, again typical of a synaptotagmin 1 null mutant (Figure 9b, right panel) (Saraswati, 
Adolfsen et al. 2007).  Thus, all indications are that this larva was in fact a double mutant.  
Recordings of minis from the double mutant revealed an almost complete suppression of 
the mini frequency phenotype observed in complexin null mutants alone (Figure 9c).  Complexin 
null mutants have an average mini frequency of 66.9 Hz, while the double mutant had an average 
mini frequency of 6.6 Hz.  This is still significantly elevated compared to the control frequency 
of 3.1 Hz.  This may be because syt 1 mutants alone have been reported to have an elevated mini 
frequency (Littleton, Stern et al. 1993; Broadie, Bellen et al. 1994; DiAntonio and Schwarz 
1994), although in our hands during these experiments syt 1 null mutants alone did not show a 
significantly elevated mini frequency, or because complexin has some synaptotagmin-
independent function (i.e. the first model of complexin function in Figure 8a).  This evidence 
argues that complexin functions in neurotransmitter release in part to block synaptotagmin from 
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triggering fusion in the absence of calcium influx.  Without complexin present at the synapse, 
synaptotagmin’s basal calcium-independent function may drive fusion of primed vesicles 
without restriction, producing the enhanced mini frequency phenotype observed at complexin 
null mutant synapses.  Confirmation of this suppression effect awaits further experimental results 
from more double mutant animals. 
An EMS screen to identify new alleles of complexin 
To elucidate the in vivo function of a given protein, random mutation of that protein has often 
proved useful.  An important example of this is synaptotagmin, whose function as a calcium 
sensor for neurotransmitter release was in part established using alleles of synaptotagmin 
generated by random EMS mutagenesis (DiAntonio, Parfitt et al. 1993; Littleton, Stern et al. 
1993; Broadie, Bellen et al. 1994; DiAntonio and Schwarz 1994; Littleton, Stern et al. 1994).  
Complexin function has been investigated in depth by generating null alleles (Reim, Mansour et 
al. 2001; Xue, Stradomska et al. 2008), targeted mutation of residues in the binding site of 
complexin (Xue, Reim et al. 2007), and deletion analysis (Xue, Reim et al. 2007).  However, 
unbiased, random mutation of complexin has so far not been utilized to study complexin’s in vivo 
function.  To this end, we generated new complexin alleles by mutation of wild type flies with 
the chemical mutagen ethane methyl sulfonate (EMS).  Nearly 5,000 mutagenized lines were 
screened for loss-of-function complexin alleles by non-complementation of the cpx
SH1
 lethality 
and motor defect phenotypes (Figure 10a).  Lines of flies failing to fully complement cpx
SH1
 
were established and subjected to verification of the phenotype observed in primary screening.  
Phenotypes of the mutants identified are shown in (Figure 10b).  Sequencing and Western 
blotting of the mutants is ongoing, but three mutants immediately stood out as potential 
complexin mutants.  Line #570 has a motor defect reminiscent of complexin null mutants, both as 
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a homozygous stock and heterozygous with cpx
SH1
.  570 flies move slowly, tend to remain on the 
bottom of the vial (bottom-dwelling), and are slightly uncoordinated.  The 570 phenotype is 
semi-dominant, with a less dramatic phenotype observable when heterozygous with wild type.  
Thus far sequencing of 570 has not revealed a mutation in complexin, but complexin is expressed 
at wild type levels in 570 (Figure 11a, left panel), so if a complexin mutation is found in 570 
mutants, it is likely to be in the coding sequence.   
Line #2016 has a motor and lethality defect identical to complexin null mutants, and 
2016/cpx
SH1
 flies show no expression of complexin by Western blot (Figure 11a, right panel), 
indicating that line #2016 contains a new null allele of complexin.  However, 2016 is 
homozygous lethal and is also lethal when heterozygous with a deficiency uncovering 
complexin.  In both cases, lethality occurs at a stage prior to the wandering third-instar larval 
stage.  This lethality is not consistent with the complexin null phenotype, which is semi-lethal 
with most animals dying during the pupal stage.  While EMS mutagenesis for the most part 
produces point mutations, it can also cause deletions.  We therefore suspected that there might be 
a large deletion in 2016 that removes a part of complexin and a neighboring gene, thus causing 
the lethality phenotype.  To investigate whether there is a deletion in complexin in line 2016, a 
mapping PCR was performed on genomic DNA isolated from 2016/cpx
SH1
 adults.  PCR products 
1-6 from the PCR originally performed to map the cpx
SH1
 deletion were successfully polymerized 
from 2016/ cpx
SH1
 gDNA (Figure 11b).  Since products two through four cannot be polymerized 
from cpx
SH1
 gDNA, we know from this experiment that 2016 at least does not contain a large 
deletion in the region of the genomic DNA corresponding to PCR products two through four, 
which includes all of the coding sequence for complexin except the 7b exon.  Thus, rather than 
2016 containing a large deletion in complexin and a neighboring gene, it is more likely that it 
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contains both a mutation in complexin resulting in loss of expression of the complexin protein 
and a second site mutation in a necessary gene uncovered by the deficiency.  If this mutant is to 
be pursued, it should be backcrossed to wild type to remove the second site lethal. 
Line #572 shows a motor defect very similar to the complexin null mutant phenotype but 
less severe.  The animals move more quickly and are more coordinated than complexin null 
mutants.  This phenotype is recessive to wild type and the phenotypes of 572 homozygotes and 
572/cpx
SH1
 are identical.  The 572 allele shows no evidence of the lethality observed in 
complexin null mutants.  Western analysis of 572 head extracts showed that line 572 expresses a 
truncated form of complexin that has very low expression (Figure 11a, middle panel), making it 
very likely that line 572 contains a mutation in the complexin coding sequence.  Indeed, 
sequencing of 572 complexin revealed a small deletion removing the last 27 nucleotides of exon 
5 as well as 108 nucleotides in the adjacent intron, plus an insertion of 6 nucleotides in this same 
location.  Presumably this deletion prevents splicing of the intron between exons 5 and 6, 
resulting in read-through into the intron during translation.  If this is the case, then the resulting 
mutant protein would have amino acids 110 to 114 mutated from the wild type sequence EQEEL 
to VYSIL, followed by a stop codon, truncating the mutated protein to a sequence 28 amino 
acids shorter than the wild type protein (Figure 11c).  Reduced expression of the mutated protein 
was confirmed by immunohistochemistry at the larval NMJ (Figure 11d), with complexin 
staining much dimmer at the mutant synapse.  Imaging of the mutant synapse with high laser 
power to brighten the image revealed that the remaining complexin at the synapse is distributed 
in puncta, rather than being diffusely distributed in the bouton as wild type complexin is.  
Complexin staining in complexin null mutants frequently shows background staining in the axon 
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but never shows residual staining in NMJ boutons, so the axonal staining in the higher laser 
power image of the 572 mutant NMJ is probably background staining.   
The phenotype of line 572 and its reduced complexin expression demonstrate that this 
line contains a hypomorphic allele of complexin.  Consistent with this conclusion, recordings of 
minis from larval NMJs of 572 mutants reveal an extremely high mini frequency, just as is 
observed in complexin null mutants.  It is impossible to separate the effects of reduced 
expression of the mutant protein and truncation of the protein in 572 mutants, so this allele will 
likely not be useful for structure-function studies of complexin.  However, it may be useful for 
genetic studies where an allele of complexin less severe than the null is needed.  Indeed, given 
the difficulty in obtaining syt 1;cpx double null mutants, it may be more productive to attempt to 
culture syt 1 null; cpx
572
 double mutants than to continue trying to culture a double null mutant.  
In addition to the three EMS mutants described, further analysis of the remaining mutants may 
reveal new alleles of complexin useful for structure-function studies. 
Discussion 
Regulation of mini frequency and synaptic plasticity by complexin 
Since the time of Katz, it has been known that individual quanta occasionally release from the 
synaptic terminal in the absence of an action potential, producing miniature postsynaptic 
potentials, or minis.  Katz noted that mini frequency at the frog NMJ can vary over 1000-fold 
(Fatt and Katz 1952), but until recently it has been thought that minis represent background noise 
at the synapse.  Recent evidence, however, suggests that mini frequency is used as information at 
the synapse to maintain dendritic spine density (McKinney, Capogna et al. 1999), to suppress 
dendritic protein synthesis (Sutton, Wall et al. 2004), and possibly to alter spike frequency of 
pyramidal neurons in the hippocampus (Sharma and Vijayaraghavan 2003).  In Drosophila, mini 
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frequency is upregulated by over 100-fold for several minutes after high frequency stimulation 
(Yoshihara, Adolfsen et al. 2005).  This upregulation requires function of a PKA- and 
synaptotagmin-4- dependent pathway that also drives synaptic growth.  Based on the synaptic 
growth phenotype of complexin null mutants, we hypothesized that enhanced mini frequency can 
drive synaptic growth and that complexin is the downstream target of PKA that regulates mini 
frequency in this pathway. 
 Consistent with the idea that enhanced mini frequency drives synaptic growth, syntaxin
3-
69
 mutants, which have an elevated mini frequency similar to that observed in complexin null 
mutants, display synaptic overgrowth.  We have identified a PKA phosphorylation site in 
complexin 7b, S126, that is highly phosphorylated by PKA in vitro.  In order to determine 
whether phosphorylation of this residue impacts synaptic growth in vivo, we plan to make 
transgenic S126A and S126D point mutants and test whether they rescue the synaptic 
overgrowth phenotype observed in complexin null mutants.  If S126 phosphorylation drives 
synaptic growth, then S126A would be predicted to suppress the complexin null overgrowth 
phenotype, while S126D (a phosphomimetic mutant) would not be predicted to rescue, and 
would even be predicted to drive overgrowth when overexpressed.   
 Based on the fact that there are no expressed sequence tags (ESTs) that correspond to the 
unique exon in complexin 7b, complexin 7b is not highly expressed in adult flies or larval 
imaginal discs (tissues that most of the ESTs from Drosophila melanogaster were generated 
from).  It is possible that complexin 7b is expressed in small subsets of cells in the adult, or that 
it is only expressed at specific times during development.  This suggests that if complexin 7b 
were responsible for regulating mini frequency in the PKA-dependent plasticity model, this type 
of plasticity would not be active at all synapses, but instead would be restricted to specific cells 
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or specific times in development.  Aside from this explanation it is possible that the in vitro 
phosphorylation assays do not accurately reproduce what is happening in vivo, or that complexin 
is downstream of PKA in the pathway and regulates mini frequency, but complexin is not 
directly phosphorylated by PKA.  One way to test whether complexin is downstream of 
synaptotagmin 4 and PKA in the plasticity pathway is to make double mutants of complexin and 
the other components of the pathway for epistasis tests.  Experiments of this nature are ongoing, 
but our preliminary evidence suggests that mini frequency can contribute to synaptic plasticity, 
potentially unveiling a new method for information storage in the nervous system. 
Regulation of neurotransmitter release by synaptotagmin 1 and complexin 
Because complexin and synaptotagmin 1 function just before and during the calcium-triggering 
step of synchronous neurotransmitter release, a complete understanding of the molecular events 
of synaptic vesicle exocytosis requires knowledge of how these two proteins work together.  
Most studies thus far have examined function of the two proteins as separate entities.  We 
propose two possible pathways, based on available biochemical evidence, by which complexin 
might function as a vesicle fusion clamp to synchronize vesicle exocytosis in conjunction with 
synaptotagmin (Figure 2).  In the first model, complexin blocks fusion by preventing vesicles 
themselves from fusing, while in the second complexin blocks fusion by preventing 
synaptotagmin from triggering fusion in the absence of calcium.  The second model requires that 
synaptotagmin have the ability to trigger fusion without calcium influx, and indeed there is some 
evidence to support this (Mahal, Sequeira et al. 2002).  In order to test our two models, we have 
made a series of synaptotagmin 1; complexin double mutants and have begun to attempt to 
culture them for electrophysiological studies.  Preliminary evidence shows that synaptotagmin 
null alleles suppress the enhanced mini frequency phenotype of the complexin null allele.  This 
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result would support the second model of complexin function, in which complexin prevents 
synaptotagmin from triggering fusion in the absence of calcium.  However, this result must be 
thoroughly verified before a firm conclusion can be made.   
 Unfortunately, the synaptotagmin; complexin double mutant combination is highly lethal 
and it has therefore been difficult to culture double mutants to the third-instar stage.  However, 
there are several more allele combinations that we have not yet tried to culture and that may 
produce more viable larvae.  If the remaining double mutants are lethal as well, there are several 
potential routes around this problem.  If the elevated mini frequency observed in complexin 
mutants is dependent on synaptotagmin function, it is possible that larvae homozygous for the 
complexin null allele and heterozygous for a synaptotagmin null allele would show decreased 
mini frequency.  These larvae could be cultured with relative ease but may only show a modest 
decrease in mini frequency that may not be detectable because of the difficulty in accurately 
quantifying mini frequency in complexin null mutants.  A second possibility is to drive 
synaptotagmin and complexin RNAi constructs only in motor neurons instead of pan-neuronally.  
This may enhance viability while still allowing study of the double mutant phenotype at NMJs.  
Finally, synaptotagmin 1; cpx
572
 double mutants may be more viable than synaptotagmin 1; 
cpx
SH1
 double mutants given that there is very little lethality associated with the cpx
572
 allele.  
Should any of these approaches work, these double mutant studies have the potential to reveal 
fundamental aspects of how synaptotagmin and complexin function together at the synapse to 
trigger synchronous fusion of synaptic vesicles. 
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Figures 
 
Figure 1. Model of regulation of mini frequency by a synaptotagmin-4- and PKA-dependent signaling cascade 
adapted from Yoshihara et al, Science 2005. Before tetanic stimulation, the synapse is in a low mini frequency 
state. During tetanic stimulation, calcium influx into the post -synaptic compartment (yellow) triggers  
synaptotagmin-4- (Syt4)-dependent release of postsynaptic vesicles containing an unknown retrograde signal 
(orange triangles) into the synaptic cleft. The retrograde signaling protein is bound by presynaptic receptors, 
triggering a presynaptic increase in cyclic AMP concentration and activating PKA. PKA then acts on downstream 
effectors to increase mini frequency and synaptic growth. For several minutes after tetanic stimulation a high -
mini-frequency state persists.  Blue Squares = Neurotransmitter.  
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Figure 2. Two models of complexin's fusion clamp function at the synapse. In model 1 (left panel), complexin 
(red rectangle) prevents vesicle fusion by blocking full SNARE zippering. After calcium influx synaptotagmin 
(blue line) removes complexin from the SNARE complex and triggers vesicle fusi on. In model 2 (right panel), 
complexin blocks fusion by preventing synaptotagmin from triggering release prior to calcium influx. After 
calcium influx, synaptotagmin removes complexin from the SNARE complex and triggers fusion. The two 
different models are not necessarily mutually exclusive and may be distinguished by an electrophysiological 
analysis of synaptotagmin 1; complexin  double mutants. 
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Figure 3. syx
3-69
, a temperature sensitive paralytic mutant with elevated mini frequency, displays synaptic 
overgrowth similar to that observed in complexin mutants. (a) Mini recordings from control and syx
3-69
 mutants 
in 0.2 mM calcium showing the elevated mini frequency phenotype.  (b) Varicosity number at muscle 6/7 in CS 
and syx
3-69
 mutants. syx
3-69
 shows a highly significant increase in varicosity number compared to CS (** = 
P=0.0004). Data used in the analysis include: Control (Canton S) (bouton # =71.44±4.45, n=9); syx
3-69
 (bouton # 
=128.8±11.8, n=10). (c) Location of the T254 amino acid on the coiled-coil structure of syntaxin. T254 in syntaxin 
(yellow) and its binding partner in SNAP-25 (red), K79, are shown in black in the overall structure (left panel). 
(Right panel) a close-up view of T254 and K79. (d) Assays of complexin binding by syntaxin and syntaxin
3-69
 
across a range of syntaxin concentrations shows no major change in complexin binding affinity in the mutated 
protein. Error bars are ± s.e.m.  
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Figure 4. Decreased neuronal activity partially suppresses the complexin null mutant synaptic overgrowth 
phenotype. cpx
SH1
 mutants display significant overgrowth at muscle fiber 6/7 segments A3 and A4 compa red to 
precise excision  controls and para
ts1
; cpx
SH1
 double mutants (Student t-Test, * = P <.05, ** = P < .001). Data used 
in the analysis include: Precise excision (m6/7 segment A3 bouton # = 64.125±3.36, n=8; m6/7 segment A4 
bouton # = 44.36±3.0, n=13), cpx
SH1
 (m6/7 segment A3 bouton # = 103.5±15.98, n=4; m6/7 segment A4 bouton # 
= 83.0±8.66, n=6), para
ts1
; cpx
SH1
 (m6/7 segment A3 bouton # = 73.5±8.75, n=6; m6/7 segment A4 bouton # = 
56.9±4.64, n=9). Error bars are ± s.e.m.  
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Figure 5. Regulation of complexin by PKA phosphorylation. (a) Model of hypothesized regulation of complexin 
by PKA kinase activity to increase mini frequency at the synapse in response to high frequency stim ulation 
(tetanus). The model is based on Figure 1 and Yoshihara et al, Science 2005 and posits that complexin is 
phosphorylated by PKA in response to activation of the activity -regulated retrograde signaling pathway (middle 
panel), leading to decreased complexin function, possibly by lowering complexin's SNARE complex binding 
affinity (right panel). This in turn leads to enhanced mini frequency. ( b) A putative PKA phosphorylation site in 
complexin, T101 (* and orange box), is highly conserved throughout inv ertebrate species and is present in all 
complexin isoforms. (c) Complexin 7b is highly phosphorylated by PKA in vitro. GST-fused complexins were 
incubated with γ-
32
PATP with or without PKA. Both wild type complexin 7b and a complexin 7b T101A point 
mutant were phosphorylated by PKA in vitro, demonstrating that complexin 7b is phosphorylated by PKA but not 
at T101. GST alone controls (left lanes) were not phosphorylated, demonstrating that phosphorylation was 
specific to complexin. A positive control, CTC wi th the kinase CDK5 was successfully phosphorylated (right 
lanes). (d) Phosphomimetic (T101D) and phosphoincompetent (T101A) point mutants in complexin do not 
produce major changes in complexin's syntaxin binding affinity. GST -fused complexins were incubated with head 
extract that either had or had not been heat-shocked (hs) to distinguish between monomeric syntaxin binding 
and SNARE complex binding. A PKA inhibitor was added to some tubes to control for the possibility that PKA 
might phosphorylate complexin in the test tube after homogenizing. In all cases, no synaptobrevin binding was 
detected, indicating that the syntaxin binding observed reflects monomeric syntaxin binding and not SNARE 
complex binding. No syntaxin binding by the GST control is observed, indicating that the syntaxin binding is 
specific to complexin. A point mutant in the central alpha helix in complexin responsible for SNARE binding 
(R64H) does not bind syntaxin in this assay. Abbreviations: dm, Drosophila melanogaster ; dp, Drosophila 
pseudoobscura; ds, Drosophila simulans; dv, Drosophila virilis;  tc, Tribolium castaneum; am, Apis mellifera; lp, 
loligo pealei; hm, hirudo medicinalis.  
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Figure 6. S126 in complexin 7b is the major phosphorylation target of PKA in vitro. (a) A complexin 7b S126A 
point mutant is not phosphorylated by PKA in vitro, demonstrating that this residue is a target for 
phosphorylation by PKA. (b) Complexin 7a is only phosphorylated at a low level by PKA in vitro, suggesting that 
it is not a target for PKA kinase activity (c) Complexin is not phosphorylated by PKC in vitro. Mutating complexin 
7b T101 or the corresponding residue in complexin 7a, T102, to alanine does not remove the small  amount of 
PKC phosphorylation that does occur, indicating these residues are not targets of PKC in vitro. 
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Figure 7. Drosophila R64H mutants rescue the behavioral defect of complexin null mutants, suggesting that 
R64H retains some SNARE binding activity. (a) Alignment of invertebrate and vertebrate complexins showing 
100% conservation of R64 (R59 in mammalian complexins). R64 is located in the central alpha helix responsible 
for binding to the SNARE complex (purple bar). Green bar: accessory alpha helix. Red bar: fragment of complexin 
crystallized in Chen et al, Neuron 2002. (b) Close-up view showing R64 in complexin (purple) hydrogen bonding 
(green dashes) with N57 in syntaxin (yellow). Synaptobrevin is shown in blue and SNAP-25 is not pictured for the 
sake of clarity. (c) Western blot showing transgenic complexin expression in a wild type complexin 7b line and 
two independent complexin 7b R64H lines (3A and 2C). Expression is co mpared to a driver alone control (C155) 
and a precise excision  control. (d) Climbing assays demonstrate that R64H point mutants partially rescue the 
motor defect of complexin  null mutants. For rescue, transgenic complexin constructs were expressed pan -
neuronally in a complexin null mutant background. Wild type complexin 7b rescues the phenotype almost 
completely (7b rescue), although there is still a significant difference in climbing time between precise excision  
and 7b rescue. The R64H rescues took three times longer on average to climb the vial, but still rescued the null 
phenotype for the most part. Data used in the analysis include: Precise excision (***** = P < 0.0000005, 
Climbing time = 2.0 ± 0.174 sec., n = 12); cpx (w;cpx
SH1
/cpx
SH1
) (**** = P< 0.000005, Climbing time = 405.14 sec. 
± 97.8 sec., n = 7); 7b rescue (C155,UAS-cpx7b; cpx
SH1
/cpx
SH1
) (Climbing time = 5.43 ± 0.58 sec., n = 14); R64H3A 
rescue (C155; UAS-cpx7b R64H3A,cpx
SH1
/cpx
SH1
) (** = P< 0. 005, Climbing time = 14.33 sec. ± 0.667 sec., n = 3 ); 
R64H2C rescue (C155; UAS-cpx7b R64H2C/+;cpx
SH1
/cpx
SH1
) (** = P< 0. 005, Climbing time = 14.83 sec. ± 3.40 sec., 
n = 6). Error bars are ± s.e.m. All P values are relative to 7b rescue. Abbreviations: dm, Drosophila melanogaster ; 
ds, Drosophila simulans; tc, Tribolium castaneum; am, Apis mellifera; m, mouse; r, rat; h, human; nj, Narke 
japonica; xl, Xenopus laevis. 
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Figure 8. Summary of synaptotagmin and complexin mutant alleles used to test the two proposed models of 
complexin's function. (a) Two models of complexin's fusion clamp function at the synapse. In model 1 (left 
panel), complexin (red rectangle) prevents vesicle fusion by blocking full SNARE zippering. After calc ium influx 
synaptotagmin (blue line) removes complexin from the SNARE complex and triggers vesicle fusion. In model 2 
(right panel), complexin blocks fusion by preventing synaptotagmin from triggering release prior to calcium 
influx. After calcium influx, synaptotagmin removes complexin from the SNARE complex and triggers fusion. The 
two different models are not necessarily mutually exclusive and may be distinguished by an electrophysiological 
analysis of synaptotagmin 1; complexin  double mutants. (b) Summary table indicating genotypes of double 
mutant lines, what types of alleles are present in each strain, and the resulting lethality phenotype, if 
applicable. (c) Illustration of the domain structures of the N13, AD4, AD1, and AD3 mutant alleles of 
synaptotagmin 1. Adapted from DiAntonio et al, Neuron 1994 and Littleton et al PNAS 1994. 
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Figure 9. A synaptotagmin; complexin  double mutant suppresses the elevated mini frequency phenotype seen 
in complexin single mutants.  (a) Images of precise excision, cpx
SH1
, and syt
N13
/syt1
AD4
; cpx
SH1
/cpx
SH1
 NMJs 
stained with antisera against dlg (green) and complexin (red). Although the double mutant synapse is 
photobleached, it does not show any complexin staining. (b) Sample traces showing evoked responses (left 
panel) and paired pulse facilitation (right panel) from the double mutant in 0.2 mM extracellular calcium. 
Evoked responses show only asynchronous release, typical of synaptotagmin null mutants. Paired-pulse 
facilitation is enhanced in the double mutant, again typical of a synaptotagmin null mutant. Based on this 
evidence and the stainings in panel a, we concluded that this larva was in fact a double mutant. ( c) Sample 
traces (left panel) and quantification (right panel) of minis in a precise excision control, complexin  null mutant, 
and syt 1; cpx double mutant. Recordings were taken in 0.2 mM extracellular calcium. Arrows point to individual 
minis. Quantification of mini frequency in syt 1 mutants (syt
N13
/syt1
AD4
) is also shown in the right panel. Mini 
frequency in the double mutant is 1/10
th
 that of complexin mutants (** = P < 0.0001). The double mutant mini 
frequency is significantly elevated compared to both the precise excision control and syt 1 single mutants (** = P 
< .0001). Data used in the analysis include: Control (Mini Frequency (MF)=3.14±0.3 Hz; n=18); cpx
SH1
 
(MF=67.0±4.8 Hz; n=27); syt 1; cpx (MF=6.57±0.44 Hz, n=7); syt 1 (MF=3.98±0.35 Hz, n=9). Error bars are ± s.e.m.  
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Figure 10. Summary of EMS mutagenesis screen for loss of function alleles of complexin. (a) Diagram of the 
screen. Male Canton S adults were fed EMS and crossed to Tm3Sb,Ser/Tm6,  a line containing two 3
rd
 
chromosome balancers. Individual males or vi rgin female progeny with the Sb and Ser dominant markers 
(CS*/Tm3Sb,Ser) were crossed to cpx
SH1
/Tm3Sb. Chromosomes that failed to complement cpx
SH1 
were recovered 
to establish CS*/Tm3Sb strains (brother/sister matings).  Individual strains were recrossed to cpx
SH1 
to confirm 
non-complementation and were then analyzed by Western blotting and sequencing. ( b) Table showing available 
information about mutants recovered from the screen. Line #572 contains a small deletion in the complexin 
coding sequence resulting in a truncated form of the protein. Line #2016 does not express complexin and 
therefore represents a novel null allele of complexin. Sequencing of line #570 has so far not shown any mutation 
in the complexin coding sequence, but the 570 phenotype is remiscent of the complexin  null phenotype and 
suggests 570 may contain a loss of function allele of complexin.   
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Figure 11. Analysis of mutants generated by non-complementation screening for novel complexin  alleles. (a) 
Western blots showing complexin expression in three mutant lines, 570, 572, and 2016. 570 has wild type 
expression. 572 has reduced complexin expression and expresses complexin with a lower molecular weight than 
wild type, suggesting a truncated protein. 2016 does not express complexin. ( b) Mapping PCRs showing products 
1 through 6 are polymerized from 2016/cpx
SH1
 gDNA. This mapping PCR is the same used to map the deletion in 
cpx
SH1
. cpx
SH1
 contains a deletion spanning products two through four, which covers almost all the coding 
sequence of complexin. Thus, line #2016 does not contain a large deletion in the coding sequence of complexin. 
(c) Alignment of wild type complexin 7a and the sequence of complexin expressed by line #572. The mutant 
protein has point mutations at positions 110 to 114, and is truncated by 28 residues at the C terminus. ( d) 
Immunohistochemistry showing decreased expression of complexin in line #572 NMJs. Staining was carried out 
using antiseria against dlg (green) and complexin (cpx, red). Imaging of the 572 NMJ using higher laser power 
shows that the remaining complexin is localized in puncta at the synapse instead of being di ffusely distributed 
as wild type complexin is. Thus, line #572 contains a hypomorphic allele of complexin. (d) Sample traces and 
quantification of mini frequency in control (precise excision), cpx (cpx
SH1
/cpx
SH1
), and 572 (572/DfED5021) 
larvae. Line number 572 has an elevated mini frequency similar to that of complexin null mutants (** = P < 
0.0001). Data used in the analysis include: Control (Mini Frequency (MF)=3.14±0.3 Hz; n=18); cpx
SH1
 
(MF=66.9±4.8 Hz; n=27); 572/Df (MF=79.75±2.69, n=6). Error bars are ± s.e.m. 
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Summary and Conclusions:  Complexin’s Role as a Vesicle Fusion Clamp 
Complexin Functions as a Vesicle Fusion Clamp in Synaptic Vesicle Exocytosis 
Synaptic vesicle exocytosis occurs within 200 µsec of calcium influx and thus is the most rapid 
and exquisitely controlled vesicle fusion reaction known (Llinas, Steinberg et al. 1981; Cope and 
Mendell 1982).  The synaptic vesicle exocytosis reaction occurs via the same SNARE-driven 
mechanism as constitutive intracellular vesicle fusion reactions that occur on much slower 
timescales (Bennett and Scheller 1993).  Animals have therefore developed a number of neuron-
specific regulatory proteins that adapt vesicle fusion to the highly specialized process observed at 
synapses.   
 Because vesicle fusion is constitutive in most cellular fusion reactions but calcium-
regulated and synchronous in the nervous system, it has long been hypothesized that a vesicle 
fusion clamp functions at the synapse to synchronize fusion and maintain vesicles in a fusion-
ready state by preventing fusion until calcium influx occurs (Bennett and Scheller 1993; Popov 
and Poo 1993; Sollner, Whiteheart et al. 1993).  However, the identity of the vesicle fusion 
clamp has remained elusive.  Several groups have proposed that complexin functions as a vesicle 
fusion clamp based on X-Ray crystallography data (Bracher, Kadlec et al. 2002) and in vitro 
fusion assays (Giraudo, Eng et al. 2006; Schaub, Lu et al. 2006), but this idea was not supported 
by electrophysiology in mouse complexin 1/2 double knockouts (Reim, Mansour et al. 2001) or 
1/2/3 triple knockouts (Xue, Stradomska et al. 2008).   
These electrophysiology data have several caveats.  The in vitro recordings were done in 
the hippocampal neuron micro –island culture system, in which recordings are taken from 
autapses that have a highly variable number of synaptic contacts ranging over several orders of 
magnitude (Reim, Mansour et al. 2001; Xue, Stradomska et al. 2008).  In the case of 
synaptotagmin 1, this has resulted in missing an enhanced mini frequency phenotype in mouse 
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knockouts, in which it was recently revealed from recordings from cortical cultures that there is 
an increase in mini frequency (Pang, Sun et al. 2006) despite early reports from hippocampal 
autaptic cultures that no such enhancement in mini frequency existed (Geppert, Goda et al. 
1994).  An enhancement in mini frequency had been reported from Drosophila synaptotagmin 
knockouts earlier (Littleton, Stern et al. 1993; Broadie, Bellen et al. 1994; DiAntonio and 
Schwarz 1994), but it was discounted because the enhanced mini frequency phenotype was not 
observed in mammals. 
The third-instar larval NMJ in Drosophila offers the opportunity to observe complexin 
function at mature synapses with a stereotypical pattern of innervation.  We therefore generated 
the first complete complexin knockout in any organism.  Using recordings from Drosophila 
third-instar larval neuromuscular junctions, we have demonstrated that complexin knockouts 
display a highly elevated spontaneous release frequency at least 20 times greater than controls.  
These release events do not require calcium influx into the nerve terminal, as they persist in 0 
mM extracellular calcium.  This phenotype is exactly what would be expected from knockout of 
the vesicle fusion clamp for neurotransmitter release, and it is therefore highly probable that 
complexin functions as a vesicle fusion clamp in vivo.  One argument that could be made is that 
mammalian and Drosophila complexins serve different functions at the synapse, thus accounting 
for the differences in electrophysiology data.  However, recent preliminary data indicate that 
mammalian complexins rescue the enhanced mini frequency phenotype in Drosophila complexin 
knockouts, although confirmation of this result requires further analysis and quantification 
(personal communication, Richard Cho).  This information indicates that mammalian complexins 
serve the same in vivo function as Drosophila complexins, though it does not discount the 
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possibility that mammalian complexins have evolved new functions not found in the fly 
homolog.   
Complexin maintains the readily releasable pool of vesicles at the synapse 
Evoked potentials in complexin mutants were found to have normal amplitudes on average at low 
extracellular calcium concentrations but lower amplitudes at high extracellular calcium 
concentrations of 0.4 and 1.0 mM.  This suggests that mutant synapses have a defect in the size 
of vesicle population available for evoked responses.  Using electron microscopy to examine the 
ultrastructure of complexin mutant synapses, we found no significant change in the number of 
vesicles in the synapse or the number of docked vesicles at active zones.  The only difference 
between complexin mutant synapses and wild type synapses found was an increased number of 
cisternal structures, which result from bulk endocytosis and are synaptic vesicle precursors 
(Koenig and Ikeda 1989).  This suggests that increased bulk endocytosis is one mechanism by 
which complexin mutants maintain the vesicle population at the synapse despite the constant 
high rate of exocytosis.  Synaptic vesicle recycling through endocytic intermediates such as 
cisternae is thought to be a slow process requiring several minutes (Richards, Guatimosim et al. 
2000) that is responsible for maintaining the reserve pool, so the enhancement in the number of 
cisternae may indicate increased mobilization of vesicles from the reserve pool in complexin 
mutants.   
 Ultrastructural analysis did not reveal a depletion of vesicles that would explain the 
reduced EJP amplitude, so we performed high frequency stimulation under voltage clamp at the 
NMJ to determine whether the increase in mini frequency in complexin mutants results in a 
depletion of the readily releasable pool of vesicles (RRP).  At wild type and complexin 
overexpression synapses, high frequency stimulation at 2.0 mM extracellular calcium results in 
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rapid depression as the readily releasable pool of vesicles is depleted, followed by a sustained 
phase in which the evoked response is maintained at a constant but lower amplitude, reflecting 
rapid recycling at the synapse.  In complexin mutants, the depression phase of high frequency 
stimulation is eliminated because there is a lower amplitude initial response and only the second 
phase of sustained, lower evoked responses remains, indicating that the readily releasable pool of 
vesicles is severely depleted or eliminated, while recycling mechanisms remain intact.  Thus, 
complexin is required for maintenance of the readily releasable pool of vesicles, and in the 
absence of complexin, vesicles release once they are primed. 
Complexin specifically regulates synchronous release 
Evoked responses consist of two kinetically distinct phases of release.  Synchronous release is 
driven by the calcium sensor synaptotagmin 1 and is defined by rapid rise and fall times due to 
synchronous release of vesicles.  Asynchronous release is defined by a slower response and a 
long sustained phase of asynchronous vesicle fusion driven by an unknown calcium sensor.  A 
comparison of evoked responses normalized to the number of release sites from wild type, 
complexin mutant, and complexin overexpression flies showed that complexin null mutants have 
no deficiency in asynchronous release but decreased synchronous release.  Overexpression of 
complexin increases the amplitude of evoked responses while decreasing the duration of the 
asynchronous response.  This indicates that by overexpressing complexin, vesicles are more 
likely to fuse during the synchronous release phase.  Given that complexin is required for 
maintenance of the readily releasable pool of vesicles, it is possible that complexin 
overexpression pushes vesicles into the RRP, decreasing the asynchronous release phase and 
increasing synchronous release.  This hypothesis supposes that asynchronous release does not 
utilize the RRP.   
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An EMS screen to generate new alleles of complexin 
In order to further elucidate the mechanism by which complexin functions as a vesicle fusion 
clamp and to discover how its structure relates to that function, we screened for new loss-of-
function complexin alleles using EMS mutagenesis followed by a screen for non-
complementation of cpx
SH1
.  Sequencing of the mutants generated is not complete, but two new 
loss-of-function alleles have been confirmed.  Line #2016 does not express complexin, indicating 
that it contains a novel complexin null allele.  Line #572 contains a small deletion in complexin 
resulting in point mutations in the C terminus and truncation of the protein.  This truncated 
mutant complexin is expressed at low levels, and line #572 therefore contains a hypomorphic 
allele of complexin.  Neither of these confirmed complexin mutants are particularly useful for 
structure-function studies of complexin, but 572 will be useful for genetic studies of complexin 
function.  Continued sequencing of the remaining mutants holds promise for discovery of novel 
complexin alleles useful for structure-function studies. 
synaptotagmin 1; complexin double mutant analysis suggests complexin functions to 
prevent synaptotagmin 1 from triggering exocytosis prior to calcium influx 
In order to explain the complexin mutant phenotype of a >20-fold increase in mini frequency, we 
proposed two possible models for how complexin may function.  First, complexin may prevent 
fusion by preventing full zippering of the SNAREs.  Second, complexin may prevent fusion by 
inhibiting synaptotagmin from triggering release prior to calcium influx.  Some biochemical data 
suggests that complexin can arrest zippering of the SNAREs (Giraudo, Eng et al. 2006; Roggero, 
De Blas et al. 2007), supporting the first model.  On the other hand, it has been shown that under 
some experimental conditions synaptotagmin is capable of driving fusion asynchronously and at 
a low level in the absence of calcium (Mahal, Sequeira et al. 2002).  This information supports 
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the second model because a mechanism would be required in vivo to prevent synaptotagmin from 
triggering release in the absence of calcium at the synapse.   
In order to test our two models, we have made several lines to generate a variety of 
combinations of loss-of-function alleles of synaptotagmin 1 and complexin.  While the double 
mutant is lethal prior to the third-instar stage, we have recorded from one double null mutant 
escaper larva.  Recordings from this animal showed an almost complete suppression of the 
enhanced mini frequency phenotype of complexin single mutants, demonstrating that, for the 
most part, the minis in complexin mutants require synaptotagmin 1 function.  This suggests that 
the second model of complexin function may predominate at synapses.   
 If this result is verified by recordings from additional double mutants, it implies that 
complexin’s function as a vesicle fusion clamp is not so much to hold back vesicle fusion but 
instead to synchronize it.  Without the positive force of synaptotagmin in fusion, complexin 
mutants do not have a highly elevated mini frequency, suggesting that the neuronal SNARE 
complex itself cannot drive the high rate of fusion in complexin mutants.  Synchronous fusion 
must be tightly temporally regulated, requiring multiple layers of regulation, both positive and 
negative.  The double mutant data generated thus far imply that complexin’s function in the 
nervous system is to synchronize evoked fusion and harness the positive fusogenic force of 
synaptotagmin for evoked release.   
 Some evidence indicates that synaptotagmin itself may serve as a vesicle fusion clamp in 
vivo (Littleton, Stern et al. 1993; Broadie, Bellen et al. 1994; DiAntonio and Schwarz 1994; 
Littleton, Stern et al. 1994; Pang, Sun et al. 2006) and in vitro (Chicka, Hui et al. 2008), and that 
complexin can stimulate vesicle fusion in vitro (Yoon, Lu et al. 2008).  However, both the in 
vitro studies cited examined synaptotagmin or complexin function alone, and a detailed 
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understanding these proteins’ functions can be more clearly gained by study of their functional 
dynamics together in vesicle fusion since their mechanisms of action appear to be intimately 
connected.  Still, electrophysiology in synaptotagmin 1 knockout flies and mice reveals an 
enhanced mini frequency, suggesting a negative function for synaptotagmin in neurotransmitter 
release.  Thus, synaptotagmin’s function in neurotransmitter release may be more complex than 
the above model suggests.  Further analysis of double mutants with the range of synaptotagmin 
alleles available may reveal additional features of how synaptotagmin and complexin function 
together in neurotransmitter release. 
Future Directions: Analysis of Complexin’s Function at the Synapse 
Mammalian complexin rescue experiments 
Because of the differences between the electrophysiology results in Drosophila and those in 
mice, the chief controversy surrounding complexin will continue to be whether it functions as a 
vesicle fusion clamp or whether it functions in priming as a positive regulator of neurotransmitter 
release as proposed by those groups involved in electrophysiological analysis of the mouse 
complexin knockouts (Reim, Mansour et al. 2001; Xue, Stradomska et al. 2008).  In the end, it 
may be that complexin plays both positive and negative roles at the synapse and that it is more 
than simply a fusion clamp.  However, our data clearly demonstrate with a very dramatic 
knockout phenotype that one major role that complexin plays is a vesicle fusion clamp.  We must 
therefore take steps to determine whether the vesicle fusion clamp function is specific to 
invertebrates or flies or whether it also applies to mammalian complexins as well.  The 
biochemical data already support the idea that the clamping function of complexin is conserved 
across evolution, as both Drosophila complexin and mouse complexin 4 halt liposome fusion at 
a hemifused state (Schaub, Lu et al. 2006).  In general, homologous proteins of different species 
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serve similar functions in the cell, so it would be quite surprising if fly complexin and mouse 
complexin had different functions. 
 For our part, we need to determine whether mammalian complexins rescue the complexin 
knockout phenotype both behaviorally and electrophysiologically.  Early results indicate that 
both the behavior and mini frequency are partially rescued by mammalian complexins, but this 
result must be quantified and experimentally verified (personal communication, Richard Cho).    
A partial rescue is probably the best that can be achieved given the evolutionary distance 
between the two animals.  Once the amount of behavioral and electrophysiological rescue in 
these animals is quantified, it would be helpful to do SNARE binding assays testing how well 
mammalian complexins bind Drosophila SNARE complex.  It is likely that they would not bind 
as well as Drosophila complexin binds, which could easily explain why rescue is partial and not 
full.  Rescue of the Drosophila complexin phenotype by mammalian complexins would show 
that mouse complexin retains the ability to clamp fusion at Drosophila NMJs.   
 In mammalian complexins, it has been found that the N terminus of complexin 
suppresses a negative regulatory function of the accessory alpha helix (Xue, Reim et al. 2007) 
leading to the proposal that the accessory alpha helix mediates a clamping function and that this 
function is suppressed by the N terminus.  It was suggested that because the N terminus of 
complexin does not show much sequence conservation between Drosophila and mammals, the N 
terminus in Drosophila does not suppress the clamping function of the accessory alpha helix and 
this might explain why complexin seems to serve two different functions in the two species.  It 
seems more likely that the N terminus is not well conserved because it does not directly mediate 
binding to the SNARE complex, but nonetheless this hypothesis should be tested.  This could be 
accomplished by making chimeric proteins with different combinations of the fly and mouse N 
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termini, accessory alpha helix, and central alpha helix, followed by experiments to determine 
which chimeras rescue the enhanced mini frequency phenotype.  If, for example, the chimera 
combining the mouse N terminus with the fly accessory alpha helix, central alpha helix, and C 
terminus rescues the mini frequency phenotype, this would indicate that mouse and fly N termini 
have similar functions. 
Rescue of the complexin knockout with complexin mutants lacking SNARE binding 
Point mutants in complexin that cannot bind the SNARE complex are generally used in the 
literature as important negative controls to demonstrate that experimental results represent the in 
vivo function of complexin.  In this same line of reasoning, we attempted to rescue the complexin 
null phenotype with a point mutant that supposedly did not bind the SNARE complex.  To our 
surprise, this point mutant for the most part rescued the null behavioral phenotype.  It was later 
revealed that the R64H mutation leaves some SNARE complex binding intact, whereas several 
double point mutants in key amino acids of the binding domain completely eliminate SNARE 
binding by complexin (Xue, Reim et al. 2007).  We are therefore in the process of generating 
transgenic lines with a double mutant that abolishes SNARE binding.  Given that complexin 
requires SNARE binding for its activity, this mutant is predicted to be unable to rescue the 
behavioral and electrophysiological phenotypes of the fly complexin knockout. 
Detailed analysis of splice isoform expression in Drosophila 
There are at least five predicted splice isoforms encoding different protein sequences in 
Drosophila complexin: complexin 7a, complexin 7b, complexin A, complexin R, complexin L, 
and complexin J/K.  Two of these isoforms, 7a and 7b, are known to be expressed in Drosophila 
because they were successfully isolated from a cDNA library.  7a and 7b have distinct 
phosphorylation properties, indicating that in at least one case alternative splicing produces 
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complexins that could have distinct functions or regulation.  It is unknown whether the other four 
isoforms are expressed, but it is possible that they are found during specific developmental 
stages or in specific cell types.  As a first step, RT-PCR using splice-isoform-specific primers 
should be performed on embryos, larvae, and adult flies to determine whether the predicted 
transcripts are expressed in any of these stages.  For those isoforms that are shown to be 
expressed by RT-PCR, in situ hybridizations should also be performed using isoform-specific 
probes to determine whether they are expressed in specific tissues.  In addition, we are in the 
process of developing antibodies specific to complexins 7a and 7b, which will help to determine 
the stage and location of expression of these two splice isoforms. 
 Notably, several of the predicted splice isoforms (7a, A, R, L, J/K) differ in their N 
terminal sequences, and the N terminus of complexin is thought to regulate complexin’s 
clamping function (Xue, Reim et al. 2007). If these different isoforms are found to be expressed, 
it is possible that they may confer specific functional properties to complexin.  This could be 
tested by the degree of rescue of the enhanced mini frequency phenotype of complexin mutants 
by the different isoforms, as well as a more detailed analysis of depression during high frequency 
stimulation and effects on asynchronous release.  It is possible that this set of experiments could 
reveal novel mechanisms developed by Drosophila to subtly modulate complexin for cell-type 
specific or developmental-stage-specific function. 
synaptotagmin; complexin double mutant analysis 
Preliminary results from a syt 1;cpx double mutant suggest that the spontaneous release events 
observed in complexin single mutants are dependent on synaptotagmin, which would indicate 
that complexin’s function as a vesicle fusion clamp is partly to prevent synaptotagmin from 
triggering release prior to calcium influx.  In order to verify these results, additional double 
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mutants must be cultured to the third-instar stage.  While this has proved difficult with the three 
allele combinations we have attempted to culture so far, three additional combinations of 
synaptotagmin 1 and complexin alleles have been generated that we have not yet tried to culture 
to the third-instar stage.  The alleles include transgenic complexin and synaptotagmin RNAi 
expression constructs and synaptotagmin hypomorphs.  It is possible that one of these 
combinations will allow viability to the third-instar stage.  If not, one strategy to circumvent this 
impasse would be to drive RNAi constructs against both complexin and synaptotagmin in motor 
neurons and not pan-neuronally, potentially enhancing viability.  A second strategy would be to 
make a syt 1 null; cpx
572
 double mutant, which may enhance viability compared to the double 
null mutant combination.   
 In addition to generating double mutants in complexin and synaptotagmin, we have also 
begun studies to determine the effects of double overexpression of synaptotagmin and 
complexin.  While this approach is subject to more caveats than double mutant analysis because 
overexpression inherently involves non-physiological levels of protein expression, it is also more 
likely to produce meaningful results quickly.  We know that overexpression of complexin 
enhances the amplitude of the evoked response and decreases the duration of the asynchronous 
release phase, while overexpression of synaptotagmin has not been reported to have any 
physiological effects.  We have determined that complexin maintains the readily releasable pool 
and specifically regulates synchronous release, so a large overexpression of complexin may 
make synaptotagmin limiting for release of vesicles clamped by complexin.  If so, co-
overexpression of synaptotagmin 1 and complexin may result in a large increase in EJP 
amplitude greater than that observed when complexin alone is overexpressed.  This experiment 
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along with the double mutant analysis experiments has the potential to reveal new details of the 
mechanism of calcium-regulated synaptic vesicle exocytosis at the synapse. 
Summary and Conclusions: The Role of Minis in Synaptic Plasticity 
Complexin mutants display a severe synaptic overgrowth phenotype 
Minis have long been thought to represent background noise at the synapse, but recent evidence 
suggests that mini frequency is used at synapses for a variety of functions, including 
maintenance of dendritic spine density (McKinney, Capogna et al. 1999) and regulation of 
dendritic protein synthesis (Sutton, Wall et al. 2004).  At Drosophila NMJs, mini frequency is 
increased by over 100-fold in response to high frequency stimulation by a PKA-dependent 
retrograde signaling pathway that is required for normal synaptic growth (Yoshihara, Adolfsen et 
al. 2005).  In the complexin mutant we were able to observe the effects of a large increase in mini 
frequency on synaptic plasticity.  Based on the number of varicosities present at mutant and 
control synapses, this results in a large enhancement in synaptic growth at the NMJ.  We 
therefore hypothesized that increased mini frequency enhances synaptic plasticity and that 
complexin is the downstream target of PKA that is regulated to produce a 100-fold increase in 
mini frequency at the NMJ after high frequency stimulation.  Consistent with this idea, 
Drosophila complexin has several possible phosphorylation targets in its C terminus and mouse 
complexin is known to be phosphorylated both in vitro and in vivo (Hill, Callaghan et al. 2006; 
Shata, Saisu et al. 2007).  Mutating these phosphorylation sites and testing their ability to rescue 
the mini frequency enhancement and altered synaptic growth phenotypes should begin to reveal 
whether phosphorylation modulates this plasticity pathway. 
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Enhanced mini frequency in a syntaxin mutant results in synaptic overgrowth 
In order to test the idea that increased mini frequency drives synaptic plasticity at the NMJ, we 
utilized the syntaxin mutant syx
3-69
, the only other Drosophila mutant known to have an elevated 
mini frequency on the same scale as complexin mutants.  Like complexin mutants, syx
3-69 
larvae 
also display an increased number of varicosities at the NMJ.  This demonstrates that the synaptic 
overgrowth phenotype is not specific to complexin mutants but can be observed in a second 
mutant with a large enhancement in mini frequency.   
 Because of the enhanced mini frequency phenotype of syx
3-69 
we hypothesized that the 
point mutation in syx
3-69
, T254I, decreases complexin binding to the SNARE complex.  While in 
vitro complexin binding assays disproved this hypothesis, one other remote possibility that has 
not been tested is that syx
3-69
 has decreased complexin expression that causes the mini 
phenotype.  It is more likely that the enhanced mini frequency in syx
3-69
 is independent of 
complexin, but this possibility should be tested.  The syx
3-69
 mutant may in fact generate unstable 
SNARE complexes that are more likely to be fusogenic with or without complexin.  It will be 
interesting to test if complexin overexpression can suppress the increased mini frequency and the 
enhanced synaptic growth in the mutant. 
Complexin 7b residue S126 is the major phosphorylation target of PKA in vitro 
Our hypothesis that complexin is the target of PKA phosphorylation at the synapse to regulate 
mini frequency led us to search for a target residue in complexin that could be phosphorylated by 
PKA.  Because of sequence conservation and because it was highly predicted to be 
phosphorylated by PKA, the most likely candidate was T101, but in vitro phosphorylation assays 
strongly suggest this residue is not the target of PKA phosphorylation.  Instead, S126, a residue 
specific to complexin 7b, is highly phosphorylated by PKA in vitro.  Additionally, 
phosphoincompetent and phosphomimetic point mutations at T101 do not detectably change the 
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binding affinity of complexin for the SNARE complex.  Although binding affinity is not the only 
way that complexin function could be modulated, it is one obvious way, so there is no evidence 
from this experiment to suggest that T101 phosphorylation can modulate complexin function. 
 Judging by the fact that no ESTs support expression of exon 7b, complexin 7b expression 
may be restricted to a small subset of cell types or expressed at low abundance in all neurons.  If 
it is indeed complexin 7b that is specifically phosphorylated by PKA to regulate mini frequency, 
it may be that the retrograde signaling pathway induced by high frequency stimulation is not 
active throughout the nervous system, but instead is active at specific sites.  For example, it 
could occur specifically in neurons of the mushroom body for learning, or it could occur at 
specific developmental stages where synaptic growth is particularly pronounced.  The fact that 
complexin 7b appears to be the major isoform of complexin phosphorylated by PKA reinforces 
the importance of determining when and where complexin 7a and 7b are expressed. 
Future Directions: Regulation of Mini Frequency and Synaptic Plasticity by 
Complexin 
Generation of S126 point mutants to determine effects on SNARE binding and 
synaptic plasticity 
If complexin 7b S126 is the in vivo target of phosphorylation of PKA in the retrograde signaling 
pathway, then phosphomimetic and phosphoincompetent point mutants in S126 (S126D and 
S126A, respectively) would be predicted to have dramatic effects on the synaptic overgrowth 
phenotype of complexin null mutants.  Our hypothesis is that complexin is inactivated by 
phosphorylation, possibly by decreasing complexin’s SNARE complex binding affinity, so 
S126D mutants should not rescue the enhanced mini frequency of complexin knockouts and 
should not rescue synaptic overgrowth.  S126A would be predicted to rescue both the enhanced 
mini frequency and synaptic overgrowth phenotypes.  Additionally, overexpression of S126A 
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may produce synaptic undergrowth because, according to our hypothesis, it would never be 
inactivated by phosphorylation, thus suppressing activity-dependent increases in mini frequency 
during development of the NMJ.  All of these predictions can be tested by making transgenic 
complexin 7b S126A and S126D point mutants and determining the mean number of varicosities 
at NMJs of rescue and overexpression animals.  If a change is observed, in vitro SNARE binding 
assays should be performed on the point mutants to determine whether the mutations alter 
complexin’s SNARE binding affinity.  Also, given that complexin 7a is not phosphorylated by 
PKA in vitro, rescue of the complexin null mutant with complexin 7a may also produce synaptic 
undergrowth because complexin 7a should be unable to participate in the activity-dependent 
increase in mini frequency.  Finally, complexin 7a, complexin 7b, complexin 7b S126A, and 
complexin 7b S126D rescues should all be analyzed electrophysiologically to determine whether 
they can produce activity-dependent changes in mini frequency.  Based on our model, complexin 
7b rescues would be able to, while complexin 7a and complexin 7b S126A would not be able to.  
S126D rescues would have an increased mini frequency independent of neuronal activity. 
Double mutant analysis to determine whether complexin is downstream of PKA and 
synaptotagmin 4 in the retrograde signaling pathway 
A synaptotagmin 4 null allele, syt4
BA1
, suppresses activity-induced synaptic overgrowth observed 
in temperature-sensitive seizure mutants in Drosophila (personal communication, Cindy Barber).  
Thus, synaptotagmin 4 is required for synaptic plasticity driven by neuronal activity.  This is 
consistent with the following model of synaptic plasticity established by Yoshihara et al, 2005: 1. 
High frequency neuronal firing causes postsynaptic calcium influx through glutamate receptors. 
2. This calcium influx is sensed by synaptotagmin 4, triggering release of postsynaptic vesicles 
containing a retrograde signaling molecule.  3.  The retrograde signal is bound by receptors in the 
presynaptic terminal that activate a pathway responsible for synthesizing cAMP.  4. Increased 
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cAMP in the presynaptic terminal activates PKA, which acts on downstream effectors to increase 
mini frequency and induce synaptic growth.  
If complexin regulation by PKA and subsequent upregulation of mini frequency is the 
endpoint of this retrograde signaling pathway, then unlike the overgrowth observed in seizure 
mutants, the overgrowth phenotype of complexin mutants would not be suppressed by syt4
BA1
.  
The PKA loss-of-function mutant DC0
B3
 (Lane and Kalderon 1993) would also be predicted to 
be unable to suppress the overgrowth observed in complexin mutants.  Thus, two critical 
experiments are to make cpx
SH1
; syt4
BA1
 and cpx
SH1
; DC0
B3
 double mutants and determine 
whether the mean varicosity numbers at NMJs of these double mutants are significantly lower 
than cpx
SH1
 single mutants.  Because syx
3-69 
mutants also display enhanced mini frequency and 
enhanced synaptic growth, similar experiments should be performed on syx
3-69
; syt4
BA1
 and syx
3-
69
; DC0
B3
 double mutants. 
 The hebbian theory of synaptic plasticity states that repeated stimulation of a postsynaptic 
cell by an innervating axon produces a synapse-specific increase in synaptic efficacy (Hebb 
1949).  This synapse-specific plasticity is thought to require a retrograde signal from the 
postsynaptic to the presynaptic cell that acts locally to specifically strengthen the firing synapse.  
Induction of high mini frequency by regulation of complexin in response to a retrograde signal 
provides a mechanism to specifically mark a synapse for structural plasticity and enhanced 
synaptic efficacy.  Such a mechanism could be used during development as neuronal connections 
elaborate and strengthen or during learning and memory to specifically strengthen synapses for 
memory storage.  Thus, investigation of the role of complexin in regulating mini frequency and 
synaptic plasticity has the potential to help establish a novel function for minis at the synapse in 
synapse-specific plasticity, neuronal development, and learning and memory. 
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